
<html lang="en"     class="pb-page"  data-request-id="242c5332-b463-4fd3-bfcd-62c38b362d54"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c00107;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors" /></meta><meta name="dc.Creator" content="Olga  Balabon" /></meta><meta name="dc.Creator" content="Eleni  Pitta" /></meta><meta name="dc.Creator" content="Maciej K.  Rogacki" /></meta><meta name="dc.Creator" content="Eugenia  Meiler" /></meta><meta name="dc.Creator" content="Ruth  Casanueva" /></meta><meta name="dc.Creator" content="Laura  Guijarro" /></meta><meta name="dc.Creator" content="Sophie  Huss" /></meta><meta name="dc.Creator" content="Eva Maria  Lopez-Roman" /></meta><meta name="dc.Creator" content="Ángel  Santos-Villarejo" /></meta><meta name="dc.Creator" content="Koen  Augustyns" /></meta><meta name="dc.Creator" content="Lluis  Ballell" /></meta><meta name="dc.Creator" content="David Barros  Aguirre" /></meta><meta name="dc.Creator" content="Robert H.  Bates" /></meta><meta name="dc.Creator" content="Fraser  Cunningham" /></meta><meta name="dc.Creator" content="Monica  Cacho" /></meta><meta name="dc.Creator" content="Pieter  Van der Veken" /></meta><meta name="dc.Description" content="In search of novel drugs against tuberculosis, we previously discovered and profiled a novel hydantoin-based family that demonstrated highly promising in vitro potency against Mycobacterium. tuberc..." /></meta><meta name="Description" content="In search of novel drugs against tuberculosis, we previously discovered and profiled a novel hydantoin-based family that demonstrated highly promising in vitro potency against Mycobacterium. tuberc..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 28, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00107" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00107" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00107" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00107" /></link>
        
    
    

<title>Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00107" /></meta><meta property="og:title" content="Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0017.jpeg" /></meta><meta property="og:description" content="In search of novel drugs against tuberculosis, we previously discovered and profiled a novel hydantoin-based family that demonstrated highly promising in vitro potency against Mycobacterium. tuberculosis. The compounds were found to be noncovalent inhibitors of DprE1, a subunit of decaprenylphosphoryl-β-d-ribose-2′-epimerase. This protein, localized in the periplasmic space of the mycobacterial cell wall, was shown to be an essential and vulnerable antimycobacterial drug target. Here, we report the further SAR exploration of this chemical family through more than 80 new analogues. Among these, the most active representatives combined submicromolar cellular potency and nanomolar target affinity with balanced physicochemical properties and low human cytotoxicity. Moreover, we demonstrate in vivo activity in an acute Mtb infection model and provide further proof of DprE1 being the target of the hydantoins. Overall, the hydantoin family of DprE1 inhibitors represents a promising noncovalent lead series for the discovery of novel antituberculosis agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00107"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00107">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00107&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00107&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00107&amp;href=/doi/10.1021/acs.jmedchem.0c00107" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5367-5386</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00231" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00203" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-Ribose Oxidase (DprE1) Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Olga Balabon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Olga Balabon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</div><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Balabon">Olga Balabon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eleni Pitta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eleni Pitta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</div><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eleni++Pitta">Eleni Pitta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maciej K. Rogacki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maciej K. Rogacki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</div><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maciej+K.++Rogacki">Maciej K. Rogacki</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eugenia Meiler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eugenia Meiler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eugenia++Meiler">Eugenia Meiler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruth Casanueva</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruth Casanueva</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruth++Casanueva">Ruth Casanueva</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Guijarro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Guijarro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Guijarro">Laura Guijarro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sophie Huss</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sophie Huss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sophie++Huss">Sophie Huss</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eva Maria Lopez-Roman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eva Maria Lopez-Roman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eva+Maria++Lopez-Roman">Eva Maria Lopez-Roman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ángel Santos-Villarejo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ángel Santos-Villarejo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=%C3%81ngel++Santos-Villarejo">Ángel Santos-Villarejo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Koen Augustyns</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Koen Augustyns</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Koen++Augustyns">Koen Augustyns</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5203-4339" title="Orcid link">http://orcid.org/0000-0002-5203-4339</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lluis Ballell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lluis Ballell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lluis++Ballell">Lluis Ballell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Barros Aguirre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Barros Aguirre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+Barros++Aguirre">David Barros Aguirre</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4099-0438" title="Orcid link">http://orcid.org/0000-0002-4099-0438</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert H. Bates</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert H. Bates</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+H.++Bates">Robert H. Bates</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fraser Cunningham</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fraser Cunningham</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fraser++Cunningham">Fraser Cunningham</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Monica Cacho</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Monica Cacho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#2a47454443494b044304494b4942456a4d594104494547"><span class="__cf_email__" data-cfemail="462b29282f2527682f682527252e290621352d6825292b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Cacho">Monica Cacho</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6270-5370" title="Orcid link">http://orcid.org/0000-0001-6270-5370</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Pieter Van der Veken</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pieter Van der Veken</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#fe8e979b8a9b8cd0889f909a9b8c889b959b90be8b9f908a899b8c8e9b90d09c9b"><span class="__cf_email__" data-cfemail="bacad3dfcedfc894ccdbd4dedfc8ccdfd1dfd4facfdbd4cecddfc8cadfd494d8df">[email protected]</span></a>. Phone: +323265 27 08.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pieter++Van+der+Veken">Pieter Van der Veken</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1208-3571" title="Orcid link">http://orcid.org/0000-0003-1208-3571</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00107&amp;href=/doi/10.1021%2Facs.jmedchem.0c00107" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5367–5386</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 28, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 February 2020</li><li><span class="item_label"><b>Published</b> online</span>28 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 May 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00107" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00107</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5367%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DOlga%2BBalabon%252C%2BEleni%2BPitta%252C%2BMaciej%2BK.%2BRogacki%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D10%26contentID%3Dacs.jmedchem.0c00107%26title%3DOptimization%2Bof%2BHydantoins%2Bas%2BPotent%2BAntimycobacterial%2BDecaprenylphosphoryl-%25CE%25B2-d-Ribose%2BOxidase%2B%2528DprE1%2529%2BInhibitors%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5386%26publicationDate%3DMay%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00107"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">968</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00107" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Balabon&quot;},{&quot;first_name&quot;:&quot;Eleni&quot;,&quot;last_name&quot;:&quot;Pitta&quot;},{&quot;first_name&quot;:&quot;Maciej&quot;,&quot;last_name&quot;:&quot;K. Rogacki&quot;},{&quot;first_name&quot;:&quot;Eugenia&quot;,&quot;last_name&quot;:&quot;Meiler&quot;},{&quot;first_name&quot;:&quot;Ruth&quot;,&quot;last_name&quot;:&quot;Casanueva&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Guijarro&quot;},{&quot;first_name&quot;:&quot;Sophie&quot;,&quot;last_name&quot;:&quot;Huss&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Maria Lopez-Roman&quot;},{&quot;first_name&quot;:&quot;Ángel&quot;,&quot;last_name&quot;:&quot;Santos-Villarejo&quot;},{&quot;first_name&quot;:&quot;Koen&quot;,&quot;last_name&quot;:&quot;Augustyns&quot;},{&quot;first_name&quot;:&quot;Lluis&quot;,&quot;last_name&quot;:&quot;Ballell&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Barros Aguirre&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;H. Bates&quot;},{&quot;first_name&quot;:&quot;Fraser&quot;,&quot;last_name&quot;:&quot;Cunningham&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Cacho&quot;},{&quot;first_name&quot;:&quot;Pieter&quot;,&quot;last_name&quot;:&quot;Van der Veken&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;5367-5386&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00107&quot;},&quot;abstract&quot;:&quot;In search of novel drugs against tuberculosis, we previously discovered and profiled a novel hydantoin-based family that demonstrated highly promising in vitro potency against Mycobacterium. tuberculosis. The compounds were found to be noncovalent inhibitors of DprE1, a subunit of decaprenylphosphoryl-β-d-ribose-2′-epimerase. This protein, localized in the periplasmic space of the mycobacterial cell wall, was shown to be an essential and vulnerable antimycobacterial drug target. Here, we report the further SAR exploration of this chemical family through more than 80 new analogues. Among these, the most active representatives combined submicromolar cellular potency and nanomolar target affinity with balanced physicochemical properties and low human cytotoxicity. Moreover, we demonstrate in vivo activity in an acute Mtb infection model and provide further proof of DprE1 being the target of the hydantoins. Overall, the hydantoin family of DprE1 inhibitors represents a promising noncovalent lead series for the di&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00107&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00107" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00107&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00107" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00107&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00107" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00107&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00107&amp;href=/doi/10.1021/acs.jmedchem.0c00107" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00107" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00107" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00107%26sid%3Dliteratum%253Aachs%26pmid%3D32342688%26genre%3Darticle%26aulast%3DBalabon%26date%3D2020%26atitle%3DOptimization%2Bof%2BHydantoins%2Bas%2BPotent%2BAntimycobacterial%2BDecaprenylphosphoryl-%25CE%25B2-d-Ribose%2BOxidase%2B%2528DprE1%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D10%26spage%3D5367%26epage%3D5386%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/jmcmar.2020.63.issue-10/20200528/jmcmar.2020.63.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In search of novel drugs against tuberculosis, we previously discovered and profiled a novel hydantoin-based family that demonstrated highly promising in vitro potency against <i>Mycobacterium. tuberculosis</i>. The compounds were found to be noncovalent inhibitors of DprE1, a subunit of decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose-2′-epimerase. This protein, localized in the periplasmic space of the mycobacterial cell wall, was shown to be an essential and vulnerable antimycobacterial drug target. Here, we report the further SAR exploration of this chemical family through more than 80 new analogues. Among these, the most active representatives combined submicromolar cellular potency and nanomolar target affinity with balanced physicochemical properties and low human cytotoxicity. Moreover, we demonstrate in vivo activity in an acute <i>Mtb</i> infection model and provide further proof of DprE1 being the target of the hydantoins. Overall, the hydantoin family of DprE1 inhibitors represents a promising noncovalent lead series for the discovery of novel antituberculosis agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tuberculosis (TB), a disease primarily caused by the pathogen <i>Mycobacterium tuberculosis</i>, is among the top 10 causes of death worldwide while remaining the leading cause of death from a single infectious agent, as reported by the World Health Organization (WHO).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Around 10.0 million people developed TB globally in 2018, with an estimated 1.3 million TB deaths among HIV-negative people and an additional 300,000 deaths among HIV-positive individuals. The drugs in the current first-choice treatment regimen were identified over 60 years ago, and patients are required to take medicines for at least 6 months, even in the case of drug-sensitive infections. Pronounced side effects coupled with extended treatment regimens lead to low patient compliance and have increased the emergence of drug-resistant Mycobacteria strains. In fact, in 2018 alone, around half a million people developed TB that was resistant to rifampicin (RR-TB), the most effective first-line anti-TB drug. Moreover, 78% of these cases involve multidrug-resistant tuberculosis (MDR-TB) with resistance to at least rifampicin and isoniazid.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Therefore, the development of new antimycobacterial therapeutics, preferably with novel modes of action, remains an urgent need.</div><div class="NLM_p">DprE1, a subunit of decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose-2′-epimerase, is a periplasmic protein involved in the mycobacterial cell wall biosynthesis that was shown to be a new highly promising drug target for antimycobacterial research.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> The initial recognition was brought by the benzothiazinone series (BTZ), a DprE1 covalent inhibitor class.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4−7)</a> Later on, several research groups provided insight into the DprE1 inhibitor binding mode as well as reported numerous structurally diverse compound series with either an irreversible (covalent) or reversible noncovalent binding, validating DprE1 as an attractive antimycobacterial target.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17">(8−17)</a> All relevant DprE1-inhibitor literature to date is summarized in a recently published comprehensive review.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Benzothiazinones BTZ043, azaindole AZ7371, and PBTZ-169/macozinone are the most advanced DprE1 inhibitors that have recently entered the clinical development phase (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected reported DprE1 inhibitors.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><sup>a</sup>AZ DprE1 inhibitor benchmark, compound <b>9</b> in ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inspired by the encouraging antimycobacterial properties of the described compounds, GSK performed a target-based high-throughput screening (HTS) campaign in search of novel DprE1inhibitors (paper under preparation). This led to the identification of the hydantoin-derived compound <b>1</b> and its several analogues (<b>2</b>–<b>4</b>) as promising hits. Recently, we reported the biological profiling and initial optimization efforts on hit <b>1</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Several potent representatives with ring A modifications obtained during this study showed promising in vitro enzyme inhibition (pIC<sub>50</sub> 7–7.4) together with low micromolar whole-cell MIC values and no cytotoxicity at 100 μM in a HepG2 assay (representative compounds <b>1–4</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Most potent representatives (<b>1–4</b>) published previously by our team.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The previous findings indicate that both the hydantoin core and the acetyl linker are crucial for the potency of the series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Activity, Cytotoxicity, and Physicochemical Properties of Selected Representatives <b>1–4</b> from Our Previous Report<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0010.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of DprE1 enzyme.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">MIC against <i>M. tuberculosis</i> (H37Rv), reference: isoniazid, MIC = 1.8 μM.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Cytotoxicity against HepG2 human Caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Kinetic aqueous solubility (CLND).</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Lipophilicity, chromlogD at pH = 7.4.</p></div></div><div></div></div><div class="NLM_p">Earlier, we reported that the hydantoin core functions not only as a scaffold that ensures proper spatial orientation of the peripheral moieties but also appears to take part in protein interactions, crucial for the series potency.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Likewise, several modifications of the acetyl linker in these molecules led to significant potency loss, indicating its importance. In addition, several analogues of <b>1</b> and <b>4</b> with varied substitutions around ring B were evaluated. Several modifications were observed to be permitted in that part of the molecule, although none of the analogues showed significant potency improvement.</div><div class="NLM_p last">Overall, the obtained results suggested that the SAR around rings A and B should be further explored to optimize the potency and properties of the series. Finally, we also demonstrated in the previous publication that only the <i>R</i>-enantiomer of the hit hydantoin <b>1</b> contributes to both enzymatic and whole-cell activity. However, the assays in this manuscript were generally run with racemates for procedural simplicity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry and SAR</h3><div class="NLM_p">We reported earlier that replacing the ring A cyano moiety in compound <b>1</b> with different polar substituents seemed to be favorable for retaining antimycobacterial potency in the phenotypic MIC assay.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Therefore, we first focused on the introduction of additional polar groups on ring A, such as a carboxylic acid <b>17</b>, an ester <b>10</b> and amide function <b>16</b>, a urea moiety <b>11</b>, and several polar heterocycles, including a fused bicyclic analogue of the benzene ring <b>14</b> (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Similar to the approach reported earlier, most analogues with ring A substitution modifications (<b>10–14</b>) were synthesized starting from ketones according to a modified Bucherer–Berg hydantoin cyclization,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> followed by an alkylation as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The ketones were either available commercially or prepared based on standard literature procedures (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_001.pdf" class="ext-link">Supporting Information</a>). The selective alkylation on the N<sub>3</sub>-nitrogen was previously confirmed by full NMR assignment and crystal structure analysis.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Approach toward Analogues with a Modified <i>Para</i>-Substitution Pattern on Ring A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, EtOH-H<sub>2</sub>O, microwave irradiation 70 °C or heating 55 °C, 7–17 h; (b) K<sub>2</sub>CO<sub>3</sub>, DMF or acetone, rt, 24–48 h.</p><p class="last">*The main isolated reaction product was the hydantoin sodium salt <b>8a</b> used for the alkylation.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Approach toward Analogues <b>16–18</b> with a Modified <i>Para</i>-Substitution Pattern on Ring A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>4</sub>OH, 90 °C, overnight; (b) K<sub>2</sub>CO<sub>3</sub>, DMF or acetone, rt, 24 h; (c) LiOH, THF, H<sub>2</sub>O, rt, 1 h; (d) NaN<sub>3</sub>, ZnCl<sub>2</sub>, <i>n</i>-PrOH, 95 °C, 24 h.</p></p></figure><div class="NLM_p">Intermediate <b>15</b>, bearing an amide group on ring A, was prepared by reaction of <b>5</b> with ammonia, and subsequent alkylation of the hydantoin ring resulted in final product <b>16</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). In the case of analogues <b>17</b> and <b>18</b>, the substituents on ring A seemed to be reactive in the last alkylation step. Therefore, the non-substituted acid derivative <b>17</b> was prepared by base-promoted hydrolysis of the corresponding ester <b>10</b>. Lastly, the tetrazole ring in <b>18</b> was formed by zinc-promoted [3 + 2] cycloaddition of the nitrile in <b>1</b> with sodium azide.</div><div class="NLM_p">Inspired by methylsulfonamide <b>2</b>’s overall activity profile (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), we decided to prepare a small subseries of compounds covering analogues that are linked to ring A via either the N or S atom of the sulfonamide functionality (compounds <b>20–22</b> and <b>30–36</b>, respectively, <a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The synthetic approach shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> was anticipated to be unfit for the preparation of the <i>N</i>-linked analogues. In essence, undesired alkylation of the acidic sulfonamide nitrogen was expected to occur during the final synthetic step (N-alkylation of the hydantoin moiety). Therefore, sulfonamides <b>20–22</b> were prepared in moderate yields from bromo-substituted precursor <b>19</b> following a literature procedure for palladium-catalyzed amidation of aryl rings (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Approach to Analogues with N-Linked Sulfonamide Substituents on Ring A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) [PdCl(allyl)]<sub>2,</sub> t-BuXPhos, K<sub>2</sub>CO<sub>3</sub>, 2-MeTHF, 80 °C, 2 h.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Approach to Analogues with S-Linked Sulfonamide Substituents on Ring A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) amine·HCl, Et<sub>3</sub>N, or amine with no base, DCM, rt, 1 h; (b) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, EtOH-H<sub>2</sub>O, 70 °C (MW or heating), 7–17 h; (c) K<sub>2</sub>CO<sub>3</sub>, acetone, rt, 24–48 h.</p></p></figure><div class="NLM_p">Since no literature procedures were available for the late-stage introduction of S-linked sulfonamide groups, we decided to return to the strategy shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and evaluate its potential for the synthesis of analogues <b>30–36</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The sulfonamide moiety was first installed by the reaction of 4-acetylbenzenesulfonyl chloride with different amines followed by applying the modified Bucherer–Berg protocol to obtain intermediates <b>23</b>–<b>29</b>. Alkylation of the hydantoin ring provided the desired products <b>30</b>–<b>36</b> in moderate to high yields. Remarkably, no alkylation of the sulfonamide moiety was observed under these conditions.</div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> summarizes the biological and biophysical evaluation results for the compounds that carry a polar A-ring substituent. Overall, good solubility and no detectable cytotoxicity in the HepG2 assay (IC<sub>50</sub> > 100 μM) were observed.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Activity, Cytotoxicity, and Physicochemical Properties of the Compounds with Varying Substituents at the 4-Position of Ring A</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0011.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of DprE1 enzyme.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">MIC against <i>M. tuberculosis</i> (H37Rv), reference: isoniazid, MIC = 1.8 μM.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Cytotoxicity against HepG2 human Caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Kinetic aqueous solubility (CLND).</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Lipophilicity, chromlogD at pH = 7.4.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Solubility determination in 5% DMSO pH 7.4 phosphate-buffered saline and quantification of DMSO stock concentration using a charged aerosol detector (CAD).</p></div></div><div></div></div><div class="NLM_p">Most polar substituents in the first subset of compounds (<b>10–14</b> and <b>16–18</b>) nonetheless led to the loss of both DprE1 inhibitory potency and whole-cell activity compared to hit <b>1</b>. Notable exceptions are methyl ester <b>10</b> and fused bicyclic analogue <b>14</b>, both retaining the overall activity profile of <b>1.</b> Surprisingly, tetrazole <b>18</b> that is closely related to a previously reported tetrazole <b>3</b> did not retain activity.</div><div class="NLM_p">The N-linked sulfonamides <b>20–22</b> also demonstrated a significant reduction in DprE1 affinity and antimycobacterial potency compared to the previously reported analogue <b>2</b>, indicating that further structural diversification in this compound subset was not promising. Conversely, the presence of an inverted, S-linked sulfonamide group in <b>30</b> resulted in potent DprE1 inhibition (pIC<sub>50</sub> = 7.3) and significant improvement of the whole-cell activity (MIC = 0.6 μM). The introduction of additional N-substituents on <b>30</b> (as in compounds <b>31–36</b>) was again found to be detrimental to cellular and DprE1 inhibitory potency. Taken together, it is likely that steric constraints in DprE1’s active sites are responsible for the observed trends in affinity and activity in the N- and S-linked sulfonamide series. Since the S-linked sulfonamide derivative <b>30</b> was the most potent analogue identified at this point and the first submicromolar DprE1 inhibitor encountered in the hydantoin family, the aminosulfonyl group of <b>30</b> was selected as a recurrent structural feature in the compound series that was subsequently prepared. Additionally, we decided to include some analogues bearing hit <b>1</b>’s 4-cyano substituted ring A for activity comparison. The substitution pattern on aryl ring B was thoroughly investigated by means of analogues <b>38</b>–<b>71</b>. For the preparation of these molecules, the same synthetic strategy was applied again (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Alkylation of hydantoin precursors <b>23</b> or <b>37</b> with an appropriately substituted haloacetophenone derivative provided the desired products <b>38</b>–<b>71</b> in high to moderate yields.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Scheme of the Synthesis of Analogues with Variable Substitution on Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone or DMF, rt, 24–48 h.</p><p class="last">*Compound <b>50</b> was formed by hydrolysis of <b>49</b> in LiOH solution.</p></p></figure><div class="NLM_p">This series was then supplemented with compounds in which ring B was replaced by saturated or heterocyclic moieties. Compounds <b>72</b>–<b>88</b> were prepared following the general alkylation-based approach (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>), in this case relying on the appropriate alkyl halides. The aromatic ring B was changed to a simple methyl substituent in <b>72</b> or to one of several saturated ring systems in <b>73</b>–<b>75</b>. Moreover, the aryl moiety was replaced by a pyridine ring (<b>76</b>–<b>82</b>), 5-membered heterocycles (<b>83</b>–<b>86</b>), or bicyclic systems (<b>87</b> and <b>88</b>) to provide more diverse modifications in this part of the structure and to explore the physicochemical properties of novel analogues.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Approach to Analogues with Saturated or Heterocycle Moieties Replacing Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone or DMF, rt, 24–48 h.</p></p></figure><div class="NLM_p">All the alkyl halides utilized in <a class="ref internalNav" href="#sch5" aria-label="Schemes 5">Schemes 5</a> and <a class="ref internalNav" href="#sch6" aria-label="6">6</a> were commercially available or prepared according to literature procedures (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">As <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> shows, several ring B substitution modifications were tolerated. In general, all the compounds bearing a 4-aminosulfonyl moiety on ring A showed superior enzyme affinity in comparison with the 4-cyano analogues.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Activity, Cytotoxicity, and Physicochemical Properties of the Analogues with Ring B Substitution Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0012.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of the DprE1 enzyme (DprE1 assay data was generated using a modified version of the assay described, paper under preparation).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">MIC against <i>M. tuberculosis</i> (H37Rv), reference: isoniazid, MIC = 1.8 μM.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Cytotoxicity against HepG2 human Caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Kinetic aqueous solubility (CLND).</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Lipophilicity, chromlogD at pH = 7.4.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Solubility determination in 5% DMSO pH 7.4 phosphate-buffered saline and quantification of DMSO stock concentration using a charged aerosol detector (CAD).</p></div><div class="footnote" id="t3fn7"><sup><sup>g</sup></sup><p class="last">N.D., not determined.</p></div><div class="footnote" id="t3fn8"><sup><sup>h</sup></sup><p class="last">Only partial inhibition was reached.</p></div></div><div></div></div><div class="NLM_p">Stripping off the substituents on ring B leads to a significant activity drop in <b>38</b> and <b>39</b> compared to both hit <b>1</b> and its sulfonamide analogue <b>30</b> (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Nonetheless, it was desirable to include these analogues in the series for relative activity comparison with the corresponding compounds lacking fluorine atoms and containing other substituents or heterocycles. Compounds with a single fluorine substituent (<b>40–44</b>) also showed a small but consistent drop in enzymatic affinity. The presence of a 2,4-dichloro substitution pattern in <b>47</b> led to a significant drop in the whole-cell activity (MIC = 5 μM) compared to reference <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (MIC = 0.6 μM), suggesting particular importance of fluorine substituents for the series’ whole-cell activity. Although we do not have a clear rationale for this observation, it is most likely connected to small steric size and high electronegativity of the fluorine substituent. In fact, analogues with a 3,4-difluoro or 3-Cl,4-F substitution pattern (<b>45</b> and <b>46,</b> respectively) were among the most active compounds obtained (pIC<sub>50</sub> = 7.2, MIC = 1.2–1.3 μΜ). Interestingly, 3-Br substituted compound <b>48</b> retained relatively high enzymatic potency (pIC<sub>50</sub> = 7.0) with an MIC of 1.9 μM.</div><div class="NLM_p">Compounds <b>52–60</b> with an electron-donating group (−Me or -OMe) in different ring positions (2-, 3-, or 4-) demonstrated lower enzymatic and whole-cell potency in comparison to the corresponding references <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> or <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>.</div><div class="NLM_p">To further investigate the influence of electron-withdrawing substituents, we first prepared a number of analogues containing -CF<sub>3</sub>, -CN, -NO<sub>2</sub>, or -OCF<sub>3</sub> groups in ring B (<b>61–68</b>). Most of the prepared compounds showed a significant drop in enzymatic and whole-cell potency. The 2-CF<sub>3</sub>-substituted compound <b>61</b> showed an MIC value of 2.5 μM. Notably, the most potent representatives were the 3-substituted analogues <b>62</b> (3-CF<sub>3</sub>) and <b>67</b> (3-OCF<sub>3</sub>), which retained submicromolar whole-cell potencies (MIC = 0.6–0.9 μΜ). Keeping in mind the high activity of 3,4-dihalo-substituted analogues <b>45</b> and <b>46</b>, we decided to combine the two substitution patterns (3-CF<sub>3</sub>, 4-F) in products <b>69</b> and <b>70</b>, while two CF<sub>3</sub> groups were simultaneously introduced in <b>71</b>. Sulfonamide <b>69</b> (3-CF<sub>3</sub>, 4-F) retained submicromolar whole-cell potency (MIC = 0.6 μΜ) and enzymatic activity (pIC<sub>50</sub> = 7.2 vs 7.1) compared to its closest analogue <b>62</b> (3-CF<sub>3</sub>), while compounds <b>70</b> and <b>71</b> resulted in a substantial activity loss.</div><div class="NLM_p">Overall, the majority of analogues with a modified substitution pattern on ring B (apart from <b>49</b>, <b>63</b>, <b>68</b>, <b>70</b>–<b>71</b>) demonstrated no detectable cytotoxicity in the HepG2 assay (IC<sub>50</sub> > 100 μM).</div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> summarizes the biological evaluation results for compounds <b>72</b>–<b>88</b>. Methyl- or cyclopropyl-substituted compounds <b>72</b> and <b>73</b> showed a pronounced loss in both DprE1 and cellular potency, while adamantyl-containing analogue <b>75</b> retained moderate DprE1 affinity (pIC<sub>50</sub> = 5.9) but did not display significant antimycobacterial activity. Introduction of a cyclohexyl ring in place of the B ring in <b>74</b>, however, preserved the potency over its phenyl analogue <b>38</b> with pIC<sub>50</sub> values of 6.7 and 6.6 and MIC values of 7.5 and 10 μM, respectively. This could indicate that appropriately substituted cyclohexyl analogues may act as a potential replacement of the phenyl-type ring B in compound <b>30</b>. The introduction of a pyridine ring at this position (<b>76–81</b>) led to an activity drop in most compounds, and only the 2-pyridinyl-based analogues <b>76</b> and <b>77</b> retained comparable activity with the phenyl analogues <b>33</b> and <b>4</b>. Therefore, the 2-pyridinyl moiety was combined with the difluoro substitution pattern of reference <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a>, providing its closest heterocyclic analogue <b>82</b>. The latter retained comparable submicromolar whole-cell activity (MIC = 0.6 μM).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Activity, Cytotoxicity, and Physicochemical Properties of the Analogues with Saturated or Heterocyclic Moieties Instead of Ring B</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0013.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of DprE1 enzyme.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">MIC against <i>M. tuberculosis</i> (H37Rv), reference: isoniazid, MIC = 1.8 μM.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Cytotoxicity against HepG2 human Caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Kinetic aqueous solubility (CLND).</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Lipophilicity, chromlogD at pH = 7.4.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Solubility determination in 5% DMSO pH 7.4 phosphate-buffered saline and quantification of DMSO stock concentration using a charged aerosol detector (CAD).</p></div><div class="footnote" id="t4fn7"><sup><sup>g</sup></sup><p class="last">Only partial inhibition was reached.</p></div></div><div></div></div><div class="NLM_p last">The 2-thiophenyl-substituted product <b>83</b> retained enzymatic and whole-cell potency compared to its direct phenyl analogue <b>38</b>, while the chlorine substituent addition to the 5-position of the thiophene ring in <b>84</b> led to further potency improvement (pIC<sub>50</sub> = 7.0, MIC = 2.5 μM). The latter was, however, still inferior to the profile of reference <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a>. In contrast, the introduction of a (benzo)thiazole moiety in <b>86</b> and <b>87</b> was characterized by a significant loss of potency. Lastly, 2-naphthalene-containing compound <b>88</b> preserved the same whole-cell activity (MIC = 10 μM) as its phenyl analogue <b>38</b>, suggesting that the enzymatic pocket could potentially accommodate additional substituent expansion in this part of the molecule. It should be emphasized that, in the majority of analogues, even those with increased lipophilicity, no considerable cytotoxicity was detected among the reported modifications (HepG2 IC<sub>50</sub> > 100 μM), which may indicate a promising safety profile of this chemical series.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> hERG Inhibition</h3><div class="NLM_p">Potential cardiotoxicity of the series was one of our primary concerns since the previously reported hit <b>1</b> and its most potent analogues <b>2–4</b> had all demonstrated considerable hERG potassium channel inhibition (pIC<sub>50</sub> = 4.4–5.3).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> To our satisfaction, all tested sulfonamide derivatives showed no significant hERG inhibition (pIC<sub>50</sub> < 4.3), as shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. Overall, these data support our previous findings that potential cardiotoxicity is not intrinsic to the series but rather determined by the substitution pattern on rings A and B.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. hERG Inhibition of Selected Potent Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0014.gif" alt="" id="gr14" /></img><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Enantiomeric Separation</h3><div class="NLM_p">The enantiomers of the new reference <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> were separated by chiral HPLC, and the absolute configuration was determined by VCD analysis. The obtained results confirmed that only the R-isomer is responsible for both the enzymatic and whole-cell potency (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), in agreement with our previous findings.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Activity, Cytotoxicity, and Physicochemical Properties of <b>30</b> and its Enantiomers</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0015.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of DprE1 enzyme.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">MIC against <i>M. tuberculosis</i> (H37Rv).</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Cytotoxicity against HepG2 human Caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Kinetic aqueous solubility (CLND).</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">Lipophilicity, chromlogD at pH = 7.4.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Metabolic Stability</h3><div class="NLM_p">The in vitro metabolic stability assessment of compound <b>30</b> indicates the general stability of the compound with an intrinsic clearance value lower than 3 mL/min/g in mouse microsomes and under 0.4 mL/min/g in human microsomes, as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Microsomal Stability of Compound <b>30</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0016.gif" alt="" id="gr16" /></img><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Evaluation against <i>M. tuberculosis</i> DprE1 Mutants</h3><div class="NLM_p">To provide a genetic link to the mechanism of action, the primary hit compound <b>1</b> was tested against three <i>M. tuberculosis</i> DprE1 mutants (E221Q, G248S, and Y314H) that were generated in-house via oligonucleotide-mediated recombineering as previously described.<a onclick="showRef(event, 'ref11 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref11 ref24 ref25">(11,24,25)</a> Additionally, three spontaneous DprE1 mutants (L368P, G17C, and C387S) were provided by Stewart T. Cole (Institut Pasteur, Paris, France).<a onclick="showRef(event, 'ref2 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref14">(2,14)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>, a clear MIC-modulation of reference hydantoin <b>1</b> is mainly visible in the E221Q, G248S, and Y314H mutant strains. Together with the MIC-modulation that we observed earlier in a DprE1-overexpressing strain, these data bring on additional support to our hypothesis that DprE1 is the principal target of the hydantoins in <i>M. tuberculosis</i>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Moreover, the resistance profile of DprE1 mutants to compound <b>1</b> is also shared by the noncovalent reference AZ DprE1 inhibitor<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and, to a lesser extent, with the covalent ligand TCA1 (structures shown earlier in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). While these data suggest that broader cross-resistance could be present between representatives of these three compound families, they also indicate that some overlapping interactions could be present for these families within DprE1’s ligand binding site. The latter is nonetheless not straightforwardly rationalized by looking at DprE1’s crystal structure: only Tyr314 lines the ligand pocket, while the other two amino acids (Gln 221 and Gly248) are at a 6–9 Å distance and are closer to the protein’s outer surface.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. MIC of the Primary Hit <b>1</b> against a Panel of <i>M. tuberculosis</i> DprE1-Resistant Mutants</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">MIC<sub>mutant</sub>/MIC<sub>H37Rv</sub> ratio<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">E221Q</th><th class="colsep0 rowsep0" align="center" char=".">G248S</th><th class="colsep0 rowsep0" align="center" char=".">Y314H</th><th class="colsep0 rowsep0" align="center" char=".">L368P</th><th class="colsep0 rowsep0" align="center" char=".">G17C</th><th class="colsep0 rowsep0" align="center" char=".">C387S</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">>16</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TCA1<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AZ DprE1<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">>63</td><td class="colsep0 rowsep0" align="char" char=".">>63</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BTZ043<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">64</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">A mutant strain is considered resistant if the MIC<sub>mutant</sub>/MIC<sub>H37Rv</sub> ratio ratios is 8 or higher.</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">The structures of reference DprE1 inhibitors AZ DprE1, TCA1, and BTZ043 are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</p></div><div class="footnote" id="t8fn3"><sup><sup>c</sup></sup><p class="last">AZ DprE1 inhibitor benchmark is compound <b>9</b> in reference <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>.</p></div></div></div><div class="NLM_p last">Together, the observed DprE1 inhibitory potencies, the MIC modulation observed in the DprE1-overexpression strain (reported previously),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and the MIC modulation against resistant mutants to other classes of DprE1 inhibitors strongly support the assignment of DprE1 as the primary driver of antimycobacterial activity in the hydantoin series.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Vivo Therapeutic Efficacy</h3><div class="NLM_p">The two most potent compounds that were available at the time (<b>3</b> and <b>30</b>) were subsequently admitted to preclinical in vivo studies for which approval was obtained from the responsible local ethical committee. The efficacy of both compounds was determined in a C57BL/6J mouse model of acute intratracheal infection with <i>Mtb</i>. H37Rv.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compounds were administered once daily per os for 4 consecutive days, starting 5 days after the infection. Moxifloxacine (100 mg/kg) was used as a positive interassay control for efficacy in these experiments. Blood samples were obtained at specific time points from treated mice to measure the levels of the assayed molecules. Lungs were harvested on day 9, 24 h after the last compound administration. The blood levels measured for both compounds and the lung microorganism burden differences (log<sub>10</sub> CFU/lung) from the treated mice compared to untreated controls (day 9 after infection) are shown in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. No adverse clinical signs were observed in any animal.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antitubercular efficacy in an acute infection murine model of tuberculosis. Each point represents data from an individual mouse that received each product administered in a once a day schedule (qd). Treatment was administered for 4 days as detailed in the figure. *<i>p</i> < 0.05. ANOVA analysis with Dunnett’s post test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Blood Exposure Levels and log<sub>10</sub>CFU Reduction for Compounds <b>30</b> and <b>3</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">blood levels</th><th class="colsep0 rowsep0" align="center" char="±"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC (h ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">reduction of log<sub>10</sub> CFU/lung (relative to untreated controls)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">moxifloxacin</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="left">6380</td><td class="colsep0 rowsep0" align="left">31400<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">170</td><td class="colsep0 rowsep0" align="left">1870</td><td class="colsep0 rowsep0" align="left">6378<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">0.2 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Compounds were dosed per os, once daily.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">Compound <b>30</b>’s blood levels were found to remain above its MIC value for 24 h after single oral administration.</p></div><div class="footnote" id="t9fn3"><sup><sup>c</sup></sup><p class="last">Compound <b>3</b>’s blood levels were found to be below its MIC value within 6 h after single oral administration.</p></div></div></div><div class="NLM_p last">Compound <b>30</b> demonstrated the best blood exposure with a <i>C</i><sub>max</sub> value of 6380 ng/mL and an AUC value of 31,400 h ng/mL. Moreover, the same compound showed the highest reduction of log<sub>10</sub> CFU (0.5). Although this value reflects limited in vivo activity compared to reference moxifloxacin, it demonstrates that the hydantoin series is capable of reaching the lungs of mice after oral administration to achieve a statistically significant bacterial load reduction. The bioavailability of <b>3</b> (reflected in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a> by its lower AUC value and fast clearance) is significantly lower: within 6 hours, blood levels drop below the compound’s MIC value. This factor most likely contributes to the absence of efficacy for this molecule. Overall, these data also show that compound optimization, especially with respect to in vivo activity, is required before the future development of the hydantoin family into a drug candidate is possible.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein, we have reported an expanded SAR exploration of a hydantoin derivative series, recently discovered by GSK. Previously, we demonstrated that these compounds are potent and selective antimycobacterials that act via inhibition of DprE1. Our medicinal chemistry research effort described herein resulted in 69 novel hydantoin analogues and led to the identification of potent representatives with high in vitro enzymatic potency (pIC<sub>50</sub> 7–7.4) and whole-cell MIC values in the low micromolar range (0.6–0.9 μΜ). The most potent representatives were compound <b>30</b> and its close analogues <b>67</b>, <b>69</b>, and <b>82</b>. This chemical family is characterized by no appreciable cytotoxicity or cardiotoxicity (hERG), satisfactory metabolic stability, and a reasonable physicochemical profile. In vivo proof of concept for compound <b>30</b> was achieved by using an acute murine model of intratracheal infection. Although encouraging, currently available data indicate that additional research, mainly focusing on the improvement of in vivo efficacy responses, is required before preclinical development for this class of compounds can be considered successful.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Information</h3><div class="NLM_p">Laboratory reagent-grade solvents were employed unless stated otherwise. Reagents were purchased from Sigma-Aldrich, Fluorochem, Acros Organics, TCI, Enamine, or Apollo Scientific and were used without further purification unless specified otherwise. Reaction progression was monitored by TLC on silica gel and/or by UPLC–MS. Silica gel TLC analysis was performed using Polygram precoated silica gel TLC sheets SIL G/UV254 with detection by UV light (254 nm).</div><div class="NLM_p">Structural determination and characterization of all compounds were performed with <sup>1</sup>H NMR and <sup>13</sup>C NMR spectroscopy and mass spectrometry. <sup>1</sup>H NMR (400 MHz) and <sup>13</sup>C-NMR (100 MHz) spectra were recorded on a Bruker Avance III Nanobay Ultrashield 400 or a Bruker DPX 400 spectrometer. The chemical shift (δ) values are reported in parts per million (ppm), and coupling constants are expressed in hertz (Hz). The chemical shifts δ were given relative to the residual <sup>1</sup>H and <sup>13</sup>C signals of the solvent peak as an internal standard: in <sup>1</sup>H NMR (400 MHz) δ 2.50 ppm (quin, C<sub>2</sub>D<sub>5</sub>HOS) for DMSO-<i>d</i><sub>6</sub>, δ 2.05 ppm (quin, C<sub>3</sub>D<sub>5</sub>HO) for acetone-<i>d</i><sub>6</sub>, δ 3.31 ppm (quin, CD<sub>2</sub>HOD) for methanol-<i>d</i><sub>4</sub>; in <sup>13</sup>C NMR (101 MHz) δ 39.51 ppm (sept) for DMSO-<i>d</i><sub>6</sub>, δ 29.84 ppm (sept), δ 206.26 ppm (s) for acetone-<i>d</i><sub>6</sub>, and δ 49.00 ppm (sept) for methanol-<i>d</i><sub>4</sub>. Legend: s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, sept = septet, m = multiplet (denotes complex pattern), br = broad signal, dd = doublet of doublets, dt = doublet of triplets, td = triplet of doublets, etc.</div><div class="NLM_p">UPLC–MS analysis was performed according to the methods A, B, or C. In all cases, ESI (electrospray ionization) was used. The quasi-molecular ions [M + H]<sup>+</sup> or [M – H]<sup>−</sup> were typically detected, unless stated otherwise. Retention time <i>R</i><sub>t</sub> is specified for each described method. Method A involved the Waters Acquity UPLC system coupled to a Waters SQ detector. A Waters Acquity UPLC BEH C18 1.7 μm, 3 mm × 50 mm column was employed. The sample concentration was 0.1 mg/mL, and the flow was 0.8 mL/min. Solvent A consisted of aqueous ammonium acetate 25 mM and 10% acetonitrile at pH 6.6, and Solvent B was acetonitrile. The method was as follows: 0.0–0.2 min A/B 99.9:0.1, 0.2–1.0 min 10:90, 1.0–1.8 min 10:90, 1.9–2.0 min 99.9:0.1 at temperature 40 °C. The UV detection was an averaged signal from the wavelength of 210 to 400 nm. In methods B and C, ESI mass spectra were obtained with an Esquire 3000 plus ion trap mass spectrometer (Bruker Daltonics) in the direct infusion mode. A Waters Acquity H-class UPLC system coupled to a waters TQD ESI mass spectrometer and a Waters TUV detector were used with a Waters Acquity UPLC BEH C18 1.7 μm 2.1′50 mm column. Solvent A consisted of water with 0.1% formic acid. Solvent B consisted of acetonitrile with 0.1% formic acid. Method B involved the following: flow 0.7 mL/min, 0.15 min isocratic elution (A/B = 95:5), then gradient elution for 1.85 min (A/B = from 95:5 to 0:100), followed by 0.25 min of isocratic elution (A/B = 0:100), then 0.75 min of isocratic elution (A/B = 95:5). Method C involved the following: flow 0.4 mL/min, 0.15 min isocratic elution (A/B = 95:5), then gradient elution for 4.85 min (A/B = from 95:5 to 0:100), followed by 0.25 min of isocratic elution (A/B = 0:100), then 0.75 min of isocratic elution (A/B = 95:5). In methods B and C, the wavelength for UV detection was 254 nm unless stated otherwise.</div><div class="NLM_p">For the high-resolution mass spectrometry (HRMS) measurements, positive ion mass spectra were acquired using a QSTAR Elite System (AB Sciex Instruments) mass spectrometer, equipped with a turbospray source, over a mass range of 250–700.</div><div class="NLM_p">Where necessary, flash purification was performed on a Biotage ISOLERA One or Four flash system equipped with an internal variable dual-wavelength diode array detector (200–400 nm). For normal phase purifications, Biotage SNAP (10–340 g), Sylicicle SiliaSep (4–120 g), or Götec-Labortechnik EasyVarioFlash (5–100 g) cartridges were used (flow rates of 10–100 mL/min). Reversed-phase purifications were performed with Biotage KP-C18 containing cartridges. Gradients used varied for each purification. However, typical gradients used for normal phase were a gradient of 0–100% ethyl acetate in <i>n</i>-heptane or cyclohexane or 0–15% methanol in ethyl acetate. Typically, a gradient of 5% MeCN in water to 50% MeCN in water was used for the reverse phase.</div><div class="NLM_p">The preparative HPLC purification was conducted on an Agilent 1200 or Agilent 1100 instrument, employing either on an X-Bridge C<sub>18</sub> column (19 mm × 150 mm, i.d. 5 μm packing diameter or 30 mm × 150 mm, i.d. 5 μm packing diameter) or on a SunFire C<sub>18</sub> column (19 mm × 150 mm or 30 mm × 250 mm) at 35 °C. The solvents employed were as follows: A = 10 mM ammonium bicarbonate in water; B = acetonitrile (“basic” method) or A = 0.1 M formic acid in water; and B = 0.1 M formic acid in acetonitrile (“acidic” method). The purification was run as a gradient (A/B) typically from 40 to 100% over either 20 or 25 min with a flow rate of 17 mL/min (19 mm column) or 35 mL/min (30 mm column). The UV detection wavelengths were 210 and 254 nm.</div><div class="NLM_p">Microwave radiation-assisted reactions were performed in a Biotage Initiator instrument. The initial absorption was set as “high”, and 2 min of pre-stirring was applied before heating commenced.</div><div class="NLM_p">The isolated yields are reported. Purity of final compounds was 95% or higher (verified by UPLC-MS), except for compounds <b>10</b> (>85%), <b>33</b> (>90%), <b>34</b> (>90%), <b>80</b> (>90%), and <b>87</b> (>90%). These molecules displayed low potency in the DprE1 and MIC assays, and further purification was therefore not carried out. All products were obtained as amorphous solids, and melting points were not measured. The following section reports the synthetic procedures and analytical data for all final compounds and some representative intermediates reported in this publication. Complementary data for the rest of the intermediate compounds can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_001.pdf" class="ext-link">Supporting Information</a>. Synthetic procedures that were used in the preparation of several products are summarized here as “General methods”.</div><div class="NLM_p last">The literature benchmark DprE1 inhibitor (“AZ DprE1”, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, <i>N</i>-(2-fluoroethyl)-1-((6-methoxy-5-methylpyrimidin-4-yl)methyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide) was synthesized by the procedure described previously by Shirude et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> TCA1 and BTZ043 were purchased from corresponding commercial sources: TCA1 (Chemexpress (Shanghai Haoyuan) Co., Ltd., Ref. HY-12904, CAS 864941-32-2) and BTZ043 (Selleck Chemicals LLC, Ref. S1097, 957217-65-1).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Method A: Hydantoin Core Synthesis</h3><div class="NLM_p last">A modified Bucherer–Berg protocol<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was employed. The suitable ketone (1.5.0–4.0 mmol, 1.0 equiv), ammonium carbonate (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub> (9.0 equiv), and potassium cyanide KCN (1.3 equiv) were dissolved in a mixture of ethanol and water (1:1) (reaction molarity ∼0.25 to 0.4 mol/L). The reaction mixture was heated at 55 °C for 18–48 h or irradiated in a microwave oven at 70 °C for 3–9 h. After the reaction was complete, the reaction mixture was cooled down to room temperature and neutralized with 6 M hydrochloric acid to pH ∼ 7 to 8. In the case of precipitate formation, the product was collected by filtration, washed with water, and dried. Otherwise, the solvent was removed under reduced pressure and the residue was diluted with water and extracted with ethyl acetate; the combined organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness. When necessary, the product was additionally dried in the vacuum oven (40 °C, 0–10 mbar). Typically, no additional purification was performed.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Method B: Hydantoin Core Alkylation</h3><div class="NLM_p last">A mixture of the appropriate hydantoin (0.2–3.7 mmol, 1 equiv) and potassium carbonate (K<sub>2</sub>CO<sub>3</sub>, 1.1–2.0 equiv) was dissolved in DMF or acetone. After 10–15 min, the corresponding alkyl halide was added in a slight excess (1.1–1.5 equiv) (reaction molarity ∼0.08 to 0.2 mol/L). The reaction mixture was stirred at room temperature for 20–72 h. Upon reaction completion, the solvent was removed under reduced pressure and the residue was diluted with saturated ammonium chloride solution or water and extracted with ethyl acetate. The combined organic phase was typically washed with 1 M NaOH and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under vacuum. The residue was purified by normal-phase flash chromatography on silica gel (gradient c-Hex/Hep:EtOAc = 100:0 to 10:90) or reversed-phase flash chromatography (gradient water/ACN = 90:10 to 50:50). The final product was typically lyophilized.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Method C: Late-Stage Sulfonamide Introduction by a Coupling Reaction</h3><div class="NLM_p last">5-(4-Bromophenyl)-3-(2-(2,4-difluorophenyl)-2-oxoethyl)-5-methylimidazolidine-2,4-dione <b>19</b> (0.08–0.19 mmol, 1.0 equiv), appropriate sulfonamide (1.2–2.0 equiv), 2-di-<i>tert</i>-butylphosphino-2′,4′,6′-triisopropylbiphenyl (t-BuXPhos) (0.04 equiv), allylpalladium(II) chloride dimers ([Pd(allyl)Cl]<sub>2</sub>) (0.01 equiv), and potassium carbonate (2.0 equiv) were suspended in dry 2-methyltetrahydrofuran (2-MeTHF) (6 mL) and placed in the vial, which was evacuated and backfilled with nitrogen three times. The vial was capped under nitrogen flow and stirred heated at 80 °C for 7–48 h. Then, the reaction mixture was cooled to room temperature, and 1 M hydrochloric acid solution (20 mL) was added. Subsequently, the aqueous layer was extracted with ethyl acetate (3 × 20 mL). The combined organic layers were filtered through a small Celite column, rinsed with ethyl acetate, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by normal-phase flash column chromatography (gradient <i>c-</i>Hex/EtOAc = 100:0 to 10:90, solid loading) and additionally by HPLC (gradient: 40–100 basic/acid) if required. The fractions, containing the desired product, were collected and evaporated under reduced pressure. The residue was dried to provide the title compound. The final product was typically lyophilized.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Compound Syntheses</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzoate (<b>10</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from a crude mixture of methyl 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzoate <b>5</b> (110 mg, 0.443 mmol) and 2-chloro-2′,4′-difluoroacetophenone (127 mg, 0.665 mmol). Yield 33% (70.1 mg, 0.148 mmol), off-white amorphous solid, purity ≥85%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (s, 1H), 7.94–8.06 (m, 3H), 7.67–7.75 (m, 2H), 7.50 (ddd, <i>J</i> = 2.40, 9.22, 11.62 Hz, 1H), 7.28 (dt, <i>J</i> = 2.40, 8.40 Hz, 1H), 4.81 (d, <i>J</i> = 2.53 Hz, 2H), 3.87 (s, 3H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.0 (d, <i>J</i> = 5.1 Hz), 174.6, 165.8, 165.7 (dd, <i>J</i> = 255.4, 13.2 Hz), 162.4 (dd, <i>J</i> = 257.8, 13.5 Hz), 155.0, 144.4, 132.6 (dd, <i>J</i> = 11.0, 3.7 Hz), 129.4, 129.3, 126.1, 119.5 (dd, <i>J</i> = 13.2, 3.7 Hz), 112.8 (dd, <i>J</i> = 22.0, 3.6 Hz), 105.4 (t, <i>J</i> = 26.8 Hz), 63.3, 52.2, 47.2 (d, <i>J</i> = 10.2 Hz), 25.0. UPLC-MS (ESI) (A): <i>m/z</i> 403 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.16 min). HRMS (ESI) <i>m/z</i> calcd for C20H16F2N2O5 [M + H]<sup>+</sup>: 425.0919; found: 425.0924.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)phenyl)urea (<b>11</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from the crude mixture containing 1-(4-(4-methyl-2,5-dioxoimidazolidin-4-yl)phenyl)urea <b>6</b> (80 mg, 0.322 mmol) and 2-bromo-1-(2,4-difluorophenyl)ethanone (68.2 mg, 0.290 mmol, 0.9 equiv). Yield 22% (28.8 mg, 0.072 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (s, 1H), 8.62 (s, 1H), 7.97–8.07 (m, 1H), 7.52 (ddd, <i>J</i> = 2.51, 9.35, 11.48 Hz, 1H), 7.40–7.46 (m, 2H), 7.34–7.40 (m, 2H), 7.30 (dt, <i>J</i> = 2.26, 8.41 Hz, 1H), 5.88 (s, 2H), 4.80 (d, <i>J</i> = 2.26 Hz, 2H), 1.72 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.2 (d, <i>J</i> = 4.4 Hz), 175.5, 165.7 (dd, <i>J</i> = 255.3, 12.6 Hz), 162.5 (dd, <i>J</i> = 257.5, 13.2 Hz), 155.9, 155.1, 140.4, 132.7 (dd, <i>J</i> = 11.0, 4.4 Hz), 131.6, 126.0, 119.6 (dd, <i>J</i> = 13.2, 3.7 Hz), 117.5, 112.8 (dd, <i>J</i> = 22.0, 2.9 Hz), 105.5 (t, <i>J</i> = 26.8 Hz), 63.0, 47.1 (d, <i>J</i> = 10.3 Hz), 24.4. UPLC-MS (ESI) (B): <i>m/z</i> 403 [M + H]<sup>+</sup>, 425 [M + Na]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.42 min).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-(2-(2,4-Difluorophenyl)-2-oxoethyl)-5-methyl-5-(4-((methylsulfonyl)methyl)phenyl)imidazolidine-2,4-dione (<b>12</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 5-methyl-5-(4-((methylsulfonyl)methyl)phenyl)imidazolidine-2,4-dione <b>7</b> (100 mg, 0.354 mmol) and 2-chloro-1-(2,4-difluorophenyl)ethanone (74.3 mg, 0.390 mmol). Yield 50% (77 mg, 0.176 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.09 (s, 1H), 8.01 (dt, <i>J</i> = 6.82, 8.46 Hz, 1H), 7.57 (d, <i>J</i> = 8.34 Hz, 2H), 7.43–7.54 (m, 3H), 7.28 (dt, <i>J</i> = 2.27, 8.34 Hz, 1H), 4.80 (d, <i>J</i> = 2.27 Hz, 2H), 4.51 (s, 2H), 2.92 (s, 3H), 1.77 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.1 (d, <i>J</i> = 4.39 Hz), 175.0, 165.6 (dd, <i>J</i> = 13.17, 255.41 Hz), 162.4 (dd, <i>J</i> = 13.17, 258.34 Hz), 155.0, 139.4, 132.7 (dd, <i>J</i> = 3.66, 10.98 Hz), 131.1, 128.9, 125.8, 119.5 (dd, <i>J</i> = 3.66, 13.17 Hz), 112.8 (dd, <i>J</i> = 3.40, 22.20 Hz), 105.4 (t, <i>J</i> = 27.10 Hz), 63.1, 58.8, 47.2 (d, <i>J</i> = 10.98 Hz), 39.6 (overlaps with solvent peak), 24.7. UPLC-MS (ESI) (A) <i>m/z</i> 435 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.15 min).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(2-(2,4-Difluorophenyl)-2-oxoethyl)-5-methyl-5-(4-(2-oxo-1,3-oxazinan-3-yl)phenyl)imidazolidine-2,4-dione (<b>13</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from sodium 4-methyl-2,5-dioxo-4-(4-(2-oxo-1,3-oxazinan-3-yl)phenyl)imidazolidin-1-ide <b>8a</b> (76 mg, 0.244 mmol) and 2-bromo-1-(2,4-difluorophenyl)ethanone (57.4 mg, 0.244 mmol). Yield 79% (86 mg, 0.194 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.10 (s, 1H), 7.95–8.07 (m, 1H), 7.46–7.57 (m, 3H), 7.41 (d, <i>J</i> = 8.53 Hz, 2H), 7.29 (dt, <i>J</i> = 2.38, 8.47 Hz, 1H), 4.73–4.90 (m, <i>J</i> = 2.26 Hz, 2H), 4.34 (t, <i>J</i> = 5.40 Hz, 2H), 3.66 (t, <i>J</i> = 6.15 Hz, 2H), 2.10 (quin, <i>J</i> = 5.71 Hz, 2H), 1.76 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.1 (d, <i>J</i> = 5.1 Hz), 175.1, 165.7 (dd, <i>J</i> = 255.3, 12.5 Hz), 162.5 (dd, <i>J</i> = 258.2, 13.9 Hz), 155.1, 151.9, 143.2, 137.0, 132.7 (dd, <i>J</i> = 11.0, 3.7 Hz), 126.1, 126.0, 119.5 (dd, <i>J</i> = 13.2, 2.9 Hz), 112.8 (dd, <i>J</i> = 22.0, 2.9 Hz), 105.5 (t, <i>J</i> = 26.8 Hz), 66.8, 63.1, 48.1, 47.2 (d, <i>J</i> = 11.0 Hz), 24.8, 22.0. ESI-MS (B): <i>m/z</i> 444 [M + H]<sup>+</sup>, 466 [M + Na]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.50 min).</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(2-(2,4-Difluorophenyl)-2-oxoethyl)-5-methyl-5-(3-oxo-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazin-6-yl)imidazolidine-2,4-dione (<b>14</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 5-methyl-5-(3-oxo-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazin-6-yl)imidazolidine-2,4-dione <b>9</b> (100 mg, 0.383 mmol) and 2-chloro-2′,4′-difluoroacetophenone (109 mg, 0.574 mmol). Yield 44% (73.6 mg, 0.168 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.75 (br s, 1H), 9.06 (s, 1H), 7.99 (dt, <i>J</i> = 6.82, 8.59 Hz, 1H), 7.50 (ddd, <i>J</i> = 2.40, 9.22, 11.62 Hz, 1H), 7.29 (dt, <i>J</i> = 2.27, 8.46 Hz, 1H), 7.04–7.14 (m, 2H), 6.97–7.02 (m, 1H), 4.79 (d, <i>J</i> = 2.53 Hz, 2H), 4.58 (s, 2H), 1.70 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.1 (d, <i>J</i> = 4.4 Hz), 175.1, 165.7 (dd, <i>J</i> = 255.2, 12.9 Hz), 164.8, 162.4 (dd, <i>J</i> = 257.2, 13.9 Hz), 155.0, 143.0, 133.4, 132.6 (dd, <i>J</i> = 11.0, 3.9 Hz), 127.2, 120.3, 119.5 (dd, <i>J</i> = 13.7, 2.9 Hz), 116.1, 113.2, 112.8 (dd, <i>J</i> = 22.0, 2.9 Hz), 105.4 (t, <i>J</i> = 27.6 Hz), 66.7, 62.8, 47.1 (d, <i>J</i> = 10.2 Hz), 25.0. UPLC-MS (ESI) (A): <i>m/z</i> 416 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.19 min). HRMS (ESI) <i>m/z</i> calcd for C<sub>20</sub>H<sub>15</sub>F<sub>2</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>: 438.0872; found: 438.0885.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzamide (<b>16</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzamide <b>15</b> (30 mg, 0.096 mmol, ∼75% pure) and 2-bromo-1-(2,4-difluorophenyl)ethanone (33 mg, 0.141 mmol). Yield 56% (21 mg, 0.054 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.15 (s, 1H), 7.95–8.07 (m, 2H), 7.91 (d, <i>J</i> = 8.53 Hz, 2H), 7.61 (d, <i>J</i> = 8.28 Hz, 2H), 7.52 (ddd, <i>J</i> = 2.26, 9.29, 11.55 Hz, 1H), 7.44 (s, 1H), 7.29 (dt, <i>J</i> = 2.38, 8.47 Hz, 1H), 4.81 (d, <i>J</i> = 2.51 Hz, 2H), 1.77 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.2, 174.9, 167.4, 165.8 (dd, <i>J</i> = 13.21, 256.04 Hz), 162.5 (dd, <i>J</i> = 13.21, 258.24 Hz), 155.1, 142.3, 134.1, 132.7 (dd, <i>J</i> = 4.03, 11.37 Hz), 127.7, 125.6, 119.5 (dd, <i>J</i> = 3.30, 12.84 Hz), 112.9 (dd, <i>J</i> = 2.93, 22.01 Hz), 105.5 (t, <i>J</i> = 26.40 Hz), 63.3, 47.3 (d, <i>J</i> = 11.00 Hz), 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 388 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.42 min).</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzoic acid (<b>17</b>)</h4><div class="NLM_p last">Methyl 4-(1-(2-(2,4-difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzoate <b>10</b> (90 mg, 0.224 mmol) and lithium hydroxide (90 mg, 3.76 mmol) were dissolved in a mixture of THF (4 mL) and water (4,00 mL) and stirred at rt for 1 h. The mixture was acidified with 1 M aqueous HCl and extracted with AcOEt 3×. Combined organic phases were dried with sodium sulfate and evaporated. The residue was purified via flash column chromatography on the reversed phase (ACN/water 5–60%) and subsequently lyophilized to provide the title compound as a white solid. Yield 44% (38 mg, 0.098 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.09 (s, 1H), 9.17 (s, 1H), 7.92–8.10 (m, 3H), 7.65 (d, <i>J</i> = 8.28 Hz, 2H), 7.51 (ddd, <i>J</i> = 2.26, 9.29, 11.55 Hz, 1H), 7.29 (dt, <i>J</i> = 2.26, 8.41 Hz, 1H), 4.81 (d, <i>J</i> = 2.76 Hz, 2H), 1.78 (s, 3H). UPLC-MS (ESI) (B) <i>m/z</i> 387 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.50 min).</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-(4-(1<i>H</i>-Tetrazol-5-yl)phenyl)-3-(2-(2,4-difluorophenyl)-2-oxoethyl)-5-methylimidazolidine-2,4-dione (<b>18</b>)</h4><div class="NLM_p last">4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>1</b> (50 mg, 0.135 mmol) was dissolved in <i>n</i>-PrOH (1.5 mL). Sodium azide (10.56 mg, 0.162 mmol) and zinc chloride (18.45 mg, 0.135 mmol) were added, and the reaction was stirred at 95 °C for 24 h. 5% NaOH was added. Solids were filtered and washed with 5% NaOH. The filtrate was acidified with 1 M HCl and extracted with ethyl acetate (3×). Combined organic phases were dried with sodium sulfate, evaporated, and purified via flash column chromatography on the reversed phase (ACN/water 5–50% + 0.5% formic acid). The product was lyophilized to provide the title compound. Yield 70% (39 mg, 0.095 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (s, 1H), 8.06–8.20 (m, 2H), 7.92–8.06 (m, 1H), 7.78 (d, <i>J</i> = 8.53 Hz, 2H), 7.46–7.62 (m, 1H), 7.23–7.34 (m, 1H), 4.65–4.88 (m, 2H), 1.81 (s, 3H). UPLC-MS (ESI) (B) <i>m/z</i> 413 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.49 min).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-(4-Bromophenyl)-3-(2-(2,4-difluorophenyl)-2-oxoethyl)-5-methylimidazolidine-2,4-dione (<b>19</b>)</h4><div class="NLM_p last">The title compound was prepared as reported previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)phenyl)-1,1,1-trifluoromethanesulfonamide (<b>20</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_4" aria-label="General Method C">General Method C</a> from 5-(4-bromophenyl)-3-(2-(2,4-difluorophenyl)-2-oxoethyl)-5-methylimidazolidine-2,4-dione <b>19</b> (35 mg, 0.083 mmol) and trifluoromethanesulfonamide (24.66 mg, 0.165 mmol, 2 equiv). Yield 27% (11 mg, 0.022 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.99 (br s, 1H), 9.05 (s, 1H), 8.00 (dt, <i>J</i> = 6.82, 8.59 Hz, 1H), 7.46–7.58 (m, 3H), 7.22–7.35 (m, 3H), 4.80 (d, <i>J</i> = 2.53 Hz, 2H), 1.74 (s, 3H). UPLC-MS (ESI) (A): <i>m/z</i> 490 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.02 min).</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)phenyl)benzenesulfonamide (<b>21</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_4" aria-label="General Method C">General Method C</a> from 5-(4-bromophenyl)-3-(2-(2,4-difluorophenyl)-2-oxoethyl)-5-methylimidazolidine-2,4-dione <b>19</b> (80 mg, 0.189 mmol) and benzenesulfonamide (35.7 mg, 0.227 mmol, 1.2 equiv). Yield 31% (31 mg, 0.059 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>) δ 10.46 (s, 1H), 8.94 (s, 1H), 7.99 (dt, <i>J</i> = 6.82, 8.59 Hz, 1H), 7.77–7.83 (m, 2H), 7.45–7.66 (m, 4H), 7.38 (d, <i>J</i> = 8.59 Hz, 2H), 7.28 (dt, <i>J</i> = 2.27, 8.46 Hz, 1H), 7.13 (d, <i>J</i> = 8.84 Hz, 2H), 4.76 (d, <i>J</i> = 2.53 Hz, 2H), 1.67 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.1 (d, <i>J</i> = 5.1 Hz), 175.1, 165.7 (dd, <i>J</i> = 255.6, 12.4 Hz), 162.4 (dd, <i>J</i> = 257.6, 11.6 Hz), 155.0, 139.6, 137.5, 134.6, 133.0, 132.6 (dd, <i>J</i> = 11.0, 4.2 Hz), 129.3, 126.6*, 119.5–119.6 (m), 119.5, 112.8 (dd, <i>J</i> = 22.6, 2.6 Hz), 105.4 (t, <i>J</i> = 26.6 Hz), 62.8, 47.1 (d, <i>J</i> = 11.0 Hz), 24.5.<i>*</i>Two peaks possess the identical chemical shift (proven by HSQC). UPLC-MS (ESI) (A): <i>m/z</i> 500 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.39 min).</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)phenyl)butane-1-sulfonamide (<b>22</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_4" aria-label="General Method C">General Method C</a> from 5-(4-bromophenyl)-3-(2-(2,4-difluorophenyl)-2-oxoethyl)-5-methylimidazolidine-2,4-dione <b>19</b> (80 mg, 0.189 mmol) and butane-1-sulfonamide (38.9 mg, 0.284 mmol, 1.5 equiv). Yield 34% (55 mg, 0.097 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.69 (br s, 1H), 9.01 (s, 1H), 8.01 (dt, <i>J</i> = 6.57, 8.59 Hz, 1H), 7.43–7.56 (m, 3H), 7.29 (dt, <i>J</i> = 2.40, 8.40 Hz, 1H), 7.23 (d, <i>J</i> = 8.84 Hz, 2H), 4.80 (d, <i>J</i> = 2.53 Hz, 2H), 3.04–3.14 (m, 2H), 1.73 (s, 3H), 1.58–1.69 (m, 2H), 1.35 (sxt, <i>J</i> = 7.43 Hz, 2H), 0.84 (t, <i>J</i> = 7.33 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.1 (d, <i>J</i> = 4.4 Hz), 175.2, 165.7 (dd, <i>J</i> = 255.4, 13.2 Hz), 162.4 (dd, <i>J</i> = 257.6, 13.2 Hz), 155.0, 138.2, 134.3, 132.6 (dd, <i>J</i> = 11.0, 4.0 Hz), 126.7, 119.5 (dd, <i>J</i> = 12.8, 3.2 Hz), 119.1, 112.6–113.0 (m), 105.4 (t, <i>J</i> = 26.6 Hz), 62.9, 50.5, 47.1 (d, <i>J</i> = 10.2 Hz), 25.1, 24.6, 20.6, 13.4. UPLC-MS (ESI) (A): <i>m/z</i> 480 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.39 min).</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-(4-Methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>23</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_2" aria-label="General Method A">General Method A</a> from 4-acetylbenzenesulfonamide <b>S-1</b> (1230 mg, 6.17 mmol). Yield 70% (1225 mg, 4.32 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.87 (br s, 1H), 8.69 (s, 1H), 7.84 (d, <i>J</i> = 8.59 Hz, 2H), 7.67 (d, <i>J</i> = 8.59 Hz, 2H), 7.37 (s, 2H), 1.68 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 176.3, 156.1, 143.6, 143.5, 126.0, 125.8, 63.8, 25.0.UPLC-MS (ESI) (A): <i>m/z</i> 268 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 0.77 min).</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>30</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (200 mg, 0.743 mmol) and 2-chloro-2′,4′-difluoroacetophenone (212 mg, 1.114 mmol). Yield 53% (176 mg, 0.395 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (br s, 1H), 8.00 (dt, <i>J</i> = 6.82, 8.59 Hz, 1H), 7.85–7.91 (m, 2H), 7.71–7.77 (m, 2H), 7.51 (ddd, <i>J</i> = 2.40, 9.22, 11.62 Hz, 1H), 7.39 (s, 2H), 7.29 (dt, <i>J</i> = 2.27, 8.46 Hz, 1H), 4.73–4.89 (m, <i>J</i> = 2.78 Hz, 2H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.0 (d, <i>J</i> = 4.4 Hz), 174.6, 165.7 (dd, <i>J</i> = 255.4, 13.3 Hz), 162.5 (dd, <i>J</i> = 257.6, 13.9 Hz), 155.0, 143.8, 142.9, 132.7 (dd, <i>J</i> = 11.3, 3.8 Hz), 126.3, 125.9, 119.5 (dd, <i>J</i> = 13.2, 3.1 Hz), 112.8 (dd, <i>J</i> = 22.0, 2.9 Hz), 105.4 (t, <i>J</i> = 26.7 Hz), 63.2, 47.2 (d, <i>J</i> = 10.2 Hz), 24.9. UPLC-MS (ESI) (A): <i>m/z</i> 424 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.05 min). HRMS (ESI) <i>m/z</i> calcd for C<sub>18</sub>H<sub>15</sub>F<sub>2</sub>N<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup>: 446.0593; found: 446.0602.</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)-<i>N</i>-methylbenzenesulfonamide (<b>31</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from <i>N-</i>methyl-4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>24</b> (97 mg, 0.342 mmol) and 2-chloro-2′,4′-difluoroacetophenone (98 mg, 0.514 mmol). Yield 62% (98 mg, 0.213 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (br s, 1H), 8.00 (dt, <i>J</i> = 6.57, 8.59 Hz, 1H), 7.82–7.86 (m, 2H), 7.75–7.80 (m, 2H), 7.46–7.55 (m, 2H), 7.28 (dt, <i>J</i> = 2.40, 8.40 Hz, 1H), 4.82 (d, <i>J</i> = 2.53 Hz, 2H), 2.43 (s, 3H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.0 (d, <i>J</i> = 5.1 Hz), 174.5, 165.7 (dd, <i>J</i> = 255.3, 12.4 Hz), 162.5 (dd, <i>J</i> = 257.6, 13.2 Hz), 155.0, 143.5, 139.1, 132.7 (dd, <i>J</i> = 11.3, 4.0 Hz), 126.9, 126.6, 119.5 (dd, <i>J</i> = 13.2, 2.9 Hz), 112.8 (dd, <i>J</i> = 22.0, 3.2 Hz), 105.4 (t, <i>J</i> = 27.1 Hz), 63.2, 47.3 (d, <i>J</i> = 11.0 Hz), 28.7, 24.9. UPLC-MS (ESI) (A): <i>m/z</i> 438 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.11 min). HRMS (ESI) <i>m/z</i> calcd for C<sub>19</sub>H<sub>17</sub>F<sub>2</sub>N<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup>: 460.0749; found: 460.0758.</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)-<i>N</i>,<i>N</i>-dimethylbenzenesulfonamide (<b>32</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a>, using <i>N</i>,<i>N</i>-dimethyl-4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>25</b> (70 mg, 0.24 mmol) and 2-chloro-2′,4′-difluoroacetophenone (67 mg, 0.35 mmol). Yield 64% (68 mg, 0.150 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.21 (s, 1 H), 8.00 (td, <i>J</i> = 8.6, 6.6 Hz, 1 H), 7.78–7.89 (m, 4 H), 7.51 (ddd, <i>J</i> = 11.6, 9.2, 2.4 Hz, 1 H), 7.29 (td, <i>J</i> = 8.4, 2.4 Hz, 1 H), 4.82 (d, <i>J</i> = 2.5 Hz, 2 H), 2.63 (s, 6 H), 1.80 (s, 3 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 189.0 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 5.1 Hz), 174.5, 165.7 (dd,<sup>1</sup><i>J</i><sub>CF</sub> = 254.7 Hz,<sup>3</sup><i>J</i><sub>CF</sub> = 12.4 Hz), 162.4 (dd,<sup>1</sup><i>J</i><sub>CF</sub> = 256.9 Hz,<sup>3</sup><i>J</i><sub>CF</sub> = 13.9 Hz), 155.0, 144.1, 134.7, 132.6 (dd,<sup>3</sup><i>J</i><sub>CF</sub> = 11.0 Hz,<sup>3</sup><i>J</i><sub>CF</sub> = 4.4 Hz), 127.8, 126.7, 119.5 (dd,<sup>2</sup><i>J</i><sub>CF</sub> = 13.2 Hz,<sup>4</sup><i>J</i><sub>CF</sub> = 3.7 Hz), 112.8 (dd,<sup>2</sup><i>J</i><sub>CF</sub> = 22.0 Hz,<sup>4</sup><i>J</i><sub>CF</sub> = 2.9 Hz), 105.4 (t,<sup>3</sup><i>J</i><sub>CF</sub> = 26.7 Hz), 63.2, 47.3 (d,<sup>4</sup><i>J</i><sub>CF</sub> = 11.7 Hz), 37.5, 25.1. UPLC-MS (ESI) (A): <i>m/z</i> 452 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.23 min).</div></div><div id="sec4_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-Cyclopropyl-4-(1-(2-(2,4-difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>33</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_4" aria-label="General Method C">General Method C</a> from <i>N-</i>cyclopropyl-4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>26</b> (100 mg, 0.323 mmol) and 2-chloro-2′,4′-difluoroacetophenone (92 mg, 0.485 mmol). Yield 75% (118 mg, 0.242 mmol), off-white amorphous solid, purity ≥90%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (s, 1H), 7.95–8.05 (m, 2H), 7.84–7.90 (m, 2H), 7.75–7.82 (m, 2H), 7.50 (ddd, <i>J</i> = 2.40, 9.28, 11.56 Hz, 1H), 7.28 (dt, <i>J</i> = 2.40, 8.40 Hz, 1H), 4.82 (d, <i>J</i> = 2.53 Hz, 2H), 2.09 (m, 1H), 1.80 (s, 3H), 0.44–0.53 (m, 2H), 0.35–0.44 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.0 (d, <i>J</i> = 4.4 Hz), 174.5, 165.7 (dd, <i>J</i> = 255.3, 13.2 Hz), 162.5 (dd, <i>J</i> = 257.6, 13.2 Hz), 155.0, 143.6, 140.0, 132.6 (dd, <i>J</i> = 11.0, 4.4 Hz), 127.0, 126.5, 119.5 (dd, <i>J</i> = 13.2, 3.7 Hz), 112.8 (dd, <i>J</i> = 22.0, 3.1 Hz), 105.4 (t, <i>J</i> = 26.8 Hz), 63.2, 47.3 (d, <i>J</i> = 11.0 Hz), 24.9, 24.1, 5.1. UPLC-MS (ESI) (A): <i>m/z</i> 464 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.16 min).</div></div><div id="sec4_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)-<i>N</i>-(2,2,2-trifluoroethyl)benzenesulfonamide (<b>34</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)-<i>N-</i>(2,2,2-trifluoroethyl)benzenesulfonamide <b>27</b> (100 mg, 0.285 mmol) and 2-bromo-1-(2,4-difluorophenyl)ethanone (100 mg, 0.427 mmol) in acetone. Yield 16% (23.4 mg, 0.046 mmol), off-white amorphous solid, purity ≥90%. <sup>1</sup>H NMR* (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (s, 1H), 8.68 (s, 1H), 8.00 (dt, <i>J</i> = 6.57, 8.59 Hz, 1H), 7.88–7.93 (m, 2H), 7.74–7.81 (m, 2H), 7.51 (ddd, <i>J</i> = 2.40, 9.28, 11.56 Hz, 1H), 7.29 (dt, <i>J</i> = 2.40, 8.40 Hz, 1H), 4.82 (d, <i>J</i> = 2.53 Hz, 2H), 3.73 (q, <i>J</i> = 9.60 Hz, 2H), 1.79 (s, 3H). *Alk position is proven by HSQC and HMBC NMR. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.0 (d, <i>J</i> = 5.2 Hz), 174.5, 165.7 (dd, <i>J</i> = 255.4, 13.2 Hz), 162.5 (dd, <i>J</i> = 257.6, 13.2 Hz), 155.0, 143.9, 140.5, 132.6 (dd, <i>J</i> = 11.0, 3.7 Hz), 126.6<sup>**</sup>, 124.3 (q, <i>J</i> = 278.1 Hz), 119.4 (dd, <i>J</i> = 13.2, 3.7 Hz), 112.8 (dd, <i>J</i> = 22.0, 3.2 Hz), 105.4 (t, <i>J</i> = 26.8 Hz), 63.2, 47.3 (d, <i>J</i> = 10.2 Hz), 43.3 (q, <i>J</i> = 34.8 Hz), 25.0. <sup>**</sup>Two peaks possess the identical chemical shift (proven by HSQC). UPLC-MS (ESI) (A): <i>m/z</i> 504 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.14 min).</div></div><div id="sec4_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-(1-(2-(2,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)-<i>N</i>-phenylbenzenesulfonamide (<b>35</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)-<i>N-</i>phenylbenzenesulfonamide <b>28</b> (100 mg, 0.290 mmol) and 2-chloro-2′,4′-difluoroacetophenone (83 mg, 0.434 mmol). Yield 13% (21 mg, 0.038 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.38 (s, 1H), 9.11 (s, 1H), 7.99 (dt, <i>J</i> = 6.57, 8.59 Hz, 1H), 7.80–7.87 (m, 2H), 7.72 (d, <i>J</i> = 8.59 Hz, 2H), 7.49 (ddd, <i>J</i> = 2.40, 9.22, 11.62 Hz, 1H), 7.20–7.32 (m, 3H), 7.09–7.15 (m, 2H), 6.98–7.06 (m, 1H), 4.79 (d, <i>J</i> = 2.53 Hz, 2H), 1.75 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.0 (d, <i>J</i> = 4.4 Hz), 174.4,), 165.7 (dd, <i>J</i> = 255.3, 12.6 Hz), 162.4 (dd, <i>J</i> = 257.6, 13.2 Hz), 154.9, 143.9, 139.4, 137.6, 132.6 (dd, <i>J</i> = 11.1, 3.9 Hz), 129.2, 126.9, 126.7, 124.0, 119.7, 119.4 (dd, <i>J</i> = 13.9, 3.0 Hz), 112.8 (dd, <i>J</i> = 21.9, 2.9 Hz), 105.4 (t, <i>J</i> = 27.1 Hz), 63.2, 47.3 (d, <i>J</i> = 11.7 Hz), 24.8. UPLC-MS (ESI) (A)<b>:</b><i>m/z</i> 498 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.21 min).</div></div><div id="sec4_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-(2-(2,4-Difluorophenyl)-2-oxoethyl)-5-methyl-5-(4-(morpholinosulfonyl)phenyl)imidazolidine-2,4-dione (<b>36</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 5-methyl-5-(4-(morpholinosulfonyl)phenyl)imidazolidine-2,4-dione <b>29</b> (200 mg, 0.589 mmol) and 2-chloro-1-(2,4-difluorophenyl)ethanone (124 mg, 0.648 mmol). Yield 84% (243 mg, 0.492 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.22 (s, 1H), 7.95–8.08 (m, 1H), 7.77–7.89 (m, 4H), 7.50 (ddd, <i>J</i> = 2.27, 9.47, 11.49 Hz, 1H), 7.28 (dt, <i>J</i> = 2.15, 8.40 Hz, 1H), 4.82 (d, <i>J</i> = 2.27 Hz, 2H), 3.55–3.69 (m, 4H), 2.80–2.92 (m, 4H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.0 (d, <i>J</i> = 4.39 Hz), 174.4, 165.7 (dd, <i>J</i> = 13.17, 256.14 Hz), 162.5 (dd, <i>J</i> = 13.17, 257.61 Hz), 155.0, 144.6, 134.3, 132.6 (dd, <i>J</i> = 3.66, 10.98 Hz), 128.0, 126.8, 119.5 (dd, <i>J</i> = 3.66, 13.17 Hz), 112.8 (m, <i>J</i> = 2.93, 21.22 Hz), 105.4 (t, <i>J</i> = 27.10 Hz), 65.2, 63.2, 47.3 (d, <i>J</i> = 10.98 Hz), 45.9, 25.1. UPLC-MS (ESI) (A) <i>m/z</i> 494 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.23 min),</div></div><div id="sec4_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-(4-Methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile (<b>37</b>)</h4><div class="NLM_p last">The title compound was prepared as reported previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec4_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-phenylethyl)imidazolidin-4-yl)benzenesulfonamide (<b>38</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-1-phenylethanone (55.4 mg, 0.279 mmol). Yield 50% (36 mg, 0.093 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (br s, 1H), 8.02–8.07 (m, 2H), 7.86–7.91 (m, 2H), 7.69–7.78 (m, 3H), 7.55–7.61 (m, 2H), 7.39 (s, 2H), 4.99 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.1, 174.8, 155.1, 143.8, 143.0, 134.2, 133.9, 129.0, 128.1, 126.3, 125.9, 63.2, 44.6, 24.9. UPLC-MS (ESI) (A): <i>m/z</i> 386 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 0.99 min).</div></div><div id="sec4_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-phenylethyl)imidazolidin-4-yl)benzonitrile (<b>39</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-phenyl-ethanone (71.2 mg, 0.358 mmol). Yield 64% (69 mg, 0.207 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (s, 1H), 7.92 (d, <i>J</i> = 8.53 Hz, 2H), 7.88 (d, <i>J</i> = 7.28 Hz, 1H), 7.72 (d, <i>J</i> = 8.53 Hz, 2H), 7.46–7.55 (m, 1H), 7.30–7.39 (m, 2H), 4.82 (s, 2H), 2.38 (s, 3H), 1.75 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 195.8, 174.4, 155.1, 144.6, 138.0, 134.4, 132.6, 132.3, 131.9, 128.9, 126.7, 126.0, 118.5, 111.0, 63.3, 46.3, 25.0, 20.6. UPLC-MS (ESI) (B) <i>m/z</i> 332 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.62 min).</div></div><div id="sec4_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-(1-(2-(2-Fluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>40</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (100 mg, 0.371 mmol) and 2-bromo-1-(2-fluorophenyl)ethanone (121 mg, 0.557 mmol). Yield 64% (96 mg, 0.237 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (s, 1H), 7.84–7.94 (m, 3H), 7.71–7.80 (m, 3H), 7.32–7.49 (m, 4H), 4.82 (d, <i>J</i> = 2.53 Hz, 2H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.3 (d, <i>J</i> = 4.4 Hz), 174.6, 161.5 (d, <i>J</i> = 254.7 Hz), 155.0, 143.8, 142.9, 136.3 (d, <i>J</i> = 9.5 Hz), 130.3 (d, <i>J</i> = 2.2 Hz), 126.3, 125.9, 125.1 (d, <i>J</i> = 2.9 Hz), 122.4 (d, <i>J</i> = 13.2 Hz), 117.0 (d, <i>J</i> = 22.7 Hz), 63.2, 47.4 (d, <i>J</i> = 10.2 Hz), 24.8. UPLC-MS (ESI) (A): <i>m/z</i> 404 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.23 min).</div></div><div id="sec4_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-(1-(2-(2-Fluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile (<b>41</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-(2-fluorophenyl)ethanone (78 mg, 0.358 mmol). White solid, yield 64% (73 mg, 0.208 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.23 (s, 1H), 7.94 (d, <i>J</i> = 8.53 Hz, 2H), 7.89 (dt, <i>J</i> = 1.51, 7.53 Hz, 1H), 7.71–7.79 (m, 3H), 7.36–7.46 (m, 2H), 4.82 (d, <i>J</i> = 2.26 Hz, 2H), 1.78 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.3 (d, <i>J</i> = 4.40 Hz), 174.4, 161.5 (d, <i>J</i> = 254.57 Hz), 155.0, 144.6, 136.4 (d, <i>J</i> = 9.54 Hz), 132.6, 130.4 (d, <i>J</i> = 2.20 Hz), 126.8, 125.2 (d, <i>J</i> = 2.93 Hz), 122.4 (d, <i>J</i> = 13.21 Hz), 118.5, 117.1 (d, <i>J</i> = 22.74 Hz), 111.1, 63.3, 47.5 (d, <i>J</i> = 11.00 Hz), 24.9 UPLC-MS (ESI) (B) <i>m/z</i> 350 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.59 min).</div></div><div id="sec4_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-(1-(2-(3-Fluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>42</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-3′-fluoroacetophenone (60.4 mg, 0.279 mmol). Yield 45% (34 mg, 0.084 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (s, 1H), 7.81–7.92 (m, 4H), 7.72–7.77 (m, 2H), 7.55–7.67 (m, 2H), 7.39 (s, 2H), 5.01 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.4 (d, <i>J</i> = 2.4 Hz), 174.7, 162.1 (d, <i>J</i> = 245.9 Hz), 155.1, 143.8, 142.9, 136.0 (d, <i>J</i> = 6.6 Hz), 131.2 (d, <i>J</i> = 7.3 Hz), 126.3, 125.9, 124.4 (d, <i>J</i> = 2.9 Hz), 121.2 (d, <i>J</i> = 21.2 Hz), 114.8 (d, <i>J</i> = 22.7 Hz), 63.2, 44.8, 24.9. UPLC-MS (ESI) (A): <i>m/z</i> 406 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.0 min).</div></div><div id="sec4_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-(1-(2-(3-Fluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile (<b>43</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-(3-fluorophenyl)ethan-1-one (78 mg, 0,358 mmol). White solid, yield 63% (72 mg, 0.205 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (s, 1H), 7.94 (d, <i>J</i> = 8.53 Hz, 2H), 7.89 (d, <i>J</i> = 7.53 Hz, 1H), 7.85 (dd, <i>J</i> = 2.01, 9.54 Hz, 1H), 7.76 (d, <i>J</i> = 8.53 Hz, 2H), 7.55–7.68 (m, 2H), 5.02 (s, 2H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.4 (d, <i>J</i> = 2.20 Hz), 174.5, 162.2 (d, <i>J</i> = 245.77 Hz), 155.0, 144.6, 136.0 (d, <i>J</i> = 6.60 Hz), 132.6, 131.3 (d, <i>J</i> = 8.07 Hz), 126.7, 124.4 (d, <i>J</i> = 2.20 Hz), 121.2 (d, <i>J</i> = 21.28 Hz), 118.5, 114.8 (d, <i>J</i> = 22.00 Hz), 111.1, 63.3, 44.9, 25.0. UPLC-MS (ESI) (B) <i>m/z</i> 350 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.61 min).</div></div><div id="sec4_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-(1-(2-(4-Fluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>44</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (100 mg, 0.371 mmol) and 2-bromo-1-(4-fluorophenyl)ethanone (121 mg, 0.557 mmol). Yield 65% (98 mg, 0.242 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (s, 1H), 8.10–8.20 (m, 2H), 7.86–7.92 (m, 2H), 7.72–7.79 (m, 2H), 7.35–7.47 (m, 4H), 4.99 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.8, 174.8, 165.5 (d, <i>J</i> = 253.2 Hz), 155.1, 143.8, 143.0, 131.3 (d, <i>J</i> = 9.5 Hz), 130.7 (d, <i>J</i> = 2.9 Hz), 126.3, 125.9, 116.1 (d, <i>J</i> = 22.0 Hz), 63.2, 44.6, 24.9. UPLC-MS (ESI) (A): <i>m/z</i> 404 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.24 min).</div></div><div id="sec4_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(1-(2-(3,4-Difluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>45</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 2-bromo-1-(3,4-difluorophenyl)ethanone (98 mg, 0.418 mmol). Yield 54% (63.6 mg, 0.150 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.22 (s, 1H), 8.08–8.18 (m, 1H), 7.95 (d, <i>J</i> = 6.27 Hz, 1H), 7.88 (d, <i>J</i> = 8.53 Hz, 2H), 7.75 (d, <i>J</i> = 8.53 Hz, 2H), 7.61–7.71 (m, 1H), 7.41 (s, 2H), 5.02 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.4, 174.8, 155.1, 153.3 (dd, <i>J</i> = 255.3, 13.2 Hz), 149.6 (dd, <i>J</i> = 248.7, 13.2 Hz), 143.8, 143.0, 131.2–131.5 (m), 126.3, 126.2–126.3 (m), 126.0, 118.3 (d, <i>J</i> = 17.6 Hz), 117.8 (d, <i>J</i> = 18.3 Hz), 63.3, 44.7, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 424 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.50 min).</div></div><div id="sec4_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-(1-(2-(3-Chloro-4-fluorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>46</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-3′-chloro-4′-fluoroacetophenone (70.0 mg, 0.279 mmol). Yield 65% (53 mg, 0.120 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.16–9.23 (m, 1H), 8.29 (dd, <i>J</i> = 2.15, 7.20 Hz, 1H), 8.08 (ddd, <i>J</i> = 2.27, 4.74, 8.65 Hz, 1H), 7.85–7.91 (m, 2H), 7.72–7.78 (m, 2H), 7.64 (t, <i>J</i> = 8.97 Hz, 1H), 7.40 (s, 2H), 5.03 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.4 (s), 174.7 (s), 160.6 (d, <i>J</i> = 255.4 Hz), 155.0 (s), 143.8 (s), 142.9 (s), 131.7 (d, <i>J</i> = 3.7 Hz), 131.1 (s), 129.7 (d, <i>J</i> = 8.8 Hz), 126.3 (s), 125.9 (s), 120.6 (d, <i>J</i> = 18.3 Hz), 117.6 (d, <i>J</i> = 22.0 Hz), 63.2 (s), 44.6 (s), 24.9 (s). UPLC-MS (ESI) (A): <i>m/z</i> 438 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.06 min).</div></div><div id="sec4_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(1-(2-(2,4-Dichlorophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>47</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (100 mg, 0.371 mmol) and 2-bromo-2′,4′-dichloroacetophenone (100 mg, 0.371 mmol). Yield 53% (100.3 mg, 0.198 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (s, 1H), 7.84–7.89 (m, 3H), 7.79 (d, <i>J</i> = 2.02 Hz, 1H), 7.68–7.72 (m, 2H), 7.60 (dd, <i>J</i> = 2.02, 8.34 Hz, 1H), 7.39 (s, 2H), 4.84 (s, 2H), 1.76 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.4, 174.4, 154.8, 143.8, 142.8, 137.4, 133.4, 132.0, 131.4, 130.5, 127.7, 126.2, 125.9, 63.2, 46.7, 24.9. UPLC-MS (ESI) (A): <i>m/z</i> 456 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.14 min). HRMS (ESI) <i>m/z</i> calcd for C<sub>18</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup>: 478.0002; found: 478.0024.</div></div><div id="sec4_5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-(1-(2-(3-Bromophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>48</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (150 mg, 0.557 mmol) and 2-bromo-1-(3-bromophenyl)ethanone (232 mg, 0.836 mmol). Yield 53% (138.6 mg, 0.297 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (br s, 1H), 8.19 (s, 1H), 8.03 (d, <i>J</i> = 7.78 Hz, 1H), 7.83–7.96 (m, 3H), 7.74 (d, <i>J</i> = 8.53 Hz, 2H), 7.54 (t, <i>J</i> = 7.91 Hz, 1H), 7.41 (br s, 2H), 5.02 (s, 2H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.5, 174.7, 155.1, 143.8, 143.0, 136.9, 135.9, 131.2, 130.8, 127.2, 126.3, 126.0, 122.3, 63.3, 44.7, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 466, 468 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.58 min).</div></div><div id="sec4_5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-(2-(4-(4-Cyanophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl)acetyl)-5-fluorophenyl Pivalate (<b>49</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-(2-bromoacetyl)-5-fluorophenyl pivalate <b>S-11</b> (113 mg, 0.358 mmol). Yield 91% (134 mg, 0.297 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (s, 1H), 8.13 (dd, <i>J</i> = 6.27, 8.78 Hz, 1H), 7.91 (d, <i>J</i> = 8.53 Hz, 2H), 7.71–7.77 (m, 2H), 7.25–7.38 (m, 2H), 4.75–4.88 (m, 2H), 1.76 (s, 3H), 1.21–1.26 (m, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.5, 175.6, 174.4, 164.6 (d, <i>J</i> = 253.11 Hz), 155.0, 151.1 (d, <i>J</i> = 11.74 Hz), 144.6, 132.5, 132.3 (d, <i>J</i> = 11.01 Hz), 126.8, 124.9 (d, <i>J</i> = 2.93 Hz), 118.5, 113.5 (d, <i>J</i> = 22.01 Hz), 112.2 (d, <i>J</i> = 24.21 Hz), 111.0, 63.2, 46.1, 38.5, 26.6, 24.7. UPLC-MS (ESI) (B) <i>m/z</i> 450 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.86 min).</div></div><div id="sec4_5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-(1-(2-(4-Fluoro-2-hydroxyphenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile (<b>50</b>)</h4><div class="NLM_p last">2-(2-(4-(4-Cyanophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl)acetyl)-5-fluorophenyl pivalate <b>49</b> (100 mg, 0.222 mmol) was dissolved in a mixture of THF (5 mL) and water (5 mL). Lithium hydroxide (21.22 mg, 0.886 mmol) was added, and the reaction mixture was stirred at rt for 30 min. Subsequently, the mixture was acidified with 1 M HCl to pH ∼5 to 6, and a precipitate formed, which was filtered, washed with water, and dried to provide the title compound. Yield 80% (65 mg, 0.177 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.68 (br s, 1H), 9.18 (s, 1H), 7.90–7.99 (m, 2H), 7.87 (dd, <i>J</i> = 6.90, 9.66 Hz, 1H), 7.73–7.80 (m, 2H), 6.76–6.85 (m, 2H), 4.83 (s, 2H), 1.78 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.1, 174.6, 166.4 (d, <i>J</i> = 253.11 Hz), 161.6 (d, <i>J</i> = 12.47 Hz), 155.2, 144.7, 133.0 (d, <i>J</i> = 11.74 Hz), 132.6, 126.8, 118.5, 118.0 (d, <i>J</i> = 2.20 Hz), 111.0, 107.4 (d, <i>J</i> = 22.74 Hz), 104.0 (d, <i>J</i> = 24.21 Hz), 63.2, 47.3, 25.0. UPLC-MS (ESI) (B) <i>m/z</i> 366 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.68 min).</div></div><div id="sec4_5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-(1-(2-(4-Fluoro-2-hydroxyphenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>51</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (100 mg, 0.371 mmol) and 2-(2-bromoacetyl)-5-fluorophenyl pivalate <b>S-11</b> (130 mg, 0.409 mmol). Yield 20% (32 mg, 0.076 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.16 (s, 1H), 7.83–7.94 (m, 3H), 7.76 (d, <i>J</i> = 8.53 Hz, 2H), 7.42 (s, 2H), 6.75–6.88 (m, 2H), 4.84 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.1, 174.8, 166.3 (d, <i>J</i> = 253.1 Hz), 161.5 (d, <i>J</i> = 13.2 Hz), 155.3, 143.8, 143.1, 133.0 (d, <i>J</i> = 12.5 Hz), 126.3, 125.9, 118.0 (d, <i>J</i> = 2.2 Hz), 107.4 (d, <i>J</i> = 22.7 Hz), 104.0 (d, <i>J</i> = 23.5 Hz), 63.2, 47.2, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 422 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.45 min).</div></div><div id="sec4_5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(<i>o</i>-tolyl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>52</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 2-bromo-1-(<i>o</i>-tolyl)ethanone (89 mg, 0.418 mmol). Yield 40% (44.6 mg, 0.111 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.10 (s, 1H), 7.76–7.84 (m, 3H), 7.63 (d, <i>J</i> = 8.53 Hz, 2H), 7.40–7.47 (m, 1H), 7.34 (s, 2H), 7.24–7.31 (m, 2H), 4.75 (s, 2H), 2.32 (s, 3H), 1.69 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 195.8, 174.7–174.8 (m), 155.2, 143.8, 143.0, 138.0, 134.4, 132.4, 131.9, 128.9, 126.3, 126.1, 125.9, 63.2, 46.3, 24.9, 20.7. UPLC-MS (ESI) (B): <i>m/z</i> 402 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.48 min).</div></div><div id="sec4_5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(<i>o</i>-tolyl)ethyl)imidazolidin-4-yl)benzonitrile (<b>53</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-(<i>o</i>-tolyl)ethan-1-one (76 mg, 0,358 mmol). Yield 81% (91 mg, 0.262 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (s, 1H), 7.92 (d, <i>J</i> = 8.53 Hz, 2H), 7.88 (d, <i>J</i> = 7.28 Hz, 1H), 7.72 (d, <i>J</i> = 8.53 Hz, 2H), 7.46–7.55 (m, 1H), 7.30–7.39 (m, 2H), 4.82 (s, 2H), 2.38 (s, 3H), 1.75 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 195.8, 174.4, 155.1, 144.6, 138.0, 134.4, 132.6, 132.3, 131.9, 128.9, 126.7, 126.0, 118.5, 111.0, 63.3, 46.3, 25.0, 20.6. UPLC-MS (ESI) (B) <i>m/z</i> 346 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.67 min).</div></div><div id="sec4_5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(<i>m</i>-tolyl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>54</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 2-bromo-1-(<i>m</i>-tolyl)ethanone (52.2 mg, 0.245 mmol). Yield 44% (39 mg, 0.097 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (s, 1H), 7.81–7.90 (m, 4H), 7.75 (d, <i>J</i> = 8.53 Hz, 2H), 7.50–7.56 (m, 1H), 7.39–7.49 (m, 3H), 4.96 (s, 2H), 2.38 (s, 3H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.3, 174.9, 155.2, 143.8, 143.0, 138.5, 134.9, 134.0, 128.9, 128.6, 126.4, 126.0, 125.4, 63.3, 44.7, 24.9, 20.9. UPLC-MS (ESI) (B): <i>m/z</i> 402 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.54 min).</div></div><div id="sec4_5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(<i>m</i>-tolyl)ethyl)imidazolidin-4-yl)benzonitrile (<b>55</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-(<i>m</i>-tolyl)ethanone (76 mg, 0.358 mmol). Yield 76% (86 mg, 0.248 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.23 (s, 1H), 7.94 (d, <i>J</i> = 8.28 Hz, 2H), 7.80–7.86 (m, 2H), 7.77 (d, <i>J</i> = 8.53 Hz, 2H), 7.50–7.55 (m, 1H), 7.40–7.49 (m, 1H), 4.96 (s, 2H), 2.38 (s, 3H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ192.2, 174.6, 155.1, 144.6, 138.5, 134.9, 134.0, 132.6, 128.9, 128.5, 126.8, 125.4, 118.5, 111.1, 63.3, 44.7, 25.0, 20.8. UPLC-MS (ESI) (B) <i>m/z</i> 346 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.67 min).</div></div><div id="sec4_5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(<i>p</i>-tolyl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>56</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-1-(<i>p-</i>tolyl)ethanone (59.3 mg, 0.279 mmol). Yield 38% (28.6 mg, 0.071 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (s, 1H), 7.95 (d, <i>J</i> = 8.28 Hz, 2H), 7.87–7.92 (m, 2H), 7.74–7.78 (m, 2H), 7.41 (s, 2H), 7.37–7.41 (m, 2H), 4.95 (s, 2H), 2.41 (s, 3H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.5, 174.8, 155.2, 144.9, 143.8, 143.0, 131.5, 129.5, 128.2, 126.3, 125.9, 63.2, 44.5, 24.9, 21.3. UPLC-MS (ESI) (B): <i>m/z</i> 402 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.50 min).</div></div><div id="sec4_5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(<i>p</i>-tolyl)ethyl)imidazolidin-4-yl)benzonitrile (<b>57</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-(4-methylphenyl)-ethanone (76 mg, 0.358 mmol). Yield 78% (88 mg, 0.253 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.22 (s, 1H), 7.90–7.97 (m, 4H), 7.77 (d, <i>J</i> = 8.53 Hz, 2H), 7.38 (d, <i>J</i> = 8.03 Hz, 2H), 4.95 (s, 2H), 2.40 (s, 3H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.5, 174.6, 155.2, 144.9, 144.7, 132.6, 131.5, 129.5, 128.3, 126.8, 118.5, 111.1, 63.3, 44.6, 25.0, 21.3. UPLC-MS (ESI) (B) <i>m/z</i> 346 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.73 min).</div></div><div id="sec4_5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-(1-(2-(2-Methoxyphenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>58</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-1-(2-methoxyphenyl)ethanone (63.8 mg, 0.279 mmol). Yield 13% (10.2 mg, 0.024 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.13 (s, 1H), 7.84–7.92 (m, 2H), 7.70–7.78 (m, 3H), 7.65 (ddd, <i>J</i> = 1.76, 7.15, 8.66 Hz, 1H), 7.40 (s, 2H), 7.24 (d, <i>J</i> = 8.28 Hz, 1H), 7.03–7.12 (m, 1H), 4.74 (s, 2H), 3.94 (s, 3H), 1.78 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.3, 174.7, 159.5, 155.3, 143.8, 143.1, 135.5, 130.2, 126.3, 125.9, 123.7, 120.8, 112.8, 63.1, 56.0, 48.4, 24.8. UPLC-MS (ESI) (B): <i>m/z</i> 418 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.46 min).</div></div><div id="sec4_5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 4-(1-(2-(3-Methoxyphenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>59</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-1-(3-methoxyphenyl)ethanone (63.8 mg, 0.279 mmol). Yield 48% (36.8 mg, 0.088 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (s, 1H), 7.88 (d, <i>J</i> = 8.28 Hz, 2H), 7.75 (d, <i>J</i> = 8.53 Hz, 2H), 7.64 (d, <i>J</i> = 7.53 Hz, 1H), 7.46–7.54 (m, 2H), 7.40 (s, 2H), 7.28 (dd, <i>J</i> = 2.13, 8.16 Hz, 1H), 4.98 (s, 2H), 3.83 (s, 3H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.0, 174.8, 159.5, 155.2, 143.8, 143.0, 135.3, 130.2, 126.3, 125.9, 120.6, 120.4, 112.5, 63.2, 55.4, 44.8, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 418 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.45 min).</div></div><div id="sec4_5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-(1-(2-(4-Methoxyphenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>60</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-1-(4-methoxyphenyl)ethanone (63.8 mg, 0.279 mmol). Yield 32% (25.0 mg, 0.060 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.16 (s, 1H), 7.98–8.06 (m, 2H), 7.85–7.91 (m, 2H), 7.72–7.79 (m, 2H), 7.40 (br s, 2H), 7.05–7.12 (m, 2H), 4.92 (s, 2H), 3.86 (s, 3H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.2, 174.9, 163.9, 155.3, 143.8, 143.1, 130.5, 126.9, 126.3, 126.0, 114.2, 63.2, 55.7, 44.3, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 418 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.44 min).</div></div><div id="sec4_5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(2-(trifluoromethyl)phenyl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>61</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-1-(2-(trifluoromethyl)phenyl)ethanone (74.4 mg, 0.279 mmol). Yield 36% (30.4 mg, 0.067 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.23 (s, 1H), 7.77–7.92 (m, 6H), 7.71 (d, <i>J</i> = 8.53 Hz, 2H), 7.40 (s, 2H), 4.82 (s, 2H), 1.78 (s, 3H). <sup>13</sup>C NMR* (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 196.0, 174.4, 154.8, 143.8, 142.9, 135.7–135.8 (m), 132.8, 132.0, 128.4, 127.1 (q, <i>J</i> = 5.1 Hz), 126.2, 125.9, 123.3 (q, <i>J</i> = 273.6 Hz), 63.2, 46.8, 25.0. *Cq with <sup>2</sup><i>J</i><sub>CF</sub> was not detected<i>.</i> UPLC-MS (ESI) (B): <i>m/z</i> 456 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.55 min).</div></div><div id="sec4_5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(3-(trifluoromethyl)phenyl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>62</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 2-bromo-1-(3-(trifluoromethyl)phenyl)ethanone (112 mg, 0.418 mmol). Yield 19% (24.3 mg, 0.053 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (br s, 1H), 8.29–8.40 (m, 2H), 8.10 (d, <i>J</i> = 7.78 Hz, 1H), 7.89 (d, <i>J</i> = 8.53 Hz, 2H), 7.84 (t, <i>J</i> = 7.78 Hz, 1H), 7.76 (d, <i>J</i> = 8.53 Hz, 2H), 7.42 (s, 2H), 5.12 (s, 2H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.8, 174.8, 155.1, 143.8, 143.0, 134.7, 132.3, 130.6 (q, <i>J</i> = 3.7 Hz), 130.4, 129.7 (q, <i>J</i> = 32.3 Hz), 126.4, 126.0, 124.7 (q, <i>J</i> = 3.7 Hz), 123.7 (q, <i>J</i> = 272.9 Hz), 63.3, 44.9, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 454 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.55 min).</div></div><div id="sec4_5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(4-(trifluoromethyl)phenyl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>63</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 2-bromo-1-(4-(trifluoromethyl)phenyl)ethanone (74.4 mg, 0.279 mmol). Yield 54% (46 mg, 0.101 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (br s, 1H), 8.24 (d, <i>J</i> = 8.08 Hz, 2H), 7.96 (d, <i>J</i> = 8.34 Hz, 2H), 7.85–7.92 (m, 2H), 7.71–7.79 (m, 2H), 7.40 (br s, 2H), 5.07 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.0, 174.7, 155.0, 143.8, 142.9, 137.1, 133.3 (q, <i>J</i> = 32.2 Hz), 129.1, 126.3, 125.9*, 123.6 (q, <i>J</i> = 273.0 Hz), 63.3, 44.9, 24.9. *Two peaks possess the identical chemical shift (proven by HSQC). UPLC-MS (ESI) (A): <i>m/z</i> 454 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.09 min).</div></div><div id="sec4_5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 4-(1-(2-(3-Cyanophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>64</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 3-(2-bromoacetyl)benzonitrile (74.9 mg, 0.334 mmol). Yield 36% (32.6 mg, 0.079 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (s, 1H), 8.55 (s, 1H), 8.31 (d, <i>J</i> = 8.03 Hz, 1H), 8.19 (d, <i>J</i> = 7.78 Hz, 1H), 7.89 (d, <i>J</i> = 8.53 Hz, 2H), 7.72–7.83 (m, 3H), 7.43 (s, 2H), 5.09 (s, 2H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.4, 174.8, 155.1, 143.8, 143.0, 137.4, 134.6, 132.5, 132.3, 130.3, 126.3, 126.0, 118.0, 112.2, 63.3, 44.8, 25.0. UPLC-MS (ESI) (B): <i>m/z</i> 411 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.28 min).</div></div><div id="sec4_5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-(1-(2-(4-Cyanophenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>65</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (50 mg, 0.186 mmol) and 4-(2-bromoacetyl)benzonitrile (62.4 mg, 0.279 mmol). Yield 16% (12.3 mg, 0.030 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (br s, 1H), 8.19 (d, <i>J</i> = 8.59 Hz, 2H), 8.07 (d, <i>J</i> = 8.59 Hz, 2H), 7.85–7.93 (m, 2H), 7.70–7.80 (m, 2H), 7.40 (br s, 2H), 5.07 (s, 2H), 1.80 (s, 3H).<sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.0, 174.7, 155.0, 143.8, 142.9, 137.0, 133.0, 128.8, 126.3, 125.9, 118.0, 116.1, 63.3, 44.9, 24.9. UPLC-MS (ESI) (A): <i>m/z</i> 411 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 0.97 min).</div></div><div id="sec4_5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-(4-Methyl-1-(2-(3-nitrophenyl)-2-oxoethyl)-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>66</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 3-nitrophenacyl bromide (82 mg, 0.334 mmol). Yield 48% (46.2 mg, 0.107 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (s, 1H), 8.71 (s, 1H), 8.53 (dd, <i>J</i> = 1.51, 8.28 Hz, 1H), 8.47 (d, <i>J</i> = 7.78 Hz, 1H), 7.84–7.92 (m, 3H), 7.75 (d, <i>J</i> = 8.53 Hz, 2H), 7.42 (s, 2H), 5.14 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.4, 174.7, 155.1, 148.1, 143.8, 143.0, 135.1, 134.5, 130.8, 128.4, 126.3, 126.0, 122.7, 63.3, 44.9, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 431 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.38 min).</div></div><div id="sec4_5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(3-(trifluoromethoxy)phenyl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>67</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 2-bromo-1-(3-(trifluoromethoxy)phenyl)ethanone (95 mg, 0.334 mmol). Yield 24% (25.6 mg, 0.054 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (s, 1H), 8.07–8.16 (m, 1H), 7.96 (s, 1H), 7.90 (d, <i>J</i> = 8.28 Hz, 2H), 7.72–7.80 (m, 4H), 7.43 (s, 2H), 5.07 (s, 2H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.5, 174.8, 155.1, 148.6, 143.8, 143.0, 135.9, 131.4, 127.5, 126.7, 126.3, 126.0, 120.4, 120.0 (q, <i>J</i> = 257.6 Hz), 63.3, 44.9, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 472 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.55 min).</div></div><div id="sec4_5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(3-(trifluoromethoxy)phenyl)ethyl)imidazolidin-4-yl)benzonitrile (<b>68</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-(3-(trifluoromethoxy)phenyl)ethanone (101 mg, 0.358 mmol). Yield 71% (96 mg, 0.230 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (s, 1H), 8.05–8.15 (m, 1H), 7.90–7.98 (m, 3H), 7.70–7.79 (m, 4H), 5.06 (s, 2H), 1.79 (s, 3H).<sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) 191.5, 174.5, 155.0, 148.6 (d, <i>J</i> = 1.47 Hz), 144.6, 135.9, 132.6, 131.3, 127.5, 126.7, 120.4, 118.5, 120.0 (q, <i>J</i> = 256.80 Hz), 111.1, 63.3, 44.9, 25.0. UPLC-MS (ESI) (B) <i>m/z</i> 416 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.78 min).</div></div><div id="sec4_5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 4-(1-(2-(4-Fluoro-3-(trifluoromethyl)phenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>69</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 2-bromo-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone (95 mg, 0.334 mmol). Yield 80% (84.8 mg, 0.179 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.22 (s, 1H), 8.41–8.46 (m, 1H), 8.38 (d, <i>J</i> = 6.78 Hz, 1H), 7.89 (d, <i>J</i> = 8.53 Hz, 2H), 7.71–7.79 (m, 3H), 7.42 (s, 2H), 5.12 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.6, 174.8, 162.1 (dd, <i>J</i> = 261.9, 1.5 Hz), 155.1, 143.8, 143.0, 135.8 (d, <i>J</i> = 10.3 Hz), 130.9 (d, <i>J</i> = 2.9 Hz), 127.8–128.1 (m), 126.3, 126.0, 118.2 (d, <i>J</i> = 21.2 Hz), 122.1 (q, <i>J</i> = 272.2 Hz), 117.3 (qd, <i>J</i> = 33.0, 13.2 Hz), 63.3, 44.8, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 472 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.62 min).</div></div><div id="sec4_5_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 4-(1-(2-(4-Fluoro-3-(trifluoromethyl)phenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile (<b>70</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 4-fluoro-3-(trifluoromethyl)phenacylbromide (102 mg, 0,358 mmol). Yield 63% (86 mg, 0.205 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.26 (s, 1H), 8.39–8.46 (m, 1H), 8.36 (d, <i>J</i> = 6.78 Hz, 1H), 7.94 (d, <i>J</i> = 8.53 Hz, 2H), 7.70–7.80 (m, 3H), 5.12 (s, 2H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.6, 174.5, 162.0 (d, <i>J</i> = 261.91 Hz), 155.0, 144.6, 135.8 (d, <i>J</i> = 11.00 Hz), 132.6, 130.8 (d, <i>J</i> = 3.67 Hz), 127.9, 126.7, 118.5, 118.2 (d, <i>J</i> = 20.54 Hz), 122.1 (q, <i>J</i> = 272.20 Hz), 117.3 (ddd, <i>J</i> = 13.21, 33.01, 66.03 Hz), 111.1, 63.3, 44.8, 25.0. UPLC-MS (ESI) (B) <i>m/z</i> 418 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.78 min).</div></div><div id="sec4_5_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 4-(1-(2-(3,5-Bis(trifluoromethyl)phenyl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>71</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 1-(3,5-bis(trifluoromethyl)phenyl)-2-bromoethanone (112 mg, 0.334 mmol). Yield 38% (44.6 mg, 0.085 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.26 (s, 1H), 8.63 (s, 2H), 8.50 (s, 1H), 7.90 (d, <i>J</i> = 8.53 Hz, 2H), 7.76 (d, <i>J</i> = 8.53 Hz, 2H), 7.43 (s, 2H), 5.25 (s, 2H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.2, 174.7, 155.0, 143.9, 142.9, 135.9, 131.0 (q, <i>J</i> = 33.7 Hz), 128.8–129.2 (m), 127.2–127.5 (m), 126.3, 126.0, 122.9 (q, <i>J</i> = 272.9 Hz), 63.3, 45.1, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 522 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.68 min).</div></div><div id="sec4_5_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 4-(4-Methyl-2,5-dioxo-1-(2-oxopropyl)imidazolidin-4-yl)benzenesulfonamide (<b>72</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and chloroacetone (0.033 mL, 0.418 mmol). Yield 38% (34 mg, 0.105 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.10 (s, 1H), 7.85 (d, <i>J</i> = 8.53 Hz, 2H), 7.70 (d, <i>J</i> = 8.53 Hz, 2H), 7.39 (s, 2H), 4.33 (s, 2H), 2.16 (s, 3H), 1.74 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.1, 174.6, 155.1, 143.8, 143.0, 126.3, 125.9, 63.1, 47.2, 27.0, 24.8. UPLC-MS (ESI) (B): <i>m/z</i> 326 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 0.96 min).</div></div><div id="sec4_5_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 4-(1-(2-Cyclopropyl-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>73</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 2-bromo-1-cyclopropylethanone (68.1 mg, 0.418 mmol). Yield 15% (14.8 mg, 0.042 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.12 (s, 1H), 7.86 (d, <i>J</i> = 8.53 Hz, 2H), 7.71 (d, <i>J</i> = 8.53 Hz, 2H), 7.40 (s, 2H), 4.48 (s, 2H), 2.11–2.20 (m, 1H), 1.75 (s, 3H), 0.95–1.04 (m, 2H), 0.84–0.93 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 203.0, 174.6, 155.1, 143.8, 143.0, 126.3, 125.9, 63.1, 47.1, 24.8, 18.0, 10.9. UPLC-MS (ESI) (B): <i>m/z</i> 352 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.18 min).</div></div><div id="sec4_5_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 4-(1-(2-Cyclohexyl-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>74</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (90 mg, 0.334 mmol) and 2-bromo-1-cyclohexylethanone (103 mg, 0.501 mmol). Yield 69% (90.3 mg, 0.230 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.10 (s, 1H), 7.86 (d, <i>J</i> = 8.53 Hz, 2H), 7.71 (d, <i>J</i> = 8.53 Hz, 2H), 7.40 (s, 2H), 4.36 (s, 2H), 2.52–2.57 (m, 1H), 1.55–1.85 (m, 8H), 1.07–1.32 (m, 5H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 205.8, 174.6, 155.1, 143.8, 143.1, 126.3, 125.9, 63.1, 47.0, 45.2, 27.7, 25.3, 24.92, 24.86. UPLC-MS (ESI) (B): <i>m/z</i> 394 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.56 min).</div></div><div id="sec4_5_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 4-(1-(2-(Adamantan-1-yl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>75</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 1-(adamantan-1-yl)-2-bromoethanone (107 mg, 0.418 mmol). Yield 27% (34.0 mg, 0.076 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.10 (br s, 1H), 7.86 (d, <i>J</i> = 8.53 Hz, 2H), 7.70 (d, <i>J</i> = 8.53 Hz, 2H), 7.39 (br s, 2H), 4.40 (s, 2H), 1.99 (br s, 3H), 1.77–1.82 (m, 6H), 1.74 (s, 3H), 1.62–1.71 (m, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 206.9, 174.6, 155.1, 143.7, 143.0, 126.3, 125.9, 63.1, 44.8, 42.6, 37.1, 35.8, 27.2, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 446 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.70 min).</div></div><div id="sec4_5_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(pyridin-2-yl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>76</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 2-bromo-1-(pyridin-2-yl)ethanonehydrobromide (94 mg, 0.334 mmol). Yield 44% (38.2 mg, 0.098 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (s, 1H), 8.79 (d, <i>J</i> = 4.27 Hz, 1H), 8.04–8.11 (m, 1H), 7.97–8.01 (m, 1H), 7.89 (d, <i>J</i> = 8.53 Hz, 2H), 7.74–7.79 (m, 3H), 7.42 (s, 2H), 5.06 (s, 2H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.3, 174.8, 155.2, 150.8, 149.5, 143.8, 143.0, 138.0, 128.8, 126.4, 125.9, 121.9, 63.3, 44.3, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 389 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.28 min).</div></div><div id="sec4_5_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(pyridin-2-yl)ethyl)imidazolidin-4-yl)benzonitrile (<b>77</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-(pyridin-2-yl)ethanonehydrobromide (91 mg, 0.325 mmol). Yield 41% (44 mg, 0.132 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (s, 1H), 8.78 (d, <i>J</i> = 4.27 Hz, 1H), 8.03–8.11 (m, 1H), 7.90–8.01 (m, 3H), 7.71–7.81 (m, 3H), 5.05 (s, 2H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.3, 174.6, 155.2, 150.8, 149.6, 144.7, 138.0, 132.6, 128.9, 126.8, 121.9, 118.6, 111.1, 63.3, 44.4, 25.0. UPLC-MS (ESI) (B) <i>m/z</i> 333 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.52 min).</div></div><div id="sec4_5_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(pyridin-3-yl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>78</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 2-bromo-1-(pyridin-3-yl)ethanone hydrobromide (117 mg, 0.418 mmol). Yield 19% (20.1 mg, 0.052 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18–9.28 (m, 2H), 8.87 (dd, <i>J</i> = 1.51, 4.77 Hz, 1H), 8.38 (td, <i>J</i> = 1.88, 8.03 Hz, 1H), 7.90 (d, <i>J</i> = 8.53 Hz, 2H), 7.76 (d, <i>J</i> = 8.53 Hz, 2H), 7.62 (dd, <i>J</i> = 4.89, 7.91 Hz, 1H), 7.43 (s, 2H), 5.08 (s, 2H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.1, 174.8, 155.1, 154.4, 149.4, 143.8, 143.0, 135.8, 129.5, 126.4, 126.0, 124.1, 63.3, 44.8, 24.9. UPLC-MS (ESI) (C): <i>m/z</i> 389 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.88 min).</div></div><div id="sec4_5_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(pyridin-3-yl)ethyl)imidazolidin-4-yl)benzonitrile (<b>79</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-bromo-1-pyridin-3-ylethan-1-onehydrobromide (91 mg, 0.325 mmol). Yield 27% (29 mg, 0.087 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.26 (s, 1H), 9.21 (d, <i>J</i> = 1.76 Hz, 1H), 8.86 (dd, <i>J</i> = 1.51, 4.77 Hz, 1H), 8.37 (td, <i>J</i> = 1.79, 7.97 Hz, 1H), 7.95 (d, <i>J</i> = 8.28 Hz, 2H), 7.76 (d, <i>J</i> = 8.53 Hz, 2H), 7.61 (dd, <i>J</i> = 4.89, 7.91 Hz, 1H), 5.08 (s, 2H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.1, 174.5, 155.0, 154.4, 149.4, 144.6, 135.8, 132.7, 129.5, 126.8, 124.1, 118.5, 111.1, 63.3, 44.8, 25.0. UPLC-MS (ESI) (B) <i>m/z</i> 333 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.34 min).</div></div><div id="sec4_5_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(pyridin-4-yl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>80</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 2-bromo-1-(pyridin-4-yl)ethanone hydrobromide (117 mg, 0.418 mmol). Yield 12% (13.2 mg, 0.034 mmol), off-white amorphous solid, purity ≥90%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.17 (s, 1H), 8.79 (d, <i>J</i> = 6.02 Hz, 2H), 7.79–7.85 (m, 4H), 7.67 (d, <i>J</i> = 8.53 Hz, 2H), 7.35 (s, 2H), 4.99 (s, 2H), 1.73 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.0, 174.7, 155.0, 151.0, 143.8, 142.9, 139.8, 126.3, 126.0, 121.2, 63.3, 44.9, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 387 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.11 min).</div></div><div id="sec4_5_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(pyridin-4-yl)ethyl)imidazolidin-4-yl)benzonitrile (<b>81</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 4-(bromoacetyl) pyridinehydrobromide (91 mg, 0.325 mmol). Yield 7% (8 mg, 0.024 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.26 (s, 1H), 8.86 (d, <i>J</i> = 6.02 Hz, 2H), 7.94 (d, <i>J</i> = 8.28 Hz, 2H), 7.88–7.90 (m, 2H), 7.75 (d, <i>J</i> = 8.53 Hz, 2H), 5.06 (s, 2H), 1.78 (s, 3H). UPLC-MS (ESI) (B) <i>m/z</i> 333 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.34 min).</div></div><div id="sec4_5_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 4-(1-(2-(3,5-Difluoropyridin-2-yl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>82</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 2-bromo-1-(3,5-difluoropyridin-2-yl)ethanone<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (65.7 mg, 0.279 mmol). Yield 28% (33.2 mg, 0.078 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (s, 1H), 8.72 (d, <i>J</i> = 2.26 Hz, 1H), 8.20 (ddd, <i>J</i> = 2.26, 9.04, 11.04 Hz, 1H), 7.89 (d, <i>J</i> = 8.53 Hz, 2H), 7.76 (d, <i>J</i> = 8.53 Hz, 2H), 7.41 (s, 2H), 4.99 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.7 (d, <i>J</i> = 5.1 Hz), 174.7, 161.3 (dd, <i>J</i> = 267.0, 7.3 Hz), 158.5 (dd, <i>J</i> = 278.0, 8.1 Hz), 155.1, 143.8, 143.0, 135.9–136.2 (m), 134.4 (dd, <i>J</i> = 24.2, 5.1 Hz), 126.3, 125.9, 114.6 (t, <i>J</i> = 22.0 Hz), 63.2, 44.9, 24.9. UPLC-MS (ESI) (B): <i>m/z</i> 425 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.28 min).</div></div><div id="sec4_5_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(thiophen-2-yl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>83</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (75 mg, 0.279 mmol) and 2-bromo-1-(thiophen-2-yl)ethanone (86 mg, 0.418 mmol). Yield 39% (42.3 mg, 0.108 mmol), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (s, 1H), 8.17–8.21 (m, 1H), 8.12–8.16 (m, 1H), 7.89 (d, <i>J</i> = 8.53 Hz, 2H), 7.75 (d, <i>J</i> = 8.53 Hz, 2H), 7.42 (s, 2H), 7.33 (dd, <i>J</i> = 4.02, 4.77 Hz, 1H), 4.94 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.3, 174.8, 155.1, 143.8, 143.0, 140.1, 136.2, 134.6, 129.1, 126.4, 125.9, 63.2, 44.3, 24.8. UPLC-MS (ESI) (B): <i>m/z</i> 392 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.36 min).</div></div><div id="sec4_5_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 4-(1-(2-(5-Chlorothiophen-2-yl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>84</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 2-chloro-1-(5-chlorothiophen-2-yl)ethanone (47.8 mg, 0.245 mmol). Yield 43% (41 mg, 0.096 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.23 (s, 1H), 8.11 (d, <i>J</i> = 4.02 Hz, 1H), 7.88 (d, <i>J</i> = 8.53 Hz, 2H), 7.74 (d, <i>J</i> = 8.53 Hz, 2H), 7.36–7.47 (m, 3H), 4.93 (s, 2H), 1.79 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.0, 174.8, 155.0, 143.8, 142.9, 139.1, 138.9, 135.1, 129.4, 126.4, 126.0, 63.3, 43.9, 24.8. UPLC-MS (ESI) (B): <i>m/z</i> 428 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.54 min).</div></div><div id="sec4_5_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 4-(1-(2-(5-Chlorothiophen-2-yl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile (<b>85</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzonitrile <b>37</b> (70 mg, 0.325 mmol) and 2-chloro-1-(5-chlorothiophen-2-yl)ethanone (69.8 mg, 0.358 mmol). Yield 62% (75 mg, 0.201 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (s, 1H), 8.09 (d, <i>J</i> = 4.02 Hz, 1H), 7.94 (d, <i>J</i> = 8.28 Hz, 2H), 7.75 (d, <i>J</i> = 8.53 Hz, 2H), 7.40 (d, <i>J</i> = 4.02 Hz, 1H), 4.93 (s, 2H), 1.77 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 184.9, 174.5, 154.9, 144.5, 139.1, 138.9, 135.1, 132.7, 129.4, 126.8, 118.5, 111.1, 63.3, 43.9, 24.9. UPLC-MS (ESI) (B) <i>m/z</i> 372 [M – H]<sup>−</sup> (<i>R</i><sub>t</sub> = 1.69 min).</div></div><div id="sec4_5_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-(4-Methyl-2,5-dioxo-1-(2-oxo-2-(thiazol-2-yl)ethyl)imidazolidin-4-yl)benzenesulfonamide (<b>86</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 2-bromo-1-(thiazol-2-yl)ethanone (0.047 mL, 0.334 mmol). Yield 24% (21.2 mg, 0.054 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (s, 1H), 8.35 (d, <i>J</i> = 3.01 Hz, 1H), 8.24 (d, <i>J</i> = 3.01 Hz, 1H), 7.89 (d, <i>J</i> = 8.53 Hz, 2H), 7.75 (d, <i>J</i> = 8.53 Hz, 2H), 7.41 (s, 2H), 5.01 (s, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.0, 174.6, 163.3, 154.9, 145.6, 143.8, 142.9, 129.1, 126.3, 125.9, 63.3, 44.1, 24.8. UPLC-MS (ESI) (B): <i>m/z</i> 395 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.15 min).</div></div><div id="sec4_5_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 4-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)-2-oxoethyl)-4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>87</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 1-(benzo[<i>d</i>]thiazol-2-yl)-2-bromoethanone (57.1 mg, 0.223 mmol). Yield 7%* (7.3 mg, 0.016 mmol), off-white amorphous solid, purity ≥90%. <sup>1</sup>H NMR (400 MHz, Acetone-<i>d</i><sub>6</sub>) δ 8.26 (ddd, <i>J</i> = 2.13, 3.83, 7.09 Hz, 2H), 8.17 (s, 1H), 7.93–7.99 (m, 2H), 7.83–7.89 (m, 2H), 7.70 (dquin, <i>J</i> = 1.38, 7.18 Hz, 2H), 6.67 (s, 2H), 5.15–5.28 (m, 2H), 1.94 (s, 3H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.28 (s, 1H), 8.22–8.37 (m, 2H), 7.90 (d, <i>J</i> = 8.53 Hz, 2H), 7.76 (d, <i>J</i> = 8.53 Hz, 2H), 7.66–7.74 (m, 2H), 7.43 (s, 2H), 5.16 (s, 2H), 1.81 (s, 3H). UPLC-MS (ESI) (B): <i>m/z</i> 445, 446 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.59 min).</div></div><div id="sec4_5_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 4-(4-Methyl-1-(2-(naphthalen-2-yl)-2-oxoethyl)-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide (<b>88</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec4_3" aria-label="General Method B">General Method B</a> from 4-(4-methyl-2,5-dioxoimidazolidin-4-yl)benzenesulfonamide <b>23</b> (60 mg, 0.223 mmol) and 2-bromo-1-(naphthalen-2-yl)ethanone (83 mg, 0.334 mmol). Yield 63% (61 mg, 0.139 mmol), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.23 (s, 1H), 8.84 (s, 1H), 8.14 (d, <i>J</i> = 7.78 Hz, 1H), 7.96–8.10 (m, 3H), 7.90 (d, <i>J</i> = 8.53 Hz, 2H), 7.79 (d, <i>J</i> = 8.28 Hz, 2H), 7.64–7.76 (m, 2H), 7.43 (s, 2H), 5.15 (s, 2H), 1.83 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.1, 174.9, 155.3, 143.8, 143.1, 135.4, 132.0, 131.3, 130.6, 129.7, 129.2, 128.7, 127.8, 127.2, 126.4, 126.0, 123.2, 63.3, 44.7, 25.0. UPLC-MS (ESI) (B): <i>m/z</i> 438 [M + H]<sup>+</sup> (<i>R</i><sub>t</sub> = 1.56 min).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Strain and Growth Conditions</h3><div class="NLM_p last"><i>M. tuberculosis</i> H37Rv (ATC25618) wild-type or mutant strains were grown in a Middlebrook 7H9-ADC broth (Difco) supplemented with 0.025% tyloxapol and on a 7H10-OADC or 7H11-OADC agar (Difco) at 37 °C. Isoniazid was purchased from Sigma-Aldrich. The DprE1 spontaneous mutants C387S, L368P, and G17C were kindly provided by Stewart T. Cole (Institut Pasteur, Paris, France). The strains carrying the point mutations E221Q, G248S,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and Y314H<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> in DprE1 were generated via oligonucleotide-mediated recombineering as previously described.<a onclick="showRef(event, 'ref2 ref11 ref14 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref2 ref11 ref14 ref24 ref25">(2,11,14,24,25)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> MIC Determination</h3><div class="NLM_p last">MIC determination assay was performed using a resazurin reduction assay with fluorescence readout as described previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Isoniazid was used as a positive control and rifampicin was used as a no-growth control.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Microsomal Fraction Stability</h3><div class="NLM_p last">Microsomal fraction stability assays were performed as described previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The human biological samples were sourced ethically, and their research use was in accord with the terms of the informed consents.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> DprE1 Enzymatic Inhibition</h3><div class="NLM_p last">Expression and purification of Mt-DprE1 and cloning of Mt-DprE1 were performed as described by Batt et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Enzymatic data were generated using a modified version of the assay described in that report. The new protocol is in the process of being submitted for publication. DprE1 mutants were generated as previously described by Thulasi et al. in 2016.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> HepG2 Cytotoxicity Assay, Artificial Membrane Permeability (AMP), Kinetic Aqueous Solubility (CLND), and Hydrophobicity (chromlogD<sub>pH7.4</sub>)</h3><div class="NLM_p last">These assays were performed as described previously.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> hERG Inhibition</h3><div class="NLM_p last">Inhibition of the hERG potassium channel was determined using in vitro IonWorks patch-clamp electrophysiology as described in the literature.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Therapeutic Efficacy</h3><div class="NLM_p">All animal studies were ethically reviewed and carried out in accordance with European Directive 2010/63/EU and the GSK Policy on the Care, Welfare and Treatment of Animals. Specific pathogen-free 8–10 week-old female C57BL/6 mice were purchased from Harlan Laboratories and were allowed to acclimate for 1 week. Mice were infected intratracheally with 100,000 CFU/mouse (<i>M. tuberculosis</i> H37Rv strain). Compounds were orally administered for 4 consecutive days, starting from day 5 after infection. Lungs were harvested on day 9, 24 h after the last compound administration. All lung lobes were aseptically removed, homogenized, and frozen. Homogenates were plated in 10% OADC-7H11 medium supplemented with activated charcoal (0.4%) to avoid product carry over and incubated for 18 days at 37 °C. No adverse clinical signs were observed in any animal. Blood samples were obtained at different time points from the infected mice to measure the levels of the tested compounds.</div><div class="NLM_p">The number of CFU/mouse measured for each mouse and the differences in the lung microorganism burden (log10 CFUs/lungs) obtained in the treated mice with respect to untreated controls (day 9 after infection) were calculated. The CFU number in lungs of untreated mice is 7.4 log CFU. This value is included in the interval mean ± 2 SD of the values of the last experiments. Quality controls: In this experiment, moxifloxacin (100 mg/kg) was administered for 4 consecutive days starting from day 5 after infection as an interassay control. It reduced the bacterial lung number to 4.1 log CFU in comparison with the untreated mice (7.4 log CFU) (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Tables <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). This quality control value is included in the accepted interval.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Numbers of CFU/Lung Counted and Corresponding log<sub>10</sub> CFU/Lung Determined</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">log CFU per mouse (lungs)</th><th class="colsep0 rowsep0" colspan="2" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center" char=".">mouse 1</th><th class="colsep0 rowsep0" align="center" char=".">mouse 2</th><th class="colsep0 rowsep0" align="center">mouse 3</th><th class="colsep0 rowsep0" align="center">mouse 4</th><th class="colsep0 rowsep0" align="center">mouse 5</th><th class="colsep0 rowsep0" align="center" char=".">mean</th><th class="colsep0 rowsep0" align="center" char=".">SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no treatment (day 9)</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">moxifloxacin (100 mg/kg, 4 d)</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b> po (200 mg/kg, 4 d)</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b> po (170 mg/kg, 4 d)</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Moxifloxacin and Compounds Evaluated Showing the Following Differences in the Lung Microorganism Burden (log<sub>10</sub> CFU/Lung) with Respect to Untreated Controls (Day 9 after Infection) in the Aforementioned Experimental Conditions</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">target dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">administration</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">difference to untreated mice (log CFU)</th><th class="colsep0 rowsep0" align="center"><i>p</i><a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">moxifloxacin</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">once a day (days 5–8)</td><td class="colsep0 rowsep0" align="left">oral</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="left"><i>p</i> < 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="left">once a day (days 5–8)</td><td class="colsep0 rowsep0" align="left">oral</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left"><i>p</i> < 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">170</td><td class="colsep0 rowsep0" align="left">once a day (days 5–8)</td><td class="colsep0 rowsep0" align="left">oral</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left"><i>p</i> > 0.05</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup><sup>a</sup></sup><p class="last">ANOVA, Dunnett’s post test. Compared to untreated mice, <i>p</i> < 0.05 was considered significant.</p></div></div></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Vibrational Circular Dichroism</h3><div class="NLM_p last">VCD analysis and assignment was performed according to an analogous protocol published previously.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i114"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00107" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00107?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00107</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional experimental information for intermediate compounds (synthetic protocols and analytical details); references for synthetic procedures; LC-MS chromatograms for key compounds <b>30</b> (racemic mixture), <b>30R</b> (<i>R</i>-enantiomer), <b>30S</b> (<i>S</i>-enantiomer), <b>31</b>, <b>45</b>, <b>46</b>, <b>47</b>, <b>48</b>, <b>51</b>, <b>52</b>, <b>55</b>, <b>61</b>, <b>65</b>, <b>67</b>, <b>68</b>, <b>69</b>, and <b>82</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all reported final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_001.pdf">jm0c00107_si_001.pdf (1.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_002.csv">jm0c00107_si_002.csv (9.4 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00107" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Cacho</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6270-5370" title="Orcid link">http://orcid.org/0000-0001-6270-5370</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#670a08090e0406490e490406040f082700140c4904080a"><span class="__cf_email__" data-cfemail="ea87858483898bc483c4898b898285aa8d9981c4898587">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pieter Van der Veken</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1208-3571" title="Orcid link">http://orcid.org/0000-0003-1208-3571</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#88f8e1edfcedfaa6fee9e6ecedfafeede3ede6c8fde9e6fcffedfaf8ede6a6eaed"><span class="__cf_email__" data-cfemail="4e3e272b3a2b3c60382f202a2b3c382b252b200e3b2f203a392b3c3e2b20602c2b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Balabon</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eleni Pitta</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maciej K. Rogacki</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugenia Meiler</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruth Casanueva</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Guijarro</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophie Huss</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Maria Lopez-Roman</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ángel Santos-Villarejo</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koen Augustyns</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, 2610 Wilrijk, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5203-4339" title="Orcid link">http://orcid.org/0000-0002-5203-4339</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lluis Ballell</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Barros Aguirre</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4099-0438" title="Orcid link">http://orcid.org/0000-0002-4099-0438</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert H. Bates</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fraser Cunningham</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>O.B., E.P., and M.K.R. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i117">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was funded by a Marie Curie Intra-European Grant within the 7th European Community Framework Programme (FP7-PEOPLE-2012-ITN) under the European Industrial Doctorates Scheme of the Marie Curie Initial Training Networks actions with grant agreement no. 316773, and it is part of the OpenMedChem project. The authors gratefully acknowledge many scientists from GSK Tres Cantos and Stevenage involved in the research.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">μM</td><td class="NLM_def"><p class="first last">micromolar</p></td></tr><tr><td class="NLM_term">2-MeTHF</td><td class="NLM_def"><p class="first last">2-methyltetrahydrofuran</p></td></tr><tr><td class="NLM_term">AIDS</td><td class="NLM_def"><p class="first last">acquired immunodeficiency syndrome</p></td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">hepatic intrinsic clearance</p></td></tr><tr><td class="NLM_term">CLND</td><td class="NLM_def"><p class="first last">chemiluminescent nitrogen detection</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DprE1</td><td class="NLM_def"><p class="first last">decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribofuranose 2-oxidase</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">GlaxoSmithKline</p></td></tr><tr><td class="NLM_term">HepG2</td><td class="NLM_def"><p class="first last">human hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">Hz</td><td class="NLM_def"><p class="first last">hertz</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">MDR-TB</td><td class="NLM_def"><p class="first last">multidrug-resistant tuberculosis</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MHz</td><td class="NLM_def"><p class="first last">megahertz</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term"><i>Mtb</i></td><td class="NLM_def"><p class="first last"><i>Mycobacterium tuberculosis</i></p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term"><i>n</i>-PrOH</td><td class="NLM_def"><p class="first last">1-propanol</p></td></tr><tr><td class="NLM_term">ppm</td><td class="NLM_def"><p class="first last">parts per million</p></td></tr><tr><td class="NLM_term">quin</td><td class="NLM_def"><p class="first last">quintet</p></td></tr><tr><td class="NLM_term">RR-TB</td><td class="NLM_def"><p class="first last">rifampicin-resistant tuberculosis</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">sept</td><td class="NLM_def"><p class="first last">septet</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">tuberculosis</p></td></tr><tr><td class="NLM_term">t-BuXPhos</td><td class="NLM_def"><p class="first last">2-di-<i>tert</i>-butylphosphino-2′,4′,6′-triisopropylbiphenyl</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">UPLC-MS</td><td class="NLM_def"><p class="first last">ultra-performance liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term">VCD</td><td class="NLM_def"><p class="first last">vibrational circular dichroism</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Global tuberculosis report 2019</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2019</span>. Licence: CC BY-NC-SA 3.0
IGO. (accessed Nov 22, 2019)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=World+Health+Organization&title=Global+tuberculosis+report+2019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DGlobal%2520tuberculosis%2520report%25202019%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Joanis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarelli, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dianiskova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordulakova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrethsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenkrands, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosset, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones Kill Mycobacterium Tuberculosis by Blocking Arabinan Synthesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">801</span>, <span class="refDoi"> DOI: 10.1126/science.1171583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1126%2Fscience.1171583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=19299584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=801&author=V.+Makarovauthor=G.+Maninaauthor=K.+Mikusovaauthor=U.+Mollmannauthor=O.+Ryabovaauthor=B.+Saint-Joanisauthor=N.+Dharauthor=M.+R.+Pascaauthor=S.+Buroniauthor=A.+P.+Lucarelliauthor=A.+Milanoauthor=E.+De+Rossiauthor=M.+Belanovaauthor=A.+Bobovskaauthor=P.+Dianiskovaauthor=J.+Kordulakovaauthor=C.+Salaauthor=E.+Fullamauthor=P.+Schneiderauthor=J.+D.+McKinneyauthor=P.+Brodinauthor=T.+Christopheauthor=S.+Waddellauthor=P.+Butcherauthor=J.+Albrethsenauthor=I.+Rosenkrandsauthor=R.+Broschauthor=V.+Nandiauthor=S.+Bharathauthor=S.+Gaonkarauthor=R.+K.+Shandilauthor=V.+Balasubramanianauthor=T.+Balganeshauthor=S.+Tyagiauthor=J.+Grossetauthor=G.+Riccardiauthor=S.+T.+Cole&title=Benzothiazinones+Kill+Mycobacterium+Tuberculosis+by+Blocking+Arabinan+Synthesis&doi=10.1126%2Fscience.1171583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis</span></div><div class="casAuthors">Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5928</span>),
    <span class="NLM_cas:pages">801-804</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">New drugs are required to counter the tuberculosis (TB) pandemic.  Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB.  Using genetics and biochem., we identified the enzyme decaprenylphosphoryl-β-D-ribose 2'-epimerase as a major BTZ target.  Inhibition of this enzymic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death.  The most advanced compd., BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZiVvk0T_DOrVg90H21EOLACvtfcHk0ljcme-GPmv5SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D&md5=1d80f14ba88460ef5c8ea31793dbb592</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1171583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1171583%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DManina%26aufirst%3DG.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DMollmann%26aufirst%3DU.%26aulast%3DRyabova%26aufirst%3DO.%26aulast%3DSaint-Joanis%26aufirst%3DB.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DLucarelli%26aufirst%3DA.%2BP.%26aulast%3DMilano%26aufirst%3DA.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DBelanova%26aufirst%3DM.%26aulast%3DBobovska%26aufirst%3DA.%26aulast%3DDianiskova%26aufirst%3DP.%26aulast%3DKordulakova%26aufirst%3DJ.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DFullam%26aufirst%3DE.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DWaddell%26aufirst%3DS.%26aulast%3DButcher%26aufirst%3DP.%26aulast%3DAlbrethsen%26aufirst%3DJ.%26aulast%3DRosenkrands%26aufirst%3DI.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DNandi%26aufirst%3DV.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DGaonkar%26aufirst%3DS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBalganesh%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DS.%26aulast%3DGrosset%26aufirst%3DJ.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DBenzothiazinones%2520Kill%2520Mycobacterium%2520Tuberculosis%2520by%2520Blocking%2520Arabinan%2520Synthesis%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D801%26doi%3D10.1126%2Fscience.1171583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brecik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centárová, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszár, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovská, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilacsková, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokošová, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svetlíková, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korduláková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikušová, K.</span></span> <span> </span><span class="NLM_article-title">DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1631</span>– <span class="NLM_lpage">1636</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1631-1636&author=M.+Brecikauthor=I.+Cent%C3%A1rov%C3%A1author=R.+Mukherjeeauthor=G.+S.+Kollyauthor=S.+Husz%C3%A1rauthor=A.+Bobovsk%C3%A1author=E.+Kilacskov%C3%A1author=V.+Moko%C5%A1ov%C3%A1author=Z.+Svetl%C3%ADkov%C3%A1author=M.+%C5%A0arkanauthor=J.+Neresauthor=J.+Kordul%C3%A1kov%C3%A1author=S.+T.+Coleauthor=K.+Miku%C5%A1ov%C3%A1&title=DprE1+Is+a+Vulnerable+Tuberculosis+Drug+Target+Due+to+Its+Cell+Wall+Localization&doi=10.1021%2Facschembio.5b00237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization</span></div><div class="casAuthors">Brecik, Miroslav; Centarova, Ivana; Mukherjee, Raju; Kolly, Gaelle S.; Huszar, Stanislav; Bobovska, Adela; Kilacskova, Emoke; Mokosova, Veronika; Svetlikova, Zuzana; Sarkan, Michal; Neres, Joao; Kordulakova, Jana; Cole, Stewart T.; Mikusova, Katarina</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1631-1636</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The flavo-enzyme DprE1 catalyzes a key epimerization step in the decaprenyl-phosphoryl D-arabinose (DPA) pathway, which is essential for mycobacterial cell wall biogenesis and targeted by several new tuberculosis drug candidates.  Here, using differential radiolabeling with DPA precursors and high-resoln. fluorescence microscopy, we disclose the unexpected extracytoplasmic localization of DprE1 and periplasmic synthesis of DPA.  Collectively, this explains the vulnerability of DprE1 and the remarkable potency of the best inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2tTdrWjQmBrVg90H21EOLACvtfcHk0limtG_dmTwQvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWns70%253D&md5=bc1317378445d84300aca1615ef8d058</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00237%26sid%3Dliteratum%253Aachs%26aulast%3DBrecik%26aufirst%3DM.%26aulast%3DCent%25C3%25A1rov%25C3%25A1%26aufirst%3DI.%26aulast%3DMukherjee%26aufirst%3DR.%26aulast%3DKolly%26aufirst%3DG.%2BS.%26aulast%3DHusz%25C3%25A1r%26aufirst%3DS.%26aulast%3DBobovsk%25C3%25A1%26aufirst%3DA.%26aulast%3DKilacskov%25C3%25A1%26aufirst%3DE.%26aulast%3DMoko%25C5%25A1ov%25C3%25A1%26aufirst%3DV.%26aulast%3DSvetl%25C3%25ADkov%25C3%25A1%26aufirst%3DZ.%26aulast%3D%25C5%25A0arkan%26aufirst%3DM.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DKordul%25C3%25A1kov%25C3%25A1%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DMiku%25C5%25A1ov%25C3%25A1%26aufirst%3DK.%26atitle%3DDprE1%2520Is%2520a%2520Vulnerable%2520Tuberculosis%2520Drug%2520Target%2520Due%2520to%2520Its%2520Cell%2520Wall%2520Localization%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1631%26epage%3D1636%26doi%3D10.1021%2Facschembio.5b00237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Škovierová, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovská, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nenci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikušová, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-Ribofuranose 2′-Oxidase DprE1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">912</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1021/ja211042r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja211042r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1CrsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=912-915&author=C.+Trefzerauthor=H.+%C5%A0kovierov%C3%A1author=S.+Buroniauthor=A.+Bobovsk%C3%A1author=S.+Nenciauthor=E.+Molteniauthor=F.+Pojerauthor=M.+R.+Pascaauthor=V.+Makarovauthor=S.+T.+Coleauthor=G.+Riccardiauthor=K.+Miku%C5%A1ov%C3%A1author=K.+Johnsson&title=Benzothiazinones+Are+Suicide+Inhibitors+of+Mycobacterial+Decaprenylphosphoryl-%CE%B2-d-Ribofuranose+2%E2%80%B2-Oxidase+DprE1&doi=10.1021%2Fja211042r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-D-ribofuranose 2'-Oxidase DprE1</span></div><div class="casAuthors">Trefzer, Claudia; Skovierova, Henrieta; Buroni, Silvia; Bobovska, Adela; Nenci, Simone; Molteni, Elisabetta; Pojer, Florence; Pasca, Maria R.; Makarov, Vadim; Cole, Stewart T.; Riccardi, Giovanna; Mikusova, Katarina; Johnsson, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">912-915</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzothiazinones (BTZs) are antituberculosis drug candidates with nanomolar bactericidal activity against tubercle bacilli.  Here we demonstrate that BTZs are suicide substrates of the FAD-dependent decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1, an enzyme involved in cell-wall biogenesis.  BTZs are reduced by DprE1 to an electrophile, which then reacts in a near-quant. manner with an active-site cysteine of DprE1, thus providing a rationale for the extraordinary potency of BTZs.  Mutant DprE1 enzymes from BTZ-resistant strains reduce BTZs to inert metabolites while avoiding covalent inactivation.  Our results explain the basis for drug sensitivity and resistance to an exceptionally potent class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9GAW2MIogOrVg90H21EOLACvtfcHk0limtG_dmTwQvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1CrsLrJ&md5=c2f3753e2bbdba3c06e274acf550baed</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fja211042r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja211042r%26sid%3Dliteratum%253Aachs%26aulast%3DTrefzer%26aufirst%3DC.%26aulast%3D%25C5%25A0kovierov%25C3%25A1%26aufirst%3DH.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DBobovsk%25C3%25A1%26aufirst%3DA.%26aulast%3DNenci%26aufirst%3DS.%26aulast%3DMolteni%26aufirst%3DE.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DMiku%25C5%25A1ov%25C3%25A1%26aufirst%3DK.%26aulast%3DJohnsson%26aufirst%3DK.%26atitle%3DBenzothiazinones%2520Are%2520Suicide%2520Inhibitors%2520of%2520Mycobacterial%2520Decaprenylphosphoryl-%25CE%25B2-d-Ribofuranose%25202%25E2%2580%25B2-Oxidase%2520DprE1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D912%26epage%3D915%26doi%3D10.1021%2Fja211042r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabeen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhowruth, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggeling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alderwick, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fütterer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Inhibition of Mycobacterium Tuberculosis DprE1 by Benzothiazinone Inhibitors</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">11354</span>– <span class="NLM_lpage">11359</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205735109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1073%2Fpnas.1205735109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=22733761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ahtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=11354-11359&author=S.+M.+Battauthor=T.+Jabeenauthor=V.+Bhowruthauthor=L.+Quillauthor=P.+A.+Lundauthor=L.+Eggelingauthor=L.+J.+Alderwickauthor=K.+F%C3%BCttererauthor=G.+S.+Besra&title=Structural+Basis+of+Inhibition+of+Mycobacterium+Tuberculosis+DprE1+by+Benzothiazinone+Inhibitors&doi=10.1073%2Fpnas.1205735109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors</span></div><div class="casAuthors">Batt, Sarah M.; Jabeen, Talat; Bhowruth, Veemal; Quill, Lee; Lund, Peter A.; Eggeling, Lothar; Alderwick, Luke J.; Futterer, Klaus; Besra, Gurdyal S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11354-11359, S11354/1-S11354/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Resistance against currently used antitubercular therapeutics increasingly undermines efforts to contain the worldwide tuberculosis (TB) epidemic.  Recently, benzothiazinone (BTZ) inhibitors have shown nanomolar potency against both drug-susceptible and multidrug-resistant strains of the tubercle bacillus.  However, their proposed mode of action is lacking structural evidence.  The authors report here the crystal structure of the BTZ target, FAD-contg. oxidoreductase Mycobacterium tuberculosis DprE1, which is essential for viability.  Different crystal forms of ligand-free DprEl reveal considerable levels of structural flexibility of two surface loops that seem to govern accessibility of the active site.  Structures of complexes with the BTZ-derived nitroso deriv. CT325 reveal the mode of inhibitor binding, which includes a covalent link to conserved Cys387, and reveal a trifluoromethyl group as a second key determinant of interaction with the enzyme.  The authors found that a noncovalent complex was formed between DprE1 and CT319, which is structurally identical to CT325 except for an inert nitro group replacing the reactive nitroso group.  This demonstrates that binding of BTZ-class inhibitors to DprE1 is not strictly dependent on formation of the covalent link to Cys387.  On the basis of the structural and activity data, the authors propose that the complex of DrpE1 bound to CT325 is a representative of the BTZ-target complex.  These results mark a significant step forward in the characterization of a key TB drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6SdfDjSFjobVg90H21EOLACvtfcHk0lgVxMlPnR6YIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ahtLrF&md5=a0aca9361eb3a84ad27a6d6cb58f9b7c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205735109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205735109%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DJabeen%26aufirst%3DT.%26aulast%3DBhowruth%26aufirst%3DV.%26aulast%3DQuill%26aufirst%3DL.%26aulast%3DLund%26aufirst%3DP.%2BA.%26aulast%3DEggeling%26aufirst%3DL.%26aulast%3DAlderwick%26aufirst%3DL.%2BJ.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26atitle%3DStructural%2520Basis%2520of%2520Inhibition%2520of%2520Mycobacterium%2520Tuberculosis%2520DprE1%2520by%2520Benzothiazinone%2520Inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D2012%26volume%3D109%26spage%3D11354%26epage%3D11359%26doi%3D10.1073%2Fpnas.1205735109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krchňák, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colon-Martinez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3549</span>, <span class="refDoi"> DOI: 10.1021/ja311058q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja311058q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=3539-3549&author=R.+Tiwariauthor=G.+C.+Moraskiauthor=V.+Krch%C5%88%C3%A1kauthor=P.+A.+Millerauthor=M.+Colon-Martinezauthor=E.+Herreroauthor=A.+G.+Oliverauthor=M.+J.+Miller&title=Thiolates+Chemically+Induce+Redox+Activation+of+BTZ043+and+Related+Potent+Nitroaromatic+Anti-Tuberculosis+Agents&doi=10.1021%2Fja311058q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span></div><div class="casAuthors">Tiwari, Rohit; Moraski, Garrett C.; Krchnak, Viktor; Miller, Patricia A.; Colon-Martinez, Mariangelli; Herrero, Eliza; Oliver, Allen G.; Miller, Marvin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3539-3549</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of multidrug resistant (MDR) and extensively drug resistant (XDR) forms of tuberculosis (TB) has stimulated research efforts globally to expand the new drug pipeline.  Nitroarom. compds., including 1,3-benzothiazin-4-ones (BTZs) and related agents, are a promising new class for the treatment of TB.  Research has shown that the nitroso intermediates of BTZs that are generated in vivo cause suicide inhibition of decaprenylphosphoryl-β-d-ribose 2' oxidase (DprE1), which is responsible for cell wall arabinogalactan biosynthesis.  We have designed and synthesized novel anti-TB agents inspired from BTZs and other nitroarom. compds.  Computational studies indicated that the unsubstituted arom. carbons of BTZ043 and related nitroarom. compds. are the most electron-deficient and might be prone to nucleophilic attack.  Our chem. studies on BTZ043 and the addnl. nitroarom. compds. synthesized by us and others confirmed the postulated reactivity.  The results indicate that nucleophiles such as thiolates, cyanide, and hydride induce nonenzymic redn. of the nitro groups present in these compds. to the corresponding nitroso intermediates by addn. at the unsubstituted electron-deficient arom. carbon present in these compds.  Furthermore, we demonstrate here that these compds. are good candidates for the classical von Richter reaction.  These chem. studies offer an alternate hypothesis for the mechanism of action of nitroarom. anti-TB agents, in that the cysteine thiol(ate) or a hydride source at the active site of DprE1 may trigger the redn. of the nitro groups in a manner similar to the von Richter reaction to the nitroso intermediates, to initiate the inhibition of DprE1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEXS_ZRRGRArVg90H21EOLACvtfcHk0lgVxMlPnR6YIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D&md5=e3671cfef9ef47c15087e8299d9db64e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja311058q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja311058q%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DKrch%25C5%2588%25C3%25A1k%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DColon-Martinez%26aufirst%3DM.%26aulast%3DHerrero%26aufirst%3DE.%26aulast%3DOliver%26aufirst%3DA.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DThiolates%2520Chemically%2520Induce%2520Redox%2520Activation%2520of%2520BTZ043%2520and%2520Related%2520Potent%2520Nitroaromatic%2520Anti-Tuberculosis%2520Agents%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D3539%26epage%3D3549%26doi%3D10.1021%2Fja311058q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boy-Röttger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degiacomi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarelli, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascal, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindal, C.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium Tuberculosis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">150ra121</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3004395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1126%2Fscitranslmed.3004395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=22956199" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=150ra121&author=J.+Neresauthor=F.+Pojerauthor=E.+Molteniauthor=L.+R.+Chiarelliauthor=N.+Dharauthor=S.+Boy-R%C3%B6ttgerauthor=S.+Buroniauthor=E.+Fullamauthor=G.+Degiacomiauthor=A.+P.+Lucarelliauthor=R.+J.+Readauthor=G.+Zanoniauthor=D.+E.+Edmondsonauthor=E.+De+Rossiauthor=M.+R.+Pascalauthor=J.+D.+McKinneyauthor=P.+J.+Dysonauthor=G.+Riccardiauthor=A.+Matteviauthor=S.+T.+Coleauthor=C.+Bindal&title=Structural+Basis+for+Benzothiazinone-Mediated+Killing+of+Mycobacterium+Tuberculosis&doi=10.1126%2Fscitranslmed.3004395"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004395%26sid%3Dliteratum%253Aachs%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DMolteni%26aufirst%3DE.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DBoy-R%25C3%25B6ttger%26aufirst%3DS.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DFullam%26aufirst%3DE.%26aulast%3DDegiacomi%26aufirst%3DG.%26aulast%3DLucarelli%26aufirst%3DA.%2BP.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DZanoni%26aufirst%3DG.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DPascal%26aufirst%3DM.%2BR.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBindal%26aufirst%3DC.%26atitle%3DStructural%2520Basis%2520for%2520Benzothiazinone-Mediated%2520Killing%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D150ra121%26doi%3D10.1126%2Fscitranslmed.3004395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fütterer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">Identification of a Small Molecule with Activity against Drug-Resistant and Persistent Tuberculosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E2510</span>– <span class="NLM_lpage">E2517</span>, <span class="refDoi"> DOI: 10.1073/pnas.1309171110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1073%2Fpnas.1309171110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=23776209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2510-E2517&author=F.+Wangauthor=D.+Sambandanauthor=R.+Halderauthor=J.+Wangauthor=S.+M.+Battauthor=B.+Weinrickauthor=I.+Ahmadauthor=P.+Yangauthor=Y.+Zhangauthor=J.+Kimauthor=M.+Hassaniauthor=S.+Huszarauthor=C.+Trefzerauthor=Z.+Maauthor=T.+Kanekoauthor=K.+E.+Mdluliauthor=S.+Franzblauauthor=A.+K.+Chatterjeeauthor=K.+Johnssonauthor=K.+Johnsonauthor=K.+Mikusovaauthor=G.+S.+Besraauthor=K.+F%C3%BCttererauthor=S.+H.+Robbinsauthor=S.+W.+Barnesauthor=J.+R.+Walkerauthor=W.+R.+Jacobsauthor=P.+G.+Schultz&title=Identification+of+a+Small+Molecule+with+Activity+against+Drug-Resistant+and+Persistent+Tuberculosis&doi=10.1073%2Fpnas.1309171110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a small molecule with activity against drug-resistant and persistent tuberculosis</span></div><div class="casAuthors">Wang, Feng; Sambandan, Dhinakaran; Halder, Rajkumar; Wang, Jianing; Batt, Sarah M.; Weinrick, Brian; Ahmad, Insha; Yang, Pengyu; Zhang, Yong; Kim, John; Hassani, Morad; Huszar, Stanislav; Trefzer, Claudia; Ma, Zhenkun; Kaneko, Takushi; Mdluli, Khisi E.; Franzblau, Scott; Chatterjee, Arnab K.; Johnsson, Kai; Mikusova, Katarina; Besra, Gurdyal S.; Fuetterer, Klaus; Robbins, Scott H.; Barnes, S. Whitney; Walker, John R.; Jacobs, William R., Jr.; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">E2510-E2517,SE2510/1-SE2510/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A cell-based phenotypic screen for inhibitors of biofilm formation in mycobacteria identified the small mol. TCA1, which has bactericidal activity against both drug-susceptible and -resistant Mycobacterium tuberculosis (Mtb) and sterilizes Mtb in vitro combined with rifampicin or isoniazid.  In addn., TCA1 has bactericidal activity against nonreplicating Mtb in vitro and is efficacious in acute and chronic Mtb infection mouse models both alone and combined with rifampicin or isoniazid.  Transcriptional anal. revealed that TCA1 down-regulates genes known to be involved in Mtb persistence.  Genetic and affinity-based methods identified decaprenyl-phosphoryl-β-D-ribofuranose oxidoreductase DprE1 and MoeW, enzymes involved in cell wall and molybdenum cofactor biosynthesis, resp., as targets responsible for the activity of TCA1.  These in vitro and in vivo results indicate that this compd. functions by a unique mechanism and suggest that TCA1 may lead to the development of a class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokxlddd-EfbbVg90H21EOLACvtfcHk0lgTe5dZ4omX7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLnL&md5=caf496e25608bb98e61ab97bd603f2ab</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1309171110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1309171110%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DSambandan%26aufirst%3DD.%26aulast%3DHalder%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DWeinrick%26aufirst%3DB.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DS.%26aulast%3DTrefzer%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMdluli%26aufirst%3DK.%2BE.%26aulast%3DFranzblau%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DJohnsson%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DRobbins%26aufirst%3DS.%2BH.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DIdentification%2520of%2520a%2520Small%2520Molecule%2520with%2520Activity%2520against%2520Drug-Resistant%2520and%2520Persistent%2520Tuberculosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2510%26epage%3DE2517%26doi%3D10.1073%2Fpnas.1309171110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhart, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnappinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manikkam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gac, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murgolo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutphin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Via, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  III</span></span> <span> </span><span class="NLM_article-title">Discovery and Structure–Activity-Relationship Study of <i>N</i> -Alkyl-5-Hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β- d -Ribose 2′-Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9952</span>– <span class="NLM_lpage">9965</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2rsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9952-9965&author=S.+Ohauthor=Y.+Parkauthor=C.+A.+Engelhartauthor=J.+B.+Wallachauthor=D.+Schnappingerauthor=K.+Aroraauthor=M.+Manikkamauthor=B.+Gacauthor=H.+Wangauthor=N.+Murgoloauthor=D.+B.+Olsenauthor=M.+Goodwinauthor=M.+Sutphinauthor=D.+M.+Weinerauthor=L.+E.+Viaauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barry&title=Discovery+and+Structure%E2%80%93Activity-Relationship+Study+of+N+-Alkyl-5-Hydroxypyrimidinone+Carboxamides+as+Novel+Antitubercular+Agents+Targeting+Decaprenylphosphoryl-%CE%B2-+d+-Ribose+2%E2%80%B2-Oxidase&doi=10.1021%2Facs.jmedchem.8b00883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-D-ribose 2'-Oxidase</span></div><div class="casAuthors">Oh, Sangmi; Park, Yumi; Engelhart, Curtis A.; Wallach, Joshua B.; Schnappinger, Dirk; Arora, Kriti; Manikkam, Michelle; Gac, Brian; Wang, Hongwu; Murgolo, Nicholas; Olsen, David B.; Goodwin, Michael; Sutphin, Michelle; Weiner, Danielle M.; Via, Laura E.; Boshoff, Helena I. M.; Barry, Clifton E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9952-9965</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Magnesium plays an important role in infection with Mycobacterium tuberculosis (Mtb) as a signal of the extracellular environment, as a cofactor for many enzymes, and as a structural element in important macromols.  Raltegravir, an antiretroviral drug that inhibits HIV-1 integrase is known to derive its potency from selective sequestration of active-site magnesium ions in addn. to binding to a hydrophobic pocket.  In order to det. if essential Mtb-related phosphoryl transfers could be disrupted in a similar manner, a directed screen of known mols. with integrase inhibitor-like pharmacophores (N-alkyl-5-hydroxypyrimidinone carboxamides) was performed.  Initial hits afforded compds. with low-micromolar potency against Mtb, acceptable cytotoxicity and PK characteristics, and robust SAR.  Elucidation of the target of these compds. revealed that they lacked magnesium dependence and instead disappointingly inhibited a known promiscuous target in Mtb, decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1, Rv3790).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOxHRHtAf2rbVg90H21EOLACvtfcHk0lgTe5dZ4omX7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2rsrfP&md5=5c8f50d73f857fcde7277ca80109fee9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00883%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DEngelhart%26aufirst%3DC.%2BA.%26aulast%3DWallach%26aufirst%3DJ.%2BB.%26aulast%3DSchnappinger%26aufirst%3DD.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DManikkam%26aufirst%3DM.%26aulast%3DGac%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMurgolo%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DGoodwin%26aufirst%3DM.%26aulast%3DSutphin%26aufirst%3DM.%26aulast%3DWeiner%26aufirst%3DD.%2BM.%26aulast%3DVia%26aufirst%3DL.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DDiscovery%2520and%2520Structure%25E2%2580%2593Activity-Relationship%2520Study%2520of%2520N%2520-Alkyl-5-Hydroxypyrimidinone%2520Carboxamides%2520as%2520Novel%2520Antitubercular%2520Agents%2520Targeting%2520Decaprenylphosphoryl-%25CE%25B2-%2520d%2520-Ribose%25202%25E2%2580%25B2-Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9952%26epage%3D9965%26doi%3D10.1021%2Facs.jmedchem.8b00883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium Tuberculosis and Are Efficacious in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9701</span>– <span class="NLM_lpage">9708</span>, <span class="refDoi"> DOI: 10.1021/jm401382v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401382v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9701-9708&author=P.+S.+Shirudeauthor=R.+Shandilauthor=C.+Sadlerauthor=M.+Naikauthor=V.+Hosagraharaauthor=S.+Hameedauthor=V.+Shindeauthor=C.+Bathulaauthor=V.+Humnabadkarauthor=N.+Kumarauthor=J.+Reddyauthor=V.+Pandugaauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=H.+Gardnerauthor=P.+Madhavapeddiauthor=V.+Ramachandranauthor=P.+Kaurauthor=A.+Narayanauthor=S.+Gupthaauthor=D.+Awasthyauthor=C.+Narayanauthor=J.+Mahadevaswamyauthor=K.+Vishwasauthor=V.+Ahujaauthor=A.+Srivastavaauthor=K.+Prabhakarauthor=S.+Bharathauthor=R.+Kaleauthor=M.+Ramaiahauthor=N.+R.+Choudhuryauthor=V.+K.+Sambandamurthyauthor=S.+Solapureauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Azaindoles%3A+Noncovalent+DprE1+Inhibitors+from+Scaffold+Morphing+Efforts%2C+Kill+Mycobacterium+Tuberculosis+and+Are+Efficacious+in+Vivo&doi=10.1021%2Fjm401382v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha; Sadler, Claire; Naik, Maruti; Hosagrahara, Vinayak; Hameed, Shahul; Shinde, Vikas; Bathula, Chandramohan; Humnabadkar, Vaishali; Kumar, Naveen; Reddy, Jitendar; Panduga, Vijender; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Whiteaker, James; McLaughlin, Robert E.; Gardner, Humphrey; Madhavapeddi, Prashanti; Ramachandran, Vasanthi; Kaur, Parvinder; Narayan, Ashwini; Guptha, Supreeth; Awasthy, Disha; Narayan, Chandan; Mahadevaswamy, Jyothi; Vishwas, K. G.; Ahuja, Vijaykamal; Srivastava, Abhishek; Prabhakar, K. R.; Bharath, Sowmya; Kale, Ramesh; Ramaiah, Manjunatha; Choudhury, Nilanjana Roy; Sambandamurthy, Vasan K.; Solapure, Suresh; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models.  The series emerged from scaffold morphing efforts and was demonstrated to noncovalently inhibit decaprenylphosphoryl-β-d-ribose2'-epimerase (DprE1).  With "drug-like" properties and no expectation of pre-existing resistance in the clinic, this chem. class has the potential to be developed as a therapy for drug-sensitive and drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskQvJK4M2yrVg90H21EOLACvtfcHk0lgBe4_LflJqsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM&md5=eba42d1952b164f66fd0ca620aaa4f19</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm401382v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401382v%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DHameed%26aufirst%3DS.%26aulast%3DShinde%26aufirst%3DV.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVishwas%26aufirst%3DK.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DR.%26aulast%3DRamaiah%26aufirst%3DM.%26aulast%3DChoudhury%26aufirst%3DN.%2BR.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DAzaindoles%253A%2520Noncovalent%2520DprE1%2520Inhibitors%2520from%2520Scaffold%2520Morphing%2520Efforts%252C%2520Kill%2520Mycobacterium%2520Tuberculosis%2520and%2520Are%2520Efficacious%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9701%26epage%3D9708%26doi%3D10.1021%2Fjm401382v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanduri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5728</span>– <span class="NLM_lpage">5737</span>, <span class="refDoi"> DOI: 10.1021/jm500571f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500571f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5728-5737&author=P.+S.+Shirudeauthor=R.+K.+Shandilauthor=M.+R.+Manjunathaauthor=C.+Sadlerauthor=M.+Pandaauthor=V.+Pandugaauthor=J.+Reddyauthor=R.+Saralayaauthor=R.+Nanduriauthor=A.+Ambadyauthor=S.+Ravishankarauthor=V.+K.+Sambandamurthyauthor=V.+Humnabadkarauthor=L.+K.+Jenaauthor=R.+S.+Sureshauthor=A.+Srivastavaauthor=K.+R.+Prabhakarauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=S.+Sharmaauthor=C.+B.+Cooperauthor=K.+Mdluliauthor=S.+Butlerauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Lead+Optimization+of+1%2C4-Azaindoles+as+Antimycobacterial+Agents&doi=10.1021%2Fjm500571f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha K.; Manjunatha, M. R.; Sadler, Claire; Panda, Manoranjan; Panduga, Vijender; Reddy, Jitendar; Saralaya, Ramanatha; Nanduri, Robert; Ambady, Anisha; Ravishankar, Sudha; Sambandamurthy, Vasan K.; Humnabadkar, Vaishali; Jena, Lalit K.; Suresh, Rudrapatna S.; Srivastava, Abhishek; Prabhakar, K. R.; Whiteaker, James; McLaughlin, Robert E.; Sharma, Sreevalli; Cooper, Christopher B.; Mdluli, Khisi; Butler, Scott; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5728-5737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a previous report, we described the discovery of 1,4-azaindoles, a chem. series with excellent in vitro and in vivo antimycobacterial potency through noncovalent inhibition of decaprenylphosphoryl-β-D-ribose-2'-epimerase (DprE1).  Nevertheless, high mouse metabolic turnover and phosphodiesterase 6 (PDE6) off-target activity limited its advancement.  Herein, we report lead optimization of this series, culminating in potent, metabolically stable compds. that have a robust pharmacokinetic profile without any PDE6 liability.  Furthermore, we demonstrate efficacy for 1,4-azaindoles in a rat chronic TB infection model.  We believe that compds. from the 1,4-azaindole series are suitable for in vivo combination and safety studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKixMAsGzDqrVg90H21EOLACvtfcHk0ljjrgAf5gB2jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhsbY%253D&md5=058a48536ddeb1046e04a29ba68a3a17</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm500571f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500571f%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DNanduri%26aufirst%3DR.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DJena%26aufirst%3DL.%2BK.%26aulast%3DSuresh%26aufirst%3DR.%2BS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DMdluli%26aufirst%3DK.%26aulast%3DButler%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DLead%2520Optimization%2520of%25201%252C4-Azaindoles%2520as%2520Antimycobacterial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5728%26epage%3D5737%26doi%3D10.1021%2Fjm500571f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tantry, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjrekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koushik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanbhag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jatheendranath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorino-Gelo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinesh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghorpade, S. R.</span></span> <span> </span><span class="NLM_article-title">4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5419</span>– <span class="NLM_lpage">5434</span>, <span class="refDoi"> DOI: 10.1021/jm5005978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5005978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5419-5434&author=M.+Naikauthor=V.+Humnabadkarauthor=S.+J.+Tantryauthor=M.+Pandaauthor=A.+Narayanauthor=S.+Gupthaauthor=V.+Pandugaauthor=P.+Manjrekarauthor=L.+K.+Jenaauthor=K.+Koushikauthor=G.+Shanbhagauthor=S.+Jatheendranathauthor=M.+R.+Manjunathaauthor=G.+Goraiauthor=C.+Bathulaauthor=S.+Rudrapatnaauthor=V.+Acharauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Mahadevaswamyauthor=P.+Kaurauthor=V.+K.+Sambandamurthyauthor=D.+Awasthyauthor=C.+Narayanauthor=S.+Ravishankarauthor=P.+Madhavapeddiauthor=J.+Reddyauthor=K.+Prabhakarauthor=R.+Saralayaauthor=M.+Chatterjiauthor=J.+Whiteakerauthor=B.+McLaughlinauthor=L.+R.+Chiarelliauthor=G.+Riccardiauthor=M.+R.+Pascaauthor=C.+Bindaauthor=J.+Neresauthor=N.+Dharauthor=F.+Signorino-Geloauthor=J.+D.+McKinneyauthor=V.+Ramachandranauthor=R.+Shandilauthor=R.+Tommasiauthor=P.+S.+Iyerauthor=S.+Narayananauthor=V.+Hosagraharaauthor=S.+Kavanaghauthor=N.+Dineshauthor=S.+R.+Ghorpade&title=4-Aminoquinolone+Piperidine+Amides%3A+Noncovalent+Inhibitors+of+DprE1+with+Long+Residence+Time+and+Potent+Antimycobacterial+Activity&doi=10.1021%2Fjm5005978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity</span></div><div class="casAuthors">Naik, Maruti; Humnabadkar, Vaishali; Tantry, Subramanyam J.; Panda, Manoranjan; Narayan, Ashwini; Guptha, Supreeth; Panduga, Vijender; Manjrekar, Praveena; Jena, Lalit kumar; Koushik, Krishna; Shanbhag, Gajanan; Jatheendranath, Sandesh; Manjunatha, M. R.; Gorai, Gopinath; Bathula, Chandramohan; Rudrapatna, Suresh; Achar, Vijayashree; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Mahadevaswamy, Jyothi; Kaur, Parvinder; Sambandamurthy, Vasan K.; Awasthy, Disha; Narayan, Chandan; Ravishankar, Sudha; Madhavapeddi, Prashanti; Reddy, Jitendar; Prabhakar, K. R.; Saralaya, Ramanatha; Chatterji, Monalisa; Whiteaker, James; McLaughlin, Bob; Chiarelli, Laurent R.; Riccardi, Giovanna; Pasca, Maria Rosalia; Binda, Claudia; Neres, Joao; Dhar, Neeraj; Signorino-Gelo, Francois; McKinney, John D.; Ramachandran, Vasanthi; Shandil, Radha; Tommasi, Ruben; Iyer, Pravin S.; Narayanan, Shridhar; Hosagrahara, Vinayak; Kavanagh, Stefan; Dinesh, Neela; Ghorpade, Sandeep R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5419-5434</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Aminoquinolone piperidine amides (AQs) were identified as a novel scaffold starting from a whole cell screen, with potent cidality on Mycobacterium tuberculosis (Mtb).  Evaluation of the min. inhibitory concns., followed by whole genome sequencing of mutants raised against AQs, identified decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1) as the primary target responsible for the antitubercular activity.  Mass spectrometry and enzyme kinetic studies indicated that AQs are noncovalent, reversible inhibitors of DprE1 with slow on rates and long residence times of ∼100 min on the enzyme.  In general, AQs have excellent leadlike properties and good in vitro secondary pharmacol. profile.  Although the scaffold started off as a single active compd. with moderate potency from the whole cell screen, structure-activity relationship optimization of the scaffold led to compds. with potent DprE1 inhibition (IC50 < 10 nM) along with potent cellular activity (MIC = 60 nM) against Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo427Eycvs4I7Vg90H21EOLACvtfcHk0lhf0gbP1enVHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wqt7g%253D&md5=05e9a7f75679397a124088023762fe20</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm5005978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5005978%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DTantry%26aufirst%3DS.%2BJ.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DManjrekar%26aufirst%3DP.%26aulast%3DJena%26aufirst%3DL.%2BK.%26aulast%3DKoushik%26aufirst%3DK.%26aulast%3DShanbhag%26aufirst%3DG.%26aulast%3DJatheendranath%26aufirst%3DS.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DGorai%26aufirst%3DG.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DRudrapatna%26aufirst%3DS.%26aulast%3DAchar%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPrabhakar%26aufirst%3DK.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DChatterji%26aufirst%3DM.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DB.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DSignorino-Gelo%26aufirst%3DF.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DKavanagh%26aufirst%3DS.%26aulast%3DDinesh%26aufirst%3DN.%26aulast%3DGhorpade%26aufirst%3DS.%2BR.%26atitle%3D4-Aminoquinolone%2520Piperidine%2520Amides%253A%2520Noncovalent%2520Inhibitors%2520of%2520DprE1%2520with%2520Long%2520Residence%2520Time%2520and%2520Potent%2520Antimycobacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5419%26epage%3D5434%26doi%3D10.1021%2Fjm5005978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagalapur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raichurkar, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4761</span>– <span class="NLM_lpage">4771</span>, <span class="refDoi"> DOI: 10.1021/jm5002937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5002937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4761-4771&author=M.+Pandaauthor=S.+Ramachandranauthor=V.+Ramachandranauthor=P.+S.+Shirudeauthor=V.+Humnabadkarauthor=K.+Nagalapurauthor=S.+Sharmaauthor=P.+Kaurauthor=S.+Gupthaauthor=A.+Narayanauthor=J.+Mahadevaswamyauthor=A.+Ambadyauthor=N.+Hegdeauthor=S.+S.+Rudrapatnaauthor=V.+P.+Hosagraharaauthor=V.+K.+Sambandamurthyauthor=A.+Raichurkar&title=Discovery+of+Pyrazolopyridones+as+a+Novel+Class+of+Noncovalent+DprE1+Inhibitor+with+Potent+Anti-Mycobacterial+Activity&doi=10.1021%2Fjm5002937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity</span></div><div class="casAuthors">Panda, Manoranjan; Ramachandran, Sreekanth; Ramachandran, Vasanthi; Shirude, Pravin S.; Humnabadkar, Vaishali; Nagalapur, Kavitha; Sharma, Sreevalli; Kaur, Parvinder; Guptha, Supreeth; Narayan, Ashwini; Mahadevaswamy, Jyothi; Ambady, Anisha; Hegde, Naina; Rudrapatna, Suresh S.; Hosagrahara, Vinayak P.; Sambandamurthy, Vasan K.; Raichurkar, Anandkumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4761-4771</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel pyrazolopyridone class of inhibitors was identified from whole cell screening against Mycobacterium tuberculosis (Mtb).  The series exhibits excellent bactericidality in vitro, resulting in a 4 log redn. in colony forming units following compd. exposure.  The significant modulation of min. inhibitory concn. (MIC) against a Mtb strain overexpressing the Rv3790 gene suggested the target of pyrazolopyridones to be decaprenylphosphoryl-β-D-ribose-2'-epimerase (DprE1).  Genetic mapping of resistance mutation coupled with potent enzyme inhibition activity confirmed the mol. target.  Detailed biochem. characterization revealed the series to be a noncovalent inhibitor of DprE1.  Docking studies at the active site suggest that the series can be further diversified to improve the physicochem. properties without compromising the antimycobacterial activity.  The pyrazolopyridone class of inhibitors offers an attractive non-nitro lead series targeting the essential and vulnerable DprE1 enzyme for the discovery of novel antimycobacterial agents to treat both drug susceptible and drug resistant strains of Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdYV8Pi2ynA7Vg90H21EOLACvtfcHk0lh-WCJRNKBQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShtrw%253D&md5=dd3c1daf880d2f50d3187a0f9d1ab363</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm5002937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5002937%26sid%3Dliteratum%253Aachs%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DNagalapur%26aufirst%3DK.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DRudrapatna%26aufirst%3DS.%2BS.%26aulast%3DHosagrahara%26aufirst%3DV.%2BP.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DRaichurkar%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Pyrazolopyridones%2520as%2520a%2520Novel%2520Class%2520of%2520Noncovalent%2520DprE1%2520Inhibitor%2520with%2520Potent%2520Anti-Mycobacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4761%26epage%3D4771%26doi%3D10.1021%2Fjm5002937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadupudi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorme, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jesus
Lopes Ribeiro, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">2-Carboxyquinoxalines Kill <i>Mycobacterium Tuberculosis</i> through Noncovalent Inhibition of DprE1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1021/cb5007163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5007163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyqt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=705-714&author=J.+Neresauthor=R.+C.+Hartkoornauthor=L.+R.+Chiarelliauthor=R.+Gadupudiauthor=M.+R.+Pascaauthor=G.+Moriauthor=A.+Venturelliauthor=S.+Savinaauthor=V.+Makarovauthor=G.+S.+Kollyauthor=E.+Molteniauthor=C.+Bindaauthor=N.+Dharauthor=S.+Ferrariauthor=P.+Brodinauthor=V.+Delormeauthor=V.+Landryauthor=A.+L.+de+Jesus%0ALopes+Ribeiroauthor=D.+Farinaauthor=P.+Saxenaauthor=F.+Pojerauthor=A.+Cartaauthor=R.+Lucianiauthor=A.+Portaauthor=G.+Zanoniauthor=E.+De+Rossiauthor=M.+P.+Costiauthor=G.+Riccardiauthor=S.+T.+Cole&title=2-Carboxyquinoxalines+Kill+Mycobacterium+Tuberculosis+through+Noncovalent+Inhibition+of+DprE1&doi=10.1021%2Fcb5007163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1</span></div><div class="casAuthors">Neres, Joao; Hartkoorn, Ruben C.; Chiarelli, Laurent R.; Gadupudi, Ramakrishna; Pasca, Maria Rosalia; Mori, Giorgia; Venturelli, Alberto; Savina, Svetlana; Makarov, Vadim; Kolly, Gaelle S.; Molteni, Elisabetta; Binda, Claudia; Dhar, Neeraj; Ferrari, Stefania; Brodin, Priscille; Delorme, Vincent; Landry, Valerie; de Jesus Lopes Ribeiro, Ana Luisa; Farina, Davide; Saxena, Puneet; Pojer, Florence; Carta, Antonio; Luciani, Rosaria; Porta, Alessio; Zanoni, Giuseppe; De Rossi, Edda; Costi, Maria Paola; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">705-714</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phenotypic screening of a quinoxaline library against replicating Mycobacterium tuberculosis led to the identification of lead compd. Ty38c (3-((4-methoxybenzyl)amino)-6-(trifluoromethyl)quinoxaline-2-carboxylic acid).  With an MIC99 and MBC of 3.1 μM, Ty38c is bactericidal and active against intracellular bacteria.  To investigate its mechanism of action, we isolated mutants resistant to Ty38c and sequenced their genomes.  Mutations were found in rv3405c, coding for the transcriptional repressor of the divergently expressed rv3406 gene.  Biochem. studies clearly showed that Rv3406 decarboxylates Ty38c into its inactive keto metabolite.  The actual target was then identified by isolating Ty38c-resistant mutants of an M. tuberculosis strain lacking rv3406.  Here, mutations were found in dprE1, encoding the decaprenylphosphoryl-D-ribose oxidase DprE1, essential for biogenesis of the mycobacterial cell wall.  Genetics, biochem. validation, and X-ray crystallog. revealed Ty38c to be a noncovalent, noncompetitive DprE1 inhibitor.  Structure-activity relationship studies generated a family of DprE1 inhibitors with a range of IC50's and bactericidal activity.  Co-crystal structures of DprE1 in complex with eight different quinoxaline analogs provided a high-resoln. interaction map of the active site of this extremely vulnerable target in M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUParezeusZ7Vg90H21EOLACvtfcHk0lh-WCJRNKBQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyqt7rL&md5=83e64a019613003778c80079e4f8b978</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fcb5007163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5007163%26sid%3Dliteratum%253Aachs%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DGadupudi%26aufirst%3DR.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DMori%26aufirst%3DG.%26aulast%3DVenturelli%26aufirst%3DA.%26aulast%3DSavina%26aufirst%3DS.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DKolly%26aufirst%3DG.%2BS.%26aulast%3DMolteni%26aufirst%3DE.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DDelorme%26aufirst%3DV.%26aulast%3DLandry%26aufirst%3DV.%26aulast%3Dde%2BJesus%2BLopes%2BRibeiro%26aufirst%3DA.%2BL.%26aulast%3DFarina%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DP.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DCarta%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DPorta%26aufirst%3DA.%26aulast%3DZanoni%26aufirst%3DG.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3D2-Carboxyquinoxalines%2520Kill%2520Mycobacterium%2520Tuberculosis%2520through%2520Noncovalent%2520Inhibition%2520of%2520DprE1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D705%26epage%3D714%26doi%3D10.1021%2Fcb5007163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullick, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagalapur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbulakshmi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellows, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachaspati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarkar, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandodkar, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of Benzothiazoles as Antimycobacterial Agents: Synthesis, Structure–Activity Relationships and Binding Studies with Mycobacterium Tuberculosis Decaprenylphosphoryl-β-d-Ribose 2′-Oxidase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7694</span>– <span class="NLM_lpage">7710</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1016%2Fj.bmc.2015.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=26643218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7694-7710&author=S.+Landgeauthor=A.+B.+Mullickauthor=K.+Nagalapurauthor=J.+Neresauthor=V.+Subbulakshmiauthor=K.+Muruganauthor=A.+Ghoshauthor=C.+Sadlerauthor=M.+D.+Fellowsauthor=V.+Humnabadkarauthor=J.+Mahadevaswamyauthor=P.+Vachaspatiauthor=S.+Sharmaauthor=P.+Kaurauthor=M.+Mallyaauthor=S.+Rudrapatnaauthor=D.+Awasthyauthor=V.+K.+Sambandamurthyauthor=F.+Pojerauthor=S.+T.+Coleauthor=T.+S.+Balganeshauthor=B.+G.+Ugarkarauthor=V.+Balasubramanianauthor=B.+S.+Bandodkarauthor=M.+Pandaauthor=V.+Ramachandran&title=Discovery+of+Benzothiazoles+as+Antimycobacterial+Agents%3A+Synthesis%2C+Structure%E2%80%93Activity+Relationships+and+Binding+Studies+with+Mycobacterium+Tuberculosis+Decaprenylphosphoryl-%CE%B2-d-Ribose+2%E2%80%B2-Oxidase&doi=10.1016%2Fj.bmc.2015.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase</span></div><div class="casAuthors">Landge, Sudhir; Mullick, Amrita B.; Nagalapur, Kavitha; Neres, Joao; Subbulakshmi, Venkita; Murugan, Kannan; Ghosh, Anirban; Sadler, Claire; Fellows, Mick D.; Humnabadkar, Vaishali; Mahadevaswamy, Jyothi; Vachaspati, Prakash; Sharma, Sreevalli; Kaur, Parvinder; Mallya, Meenakshi; Rudrapatna, Suresh; Awasthy, Disha; Sambandamurthy, Vasan K.; Pojer, Florence; Cole, Stewart T.; Balganesh, Tanjore S.; Ugarkar, Bheemarao G.; Balasubramanian, V.; Bandodkar, Balachandra S.; Panda, Manoranjan; Ramachandran, Vasanthi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7694-7710</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the discovery of benzothiazoles, a novel anti-mycobacterial series, identified from a whole cell based screening campaign.  Benzothiazoles exert their bactericidal activity against Mycobacterium tuberculosis (Mtb) through potent inhibition of decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1), the key enzyme involved in arabinogalactan synthesis.  Specific target linkage and mode of binding were established using co-crystn. and protein mass spectrometry studies.  Most importantly, the current study provides insights on the utilization of systematic medicinal chem. approaches to mitigate safety liabilities while improving potency during progression from an initial genotoxic hit, the benzothiazole N-oxides (BTOs) to the lead-like AMES neg., crowded benzothiazoles (cBTs).  These findings offer opportunities for development of safe clin. candidates against tuberculosis.  The design strategy adopted could find potential application in discovery of safe drugs in other therapy areas too.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS7rEts75x7bVg90H21EOLACvtfcHk0lj0H15e8Uio2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3E&md5=cea6212afa6aee18530c45717f98b5c6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DLandge%26aufirst%3DS.%26aulast%3DMullick%26aufirst%3DA.%2BB.%26aulast%3DNagalapur%26aufirst%3DK.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DSubbulakshmi%26aufirst%3DV.%26aulast%3DMurugan%26aufirst%3DK.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DFellows%26aufirst%3DM.%2BD.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVachaspati%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DMallya%26aufirst%3DM.%26aulast%3DRudrapatna%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBalganesh%26aufirst%3DT.%2BS.%26aulast%3DUgarkar%26aufirst%3DB.%2BG.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBandodkar%26aufirst%3DB.%2BS.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520Benzothiazoles%2520as%2520Antimycobacterial%2520Agents%253A%2520Synthesis%252C%2520Structure%25E2%2580%2593Activity%2520Relationships%2520and%2520Binding%2520Studies%2520with%2520Mycobacterium%2520Tuberculosis%2520Decaprenylphosphoryl-%25CE%25B2-d-Ribose%25202%25E2%2580%25B2-Oxidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7694%26epage%3D7710%26doi%3D10.1016%2Fj.bmc.2015.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chikhale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menghani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansode, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhargavi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karodia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajasekharan, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paradkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khedekar, P.</span></span> <span> </span><span class="NLM_article-title">Development of Selective DprE1 Inhibitors: Design, Synthesis, Crystal Structure and Antitubercular Activity of Benzothiazolylpyrimidine-5-Carboxamides</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1016%2Fj.ejmech.2015.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=25874329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtF2qsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=30-46&author=R.+Chikhaleauthor=S.+Menghaniauthor=R.+Babuauthor=R.+Bansodeauthor=G.+Bhargaviauthor=N.+Karodiaauthor=M.+V.+Rajasekharanauthor=A.+Paradkarauthor=P.+Khedekar&title=Development+of+Selective+DprE1+Inhibitors%3A+Design%2C+Synthesis%2C+Crystal+Structure+and+Antitubercular+Activity+of+Benzothiazolylpyrimidine-5-Carboxamides&doi=10.1016%2Fj.ejmech.2015.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides</span></div><div class="casAuthors">Chikhale, Rupesh; Menghani, Sunil; Babu, Ramavath; Bansode, Ratnadeep; Bhargavi, G.; Karodia, Nazira; Rajasekharan, M. V.; Paradkar, Anant; Khedekar, Pramod</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-46</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Decaprenylphosphoryl-b-D-ribose 20-epimerase (DprE1) is a potential drug target for development of antitubercular agents.  Structure based drug discovery approach yielded twenty novel derivs. of benzothiazolylpyrimidine-5-carboxamides which were synthesized by three component one pot reaction involving benzothiazolyl oxobutanamide, thiourea and substituted arom. benzaldehydes.  These derivs. were evaluated for antitubercular activity to det. MIC.  Log P of these compds. is 2.0-3.0 making them suitable for oral dosing.  DprE1 selectivity and pharmacokinetic studies were carried out for these compds. of which N-(benzo[d]thiazol-2-yl)-1,2,3,4-tetrahydro-6-methyl-4-phenyl-2-thioxopyrimidine-5-carboxamide and N-(benzo[d]thiazol-2-yl)-4-(4-(dimethylamino)phenyl)1,2,3,4-tetrahydro-6-methyl-2-thioxopyrimidine-5-carboxamide are highly selective and bioavailability is >52% by oral dose.  Crystal structure of N-(benzo[d]thiazol-2-yl)-1,2,3,4-tetrahydro-6-methyl-4-phenyl-2-thioxopyrimidine-5-carboxamide was studied and mol. packing was detd., it exhibited a triclinic crystal lattice arrangement having hydrogen bonded dimeric arrangement.  Drug receptor interactions were studied which exhibited docking in the active site of receptor with hydrogen bonding, hydrophobic interactions, vdW interactions with amino acid residues such as Cys387, Asn385, Lys418, Tyr314, Gln334 and Lys367 resp. 3D QSAR anal. was carried out by kNN-MFA method to det. and develop theor. model, best suitable model is based on Simulated Annealing k-Neariest Neighbor Mol. Field Anal. (SA kNN-MFA).  The model provided with hydrophobic descriptors in pos. side indicating the need of bulky groups, steric and electroneg. descriptors in neg. coordinates hints with contribution by the electroneg. substitutions as favorable and desirable moieties for enhancing the activity.  The q2, q2_se and Pred_r2se are 0.5000, 0.6404 and 1.0094, resp.  A pharmacophore model was generated which suggested for necessity of arom., aliph. carbon center and hydrogen bond donor for development of newer DprE1 selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1VETL6MDO3LVg90H21EOLACvtfcHk0ljn9CpMqV88YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtF2qsL8%253D&md5=984772d5ddc286a1bc818635c91211a3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DChikhale%26aufirst%3DR.%26aulast%3DMenghani%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DR.%26aulast%3DBansode%26aufirst%3DR.%26aulast%3DBhargavi%26aufirst%3DG.%26aulast%3DKarodia%26aufirst%3DN.%26aulast%3DRajasekharan%26aufirst%3DM.%2BV.%26aulast%3DParadkar%26aufirst%3DA.%26aulast%3DKhedekar%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520Selective%2520DprE1%2520Inhibitors%253A%2520Design%252C%2520Synthesis%252C%2520Crystal%2520Structure%2520and%2520Antitubercular%2520Activity%2520of%2520Benzothiazolylpyrimidine-5-Carboxamides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D96%26spage%3D30%26epage%3D46%26doi%3D10.1016%2Fj.ejmech.2015.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbut, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilchèze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajayi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrassi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fütterer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span> <span> </span><span class="NLM_article-title">Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">13011</span>– <span class="NLM_lpage">13015</span>, <span class="refDoi"> DOI: 10.1002/anie.201707324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1002%2Fanie.201707324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeqs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=13011-13015&author=R.+Liuauthor=X.+Lyuauthor=S.+M.+Battauthor=M.-H.+Hsuauthor=M.+B.+Harbutauthor=C.+Vilch%C3%A8zeauthor=B.+Chengauthor=K.+Ajayiauthor=B.+Yangauthor=Y.+Yangauthor=H.+Guoauthor=C.+Linauthor=F.+Ganauthor=C.+Wangauthor=S.+G.+Franzblauauthor=W.+R.+Jacobsauthor=G.+S.+Besraauthor=E.+F.+Johnsonauthor=M.+Petrassiauthor=A.+K.+Chatterjeeauthor=K.+F%C3%BCttererauthor=F.+Wang&title=Determinants+of+the+Inhibition+of+DprE1+and+CYP2C9+by+Antitubercular+Thiophenes&doi=10.1002%2Fanie.201707324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes</span></div><div class="casAuthors">Liu, Renhe; Lyu, Xiaoxuan; Batt, Sarah M.; Hsu, Mei-Hui; Harbut, Michael B.; Vilcheze, Catherine; Cheng, Bo; Ajayi, Kehinde; Yang, Baiyuan; Yang, Yun; Guo, Hui; Lin, Changyou; Gan, Fei; Wang, Chen; Franzblau, Scott G.; Jacobs, William R., Jr.; Besra, Gurdyal S.; Johnson, Eric F.; Petrassi, Mike; Chatterjee, Arnab K.; Fuetterer, Klaus; Wang, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">13011-13015</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis (Mtb) DprE1, an essential isomerase for the biosynthesis of the mycobacterial cell wall, is a validated target for tuberculosis (TB) drug development.  Here we report the X-ray crystal structures of DprE1 and the DprE1 resistant mutant (Y314C) in complexes with TCA1 derivs. to elucidate the mol. basis of their inhibitory activities and an unconventional resistance mechanism, which enabled us to optimize the potency of the analogs.  The selected lead compd. showed excellent in vitro and in vivo activities, and low risk of toxicity profile except for the inhibition of CYP2C9.  A crystal structure of CYP2C9 in complex with a TCA1 analog revealed the similar interaction patterns to the DprE1-TCA1 complex.  Guided by the structures, an optimized mol. was generated with differential inhibitory activities against DprE1 and CYP2C9, which provides insights for development of a clin. candidate to treat TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZuWj2STE_rVg90H21EOLACvtfcHk0ljn9CpMqV88YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeqs73P&md5=ddbe9365e539f1935eeea02f1a697be3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.201707324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201707324%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLyu%26aufirst%3DX.%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DHsu%26aufirst%3DM.-H.%26aulast%3DHarbut%26aufirst%3DM.%2BB.%26aulast%3DVilch%25C3%25A8ze%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DB.%26aulast%3DAjayi%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DGan%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DPetrassi%26aufirst%3DM.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DDeterminants%2520of%2520the%2520Inhibition%2520of%2520DprE1%2520and%2520CYP2C9%2520by%2520Antitubercular%2520Thiophenes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D13011%26epage%3D13015%26doi%3D10.1002%2Fanie.201707324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chikhale, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barmade, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murumkar, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. R.</span></span> <span> </span><span class="NLM_article-title">Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8563</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00281</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00281" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVGjsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8563-8593&author=R.+V.+Chikhaleauthor=M.+A.+Barmadeauthor=P.+R.+Murumkarauthor=M.+R.+Yadav&title=Overview+of+the+Development+of+DprE1+Inhibitors+for+Combating+the+Menace+of+Tuberculosis&doi=10.1021%2Facs.jmedchem.8b00281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis</span></div><div class="casAuthors">Chikhale, Rupesh V.; Barmade, Mahesh A.; Murumkar, Prashant R.; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8563-8593</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1), a vital enzyme for cell wall synthesis, plays a crucial role in the formation of lipoarabinomannan and arabinogalactan.  It was first reported as a druggable target on the basis of inhibitors discovered in high throughput screening of a drug library.  Since then, inhibitors with different types of chem. scaffolds have been reported for their activity against this enzyme.  Formation of a covalent or noncovalent bond by the interacting ligand with the enzyme causes loss of its catalytic activity which ultimately leads to the death of the mycobacterium.  This Perspective describes various DprE1 inhibitors as anti-TB agents reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3s3ks2Vmg7Vg90H21EOLACvtfcHk0lhSnzp2odvGbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVGjsrzO&md5=b057993247c1c6c208907c474191c1d0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00281%26sid%3Dliteratum%253Aachs%26aulast%3DChikhale%26aufirst%3DR.%2BV.%26aulast%3DBarmade%26aufirst%3DM.%2BA.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DOverview%2520of%2520the%2520Development%2520of%2520DprE1%2520Inhibitors%2520for%2520Combating%2520the%2520Menace%2520of%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8563%26epage%3D8593%26doi%3D10.1021%2Facs.jmedchem.8b00281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lupien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foo, C. S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blattes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillon, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>, <span class="NLM_elocation-id">e00840</span> <span class="refDoi"> DOI: 10.1128/AAC.00840-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1128%2FAAC.00840-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=30126954" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&author=A.+Lupienauthor=A.+Vocatauthor=C.+S.-Y.+Fooauthor=E.+Blattesauthor=J.-Y.+Gillonauthor=V.+Makarovauthor=S.+T.+Cole&title=Optimized+Background+Regimen+for+Treatment+of+Active+Tuberculosis+with+the+Next-Generation+Benzothiazinone+Macozinone+%28PBTZ169%29&doi=10.1128%2FAAC.00840-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.00840-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00840-18%26sid%3Dliteratum%253Aachs%26aulast%3DLupien%26aufirst%3DA.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DFoo%26aufirst%3DC.%2BS.-Y.%26aulast%3DBlattes%26aufirst%3DE.%26aulast%3DGillon%26aufirst%3DJ.-Y.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DOptimized%2520Background%2520Regimen%2520for%2520Treatment%2520of%2520Active%2520Tuberculosis%2520with%2520the%2520Next-Generation%2520Benzothiazinone%2520Macozinone%2520%2528PBTZ169%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26doi%3D10.1128%2FAAC.00840-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vjecha, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiberi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span> <span> </span><span class="NLM_article-title">Accelerating the Development of Therapeutic Strategies for Drug-Resistant Tuberculosis</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1038%2Fnrd.2018.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=29567994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlWgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=607-608&author=M.+J.+Vjechaauthor=S.+Tiberiauthor=A.+Zumla&title=Accelerating+the+Development+of+Therapeutic+Strategies+for+Drug-Resistant+Tuberculosis&doi=10.1038%2Fnrd.2018.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerating the development of therapeutic strategies for drug-resistant tuberculosis</span></div><div class="casAuthors">Vjecha, Michael J.; Tiberi, Simon; Zumla, Alimuddin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">607-608</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Recent progress in the discovery, development and evaluation of new drugs and combination regimens for drug-resistant tuberculosis through greater collaboration between industry, donors and academia provides renewed hope for overcoming the challenges in tuberculosis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriQpkkVoCzWLVg90H21EOLACvtfcHk0lhSnzp2odvGbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlWgt74%253D&md5=2132b33f71055e8fc076a1d1ae03d383</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.28%26sid%3Dliteratum%253Aachs%26aulast%3DVjecha%26aufirst%3DM.%2BJ.%26aulast%3DTiberi%26aufirst%3DS.%26aulast%3DZumla%26aufirst%3DA.%26atitle%3DAccelerating%2520the%2520Development%2520of%2520Therapeutic%2520Strategies%2520for%2520Drug-Resistant%2520Tuberculosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D607%26epage%3D608%26doi%3D10.1038%2Fnrd.2018.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogacki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Ruano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vande Velde, C. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span> <span> </span><span class="NLM_article-title">Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11221</span>– <span class="NLM_lpage">11249</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11221-11249&author=M.+K.+Rogackiauthor=E.+Pittaauthor=O.+Balabonauthor=S.+Hussauthor=E.+M.+Lopez-Romanauthor=A.+Argyrouauthor=D.+Blanco-Ruanoauthor=M.+Cachoauthor=C.+M.+L.+Vande+Veldeauthor=K.+Augustynsauthor=L.+Ballellauthor=D.+Barrosauthor=R.+H.+Batesauthor=F.+Cunninghamauthor=P.+Van+der+Veken&title=Identification+and+Profiling+of+Hydantoins%E2%80%94A+Novel+Class+of+Potent+Antimycobacterial+DprE1+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors</span></div><div class="casAuthors">Rogacki, Maciej K.; Pitta, Eleni; Balabon, Olga; Huss, Sophie; Lopez-Roman, Eva Maria; Argyrou, Argyrides; Blanco-Ruano, Delia; Cacho, Monica; Vande Velde, Christophe M. L.; Augustyns, Koen; Ballell, Lluis; Barros, David; Bates, Robert H.; Cunningham, Fraser; Van der Veken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11221-11249</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis is the leading cause of death worldwide from infectious diseases.  With the development of drug-resistant strains of Mycobacterium tuberculosis, there is an acute need for new medicines with novel modes of action.  Herein, we report the discovery and profiling of a novel hydantoin-based family of antimycobacterial inhibitors of the decaprenylphospho-β-D-ribofuranose 2-oxidase (DprE1).  In this study, we have prepd. a library of more than a 100 compds. and evaluated them for their biol. and physicochem. properties.  The series is characterized by high enzymic and whole-cell activity, low cytotoxicity, and a good overall physicochem. profile.  In addn., we show that the series acts via reversible inhibition of the DprE1 enzyme.  Overall, the novel compd. family forms an attractive base for progression to further stages of optimization and may provide a promising drug candidate in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMw2Vn8XKan7Vg90H21EOLACvtfcHk0lhSnzp2odvGbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzE&md5=647fdfe146a1802016d7e38a8543e522</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01356%26sid%3Dliteratum%253Aachs%26aulast%3DRogacki%26aufirst%3DM.%2BK.%26aulast%3DPitta%26aufirst%3DE.%26aulast%3DBalabon%26aufirst%3DO.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DArgyrou%26aufirst%3DA.%26aulast%3DBlanco-Ruano%26aufirst%3DD.%26aulast%3DCacho%26aufirst%3DM.%26aulast%3DVande%2BVelde%26aufirst%3DC.%2BM.%2BL.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DCunningham%26aufirst%3DF.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DIdentification%2520and%2520Profiling%2520of%2520Hydantoins%25E2%2580%2594A%2520Novel%2520Class%2520of%2520Potent%2520Antimycobacterial%2520DprE1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11221%26epage%3D11249%26doi%3D10.1021%2Facs.jmedchem.8b01356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bucherer, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieb, V. A.</span></span> <span> </span><span class="NLM_article-title">Über Die Bildung Substituierter Hydantoine Aus Aldehyden Und Ketonen. Synthese von Hydantoinen</span>. <i>J. Prakt. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1934</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1002/prac.19341410102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1002%2Fprac.19341410102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADyaA2MXhtVOk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=1934&pages=5-43&author=H.+T.+Buchererauthor=V.+A.+Lieb&title=%C3%9Cber+Die+Bildung+Substituierter+Hydantoine+Aus+Aldehyden+Und+Ketonen.+Synthese+von+Hydantoinen&doi=10.1002%2Fprac.19341410102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of hydantoins. II. Formation of substituted hydantoins from aldehydes and ketones</span></div><div class="casAuthors">Bucherer, Hans Th.; Libe, Viktor A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal fuer Praktische Chemie (Leipzig)</span>
        (<span class="NLM_cas:date">1934</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-43</span>CODEN:
                <span class="NLM_cas:coden">JPCEAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-8383</span>.
    </div><div class="casAbstract">The following methods were used for the synthesis of hydantoins: 1 mol. ketone or aldehyde, 3 mols. (NH4)2CO3 and 4 parts by wt. of ligroin, treated with 1.5-2 mols. HCN and allowed to stand 3-4 days at room temp. (I); the same but in 50% EtOH, 4-5 hrs. at 50° and 1 hr. at 70-80° (II); the same as I but with 1-1.5 mols. KCN 4-10 days at room temp. (III); the same as III but with 50% EtOH (IV); 1 mol. NaHSO3 compd., 2 mols. KCN and 4 mols. (NH4)2CO3 in 50% EtOH 4-5 hrs. at 50-5° (V).  The following yields are reported: Dimethylhydantoin from Me2CO, I 30-40%, II 40%, III 30%, IV 80%, V 90%; pentamethylenehydantoin (VI) from cyclohexanone, I 50-60%, II 90%, III small, IV 95%, V 95%; methylethylhydantoin from MeEtCO, I 50%, IV 90%; phenylmethylhydantoin from PhAc, I 40-50%, II 90%, IV 90%; phenylethylhydantoin from PhCOEt, II 80-5%, IV 80-5%; benzylmethylhydantoin, m. 225°, from PhCH2Ac, II 70%, IV 80%, V 80-5%; it does not yield an ω-Br deriv. (PhCH2)2CO, with IV, gives a poor yield of dibenzylhydantoin(?).  Ac2, with II, gives 10% of the hypothetical dimethylbishydantoin (VII), decompg. 265-70°; the cyanohydrin with (NH4)2CO3 gives about 20% of the same compd.; hydrolysis gives a compd., C6H12O4N2, m. 280° (decompn.); MeC(NOH)Ac gives 20% of VII.  Phenylhydantoin (VIII) from BzH, I 10%, II 25-30%, IV 20%, V 85%; BZ2 gives 20% and BzAc 45% VIII.  Benzylhydantoin from PhCH2CHO, I 10-12%, II 20-5%, IV 15%, V 80%; carbethoxydimethylhydantoin from AcCH2CO2Et, II 60%, V 80%.  1,3-Diketones (Ac2CH2) and hydroxy ketones (benzoin) did not react.  Hydrolysis of the hydantoins with 60% H2SO4 yields NH2 acids.  The acid from VI and BzCl give the N-Bz deriv. of hexahydroanilinecarboxylic acid, m. 190°.  Tyrosine (IX) was prepd. by the following steps: benzylhydantoin yields 95% of a mixt. of o-, m. 213-15°, and p-NO2 derivs., m. 240-5°; through the NH2 and diazo compds. there was prepd. the p-HO deriv., m. 260-2°; hydrolysis with H2SO4 gives IX.  Me2C(OH)CN (X) or cyclohexanone cyanohydrin (XI) do not react with MeNH2.HCl and Na2CO3 in EtOH.  XI, CS2 and 25% NH4OH in EtOH give a compd., m. 225° (see part I), and a compd. C13H21NS2, golden yellow with violet reflex, m. 195°; without EtOH there results a compd. m. 261-5°.  XI, CS2 and gaseous NH3 give compds. m. 223°, 195° and 72-5° (see part I).  X, CS2 and NH4OH give the compd. C7H14N2S, m. 154-5°; gaseous NH3 gives this compd. and one, m. 297°.  Me2C(NH2)CN gives the same compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFUmP0PMcp_bVg90H21EOLACvtfcHk0lghhO8QTbFHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA2MXhtVOk&md5=34b29a54e7ba20796e5fe8b8c14e60e2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fprac.19341410102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprac.19341410102%26sid%3Dliteratum%253Aachs%26aulast%3DBucherer%26aufirst%3DH.%2BT.%26aulast%3DLieb%26aufirst%3DV.%2BA.%26atitle%3D%25C3%259Cber%2520Die%2520Bildung%2520Substituierter%2520Hydantoine%2520Aus%2520Aldehyden%2520Und%2520Ketonen.%2520Synthese%2520von%2520Hydantoinen%26jtitle%3DJ.%2520Prakt.%2520Chem.%26date%3D1934%26volume%3D141%26spage%3D5%26epage%3D43%26doi%3D10.1002%2Fprac.19341410102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruble, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, A.</span></span> <span> </span><span class="NLM_article-title">Mild Pd-Catalyzed N -Arylation of Methanesulfonamide and Related Nucleophiles: Avoiding Potentially Genotoxic Reagents and Byproducts</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2564</span>– <span class="NLM_lpage">2567</span>, <span class="refDoi"> DOI: 10.1021/ol200660s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol200660s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVGgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=2564-2567&author=B.+R.+Rosenauthor=J.+C.+Rubleauthor=T.+J.+Beauchampauthor=A.+Navarro&title=Mild+Pd-Catalyzed+N+-Arylation+of+Methanesulfonamide+and+Related+Nucleophiles%3A+Avoiding+Potentially+Genotoxic+Reagents+and+Byproducts&doi=10.1021%2Fol200660s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mild Pd-catalyzed N-arylation of methanesulfonamide and related nucleophiles: avoiding potentially genotoxic reagents and byproducts</span></div><div class="casAuthors">Rosen, Brandon R.; Ruble, J. Craig; Beauchamp, Thomas J.; Navarro, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2564-2567</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A convenient, general, and high yielding Pd-catalyzed cross-coupling of methanesulfonamide with aryl bromides and chlorides is reported.  The use of this method eliminates concern over genotoxic impurities that can arise when an aniline is reacted with methanesulfonyl chloride.  The application of this method to the synthesis of dofetilide (I) is also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4xC6C7zikuLVg90H21EOLACvtfcHk0lghhO8QTbFHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVGgsbs%253D&md5=4bb02fa40337c4a0e858893f712f2e03</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fol200660s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol200660s%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DB.%2BR.%26aulast%3DRuble%26aufirst%3DJ.%2BC.%26aulast%3DBeauchamp%26aufirst%3DT.%2BJ.%26aulast%3DNavarro%26aufirst%3DA.%26atitle%3DMild%2520Pd-Catalyzed%2520N%2520-Arylation%2520of%2520Methanesulfonamide%2520and%2520Related%2520Nucleophiles%253A%2520Avoiding%2520Potentially%2520Genotoxic%2520Reagents%2520and%2520Byproducts%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D2564%26epage%3D2567%26doi%3D10.1021%2Fol200660s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho Izquierdo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro Pichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela-Glez
Del Peral, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouzon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros Aguirre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span> <span> </span><span class="NLM_article-title">Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium Tuberculosis Decaprenylphosphoryl-β- d -Ribose Oxidase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00065</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2016&pages=615-626&author=S.+M.+Battauthor=M.+Cacho+Izquierdoauthor=J.+Castro+Pichelauthor=C.+J.+Stubbsauthor=L.+Vela-Glez%0ADel+Peralauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=N.+Dharauthor=B.+Mouzonauthor=M.+Reesauthor=J.+P.+Hutchinsonauthor=R.+J.+Youngauthor=J.+D.+McKinneyauthor=D.+Barros+Aguirreauthor=L.+Ballellauthor=G.+S.+Besraauthor=A.+Argyrou&title=Whole+Cell+Target+Engagement+Identifies+Novel+Inhibitors+of+Mycobacterium+Tuberculosis+Decaprenylphosphoryl-%CE%B2-+d+-Ribose+Oxidase&doi=10.1021%2Facsinfecdis.5b00065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00065%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DCacho%2BIzquierdo%26aufirst%3DM.%26aulast%3DCastro%2BPichel%26aufirst%3DJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DVela-Glez%2BDel%2BPeral%26aufirst%3DL.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DMouzon%26aufirst%3DB.%26aulast%3DRees%26aufirst%3DM.%26aulast%3DHutchinson%26aufirst%3DJ.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBarros%2BAguirre%26aufirst%3DD.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DArgyrou%26aufirst%3DA.%26atitle%3DWhole%2520Cell%2520Target%2520Engagement%2520Identifies%2520Novel%2520Inhibitors%2520of%2520Mycobacterium%2520Tuberculosis%2520Decaprenylphosphoryl-%25CE%25B2-%2520d%2520-Ribose%2520Oxidase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D1%26spage%3D615%26epage%3D626%26doi%3D10.1021%2Facsinfecdis.5b00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warrier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapilashrami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandakumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somersan-Karakaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porras-De Francisco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Hoyos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Huang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span> <span> </span><span class="NLM_article-title">N-Methylation of a Bactericidal Compound as a Resistance Mechanism in Mycobacterium Tuberculosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E4523</span>– <span class="NLM_lpage">E4530</span>, <span class="refDoi"> DOI: 10.1073/pnas.1606590113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1073%2Fpnas.1606590113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=27432954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOrsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E4523-E4530&author=T.+Warrierauthor=K.+Kapilashramiauthor=A.+Argyrouauthor=T.+R.+Ioergerauthor=D.+Littleauthor=K.+C.+Murphyauthor=M.+Nandakumarauthor=S.+Parkauthor=B.+Goldauthor=J.+Miauthor=T.+Zhangauthor=E.+Meilerauthor=M.+Reesauthor=S.+Somersan-Karakayaauthor=E.+Porras-De+Franciscoauthor=M.+Martinez-Hoyosauthor=K.+Burns-Huangauthor=J.+Robertsauthor=Y.+Lingauthor=K.+Y.+Rheeauthor=A.+Mendoza-Losanaauthor=M.+Luoauthor=C.+F.+Nathan&title=N-Methylation+of+a+Bactericidal+Compound+as+a+Resistance+Mechanism+in+Mycobacterium+Tuberculosis&doi=10.1073%2Fpnas.1606590113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis</span></div><div class="casAuthors">Warrier, Thulasi; Kapilashrami, Kanishk; Argyrou, Argyrides; Ioerger, Thomas R.; Little, David; Murphy, Kenan C.; Nandakumar, Madhumitha; Park, Suna; Gold, Ben; Mi, Jianjie; Zhang, Tuo; Meiler, Eugenia; Rees, Mike; Somersan-Karakaya, Selin; Porras-De Francisco, Esther; Martinez-Hoyos, Maria; Burns-Huang, Kristin; Roberts, Julia; Ling, Yan; Rhee, Kyu Y.; Mendoza-Losana, Alfonso; Luo, Minkui; Nathan, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">E4523-E4530</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The rising incidence of antimicrobial resistance (AMR) makes it imperative to understand the underlying mechanisms.  Mycobacterium tuberculosis (Mtb) is the single leading cause of death from a bacterial pathogen and estd. to be the leading cause of death from AMR.  A pyrido-benzimidazole, 14, was reported to have potent bactericidal activity against Mtb.  Here, we isolated multiple Mtb clones resistant to 14.  Each had mutations in the putative DNA-binding and dimerization domains of rv2887, a gene encoding a transcriptional repressor of the MarR family.  The mutations in Rv2887 led to markedly increased expression of rv0560c.  We characterized Rv0560c as an S-adenosyl-L-methionine-dependent methyltransferase that N-methylates 14, abolishing its mycobactericidal activity.  An Mtb strain lacking rv0560c became resistant to 14 by mutating decaprenylphosphoryl-β-d-ribose 2-oxidase (DprE1), an essential enzyme in arabinogalactan synthesis; 14 proved to be a nanomolar inhibitor of DprE1, and methylation of 14 by Rv0560c abrogated this activity.  Thus, 14 joins a growing list of DprE1 inhibitors that are potently mycobactericidal.  Bacterial methylation of an antibacterial agent, 14, catalyzed by Rv0560c of Mtb, is a previously unreported mechanism of AMR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW6Cwmyogp3bVg90H21EOLACvtfcHk0liSapkIOfXWGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOrsr7I&md5=9042ee902a0bf5ad1710f0dc2a0d0ffd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1606590113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1606590113%26sid%3Dliteratum%253Aachs%26aulast%3DWarrier%26aufirst%3DT.%26aulast%3DKapilashrami%26aufirst%3DK.%26aulast%3DArgyrou%26aufirst%3DA.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DLittle%26aufirst%3DD.%26aulast%3DMurphy%26aufirst%3DK.%2BC.%26aulast%3DNandakumar%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DGold%26aufirst%3DB.%26aulast%3DMi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DMeiler%26aufirst%3DE.%26aulast%3DRees%26aufirst%3DM.%26aulast%3DSomersan-Karakaya%26aufirst%3DS.%26aulast%3DPorras-De%2BFrancisco%26aufirst%3DE.%26aulast%3DMartinez-Hoyos%26aufirst%3DM.%26aulast%3DBurns-Huang%26aufirst%3DK.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DRhee%26aufirst%3DK.%2BY.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26atitle%3DN-Methylation%2520of%2520a%2520Bactericidal%2520Compound%2520as%2520a%2520Resistance%2520Mechanism%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE4523%26epage%3DE4530%26doi%3D10.1073%2Fpnas.1606590113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Pérez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelievre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diacon, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugonnet, J.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros-Aguirre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span> <span> </span><span class="NLM_article-title">Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4997</span>– <span class="NLM_lpage">4999</span>, <span class="refDoi"> DOI: 10.1128/AAC.01063-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1128%2FAAC.01063-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=25987618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KntL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=4997-4999&author=J.+Rullasauthor=N.+Dharauthor=J.+D.+McKinneyauthor=A.+Garc%C3%ADa-P%C3%A9rezauthor=J.+Lelievreauthor=A.+H.+Diaconauthor=J.-E.+Hugonnetauthor=M.+Arthurauthor=I.+Angulo-Barturenauthor=D.+Barros-Aguirreauthor=L.+Ballell&title=Combinations+of+%CE%B2-Lactam+Antibiotics+Currently+in+Clinical+Trials+Are+Efficacious+in+a+DHP-I-Deficient+Mouse+Model+of+Tuberculosis+Infection&doi=10.1128%2FAAC.01063-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Combinations of β-lactam antibiotics currently in clinical trials are efficacious in a DHP-I-deficient mouse model of tuberculosis infection</span></div><div class="casAuthors">Rullas, Joaquin; Dhar, Neeraj; McKinney, John D.; Garcia-Perez, Adolfo; Lelievre, Joel; Diacon, Andreas H.; Hugonnet, Jean-Emmanuel; Arthur, Michel; Angulo-Barturen, Inigo; Barros-Aguirre, David; Ballell, Lluis</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4997-4999</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report here a dehydropeptidase-deficient murine model of tuberculosis (TB) infection that is able to partially uncover the efficacy of marketed broad-spectrum β-lactam antibiotics alone and in combination.  Redns. of up to 2 log CFU in the lungs of TB-infected mice after 8 days of treatment compared to untreated controls were obtained at blood drug concns. and time above the MIC (T>MIC) below clin. achievable levels in humans.  These findings provide evidence supporting the potential of β-lactams as safe and mycobactericidal components of new combination regimens against TB with or without resistance to currently used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVH9ILBVaFDrVg90H21EOLACvtfcHk0liSapkIOfXWGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KntL7J&md5=6f58fae04c45bbd01c4202899856236f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.01063-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01063-15%26sid%3Dliteratum%253Aachs%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DGarc%25C3%25ADa-P%25C3%25A9rez%26aufirst%3DA.%26aulast%3DLelievre%26aufirst%3DJ.%26aulast%3DDiacon%26aufirst%3DA.%2BH.%26aulast%3DHugonnet%26aufirst%3DJ.-E.%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DBarros-Aguirre%26aufirst%3DD.%26aulast%3DBallell%26aufirst%3DL.%26atitle%3DCombinations%2520of%2520%25CE%25B2-Lactam%2520Antibiotics%2520Currently%2520in%2520Clinical%2520Trials%2520Are%2520Efficacious%2520in%2520a%2520DHP-I-Deficient%2520Mouse%2520Model%2520of%2520Tuberculosis%2520Infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D4997%26epage%3D4999%26doi%3D10.1128%2FAAC.01063-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogacki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span> <span> </span><span class="NLM_article-title">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-Yloxyacetamides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6709</span>– <span class="NLM_lpage">6728</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6709-6728&author=E.+Pittaauthor=M.+K.+Rogackiauthor=O.+Balabonauthor=S.+Hussauthor=F.+Cunninghamauthor=E.+M.+Lopez-Romanauthor=J.+Joossensauthor=K.+Augustynsauthor=L.+Ballellauthor=R.+H.+Batesauthor=P.+Van+der+Veken&title=Searching+for+New+Leads+for+Tuberculosis%3A+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+2-Quinolin-4-Yloxyacetamides&doi=10.1021%2Facs.jmedchem.6b00245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides</span></div><div class="casAuthors">Pitta, Eleni; Rogacki, Maciej K.; Balabon, Olga; Huss, Sophie; Cunningham, Fraser; Lopez-Roman, Eva Maria; Joossens, Jurgen; Augustyns, Koen; Ballell, Lluis; Bates, Robert H.; Van derVeken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6709-6728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, a new series of more than 60 quinoline derivs. has been synthesized and evaluated against Mycobacterium tuberculosis (H37Rv).  Apart from the SAR exploration around the initial hits, the optimization process focused on the improvement of the physicochem. properties, cytotoxicity, and metabolic stability of the series.  The best compds. obtained exhibited MIC values in the low micromolar range, excellent intracellular antimycobacterial activity, and an improved physicochem. profile without cytotoxic effects.  Further investigation revealed that the amide bond was the source for the poor blood stability obsd., while some of the compds. exhibited hERG affinity.  Compd. I, which contains a benzoxazole ring instead of the amide group, was found to be a good alternative, with good blood stability and no hERG affinity, providing new opportunities for the series.  Overall, the obtained results suggest that further optimization of soly. and microsomal stability of the series could provide a strong lead for a new anti-TB drug development program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrjBguBpaWgbVg90H21EOLACvtfcHk0lh3gohlJ8rFNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7%252FE&md5=8b4cc0d1c032dde93c91811cdbba557b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00245%26sid%3Dliteratum%253Aachs%26aulast%3DPitta%26aufirst%3DE.%26aulast%3DRogacki%26aufirst%3DM.%2BK.%26aulast%3DBalabon%26aufirst%3DO.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DF.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DSearching%2520for%2520New%2520Leads%2520for%2520Tuberculosis%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25202-Quinolin-4-Yloxyacetamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6709%26epage%3D6728%26doi%3D10.1021%2Facs.jmedchem.6b00245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Gomez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Ruiz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escribano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Villarejo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Plaza, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo-Lopez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuiñan-Blanco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavandera, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo-Benito, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span> <span> </span><span class="NLM_article-title">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1002%2Fcmdc.201200428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=23307663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=313-321&author=L.+Ballellauthor=R.+H.+Batesauthor=R.+J.+Youngauthor=D.+Alvarez-Gomezauthor=E.+Alvarez-Ruizauthor=V.+Barrosoauthor=D.+Blancoauthor=B.+Crespoauthor=J.+Escribanoauthor=R.+Gonz%C3%A1lezauthor=S.+Lozanoauthor=S.+Hussauthor=A.+Santos-Villarejoauthor=J.+J.+Mart%C3%ADn-Plazaauthor=A.+Mendozaauthor=M.+J.+Rebollo-Lopezauthor=M.+Remui%C3%B1an-Blancoauthor=J.+L.+Lavanderaauthor=E.+P%C3%A9rez-Herranauthor=F.+J.+Gamo-Benitoauthor=J.+F.+Garc%C3%ADa-Bustosauthor=D.+Barrosauthor=J.+P.+Castroauthor=N.+Cammack&title=Fueling+Open-Source+Drug+Discovery%3A+177+Small-Molecule+Leads+against+Tuberculosis&doi=10.1002%2Fcmdc.201200428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span></div><div class="casAuthors">Ballell, Lluis; Bates, Robert H.; Young, Rob J.; Alvarez-Gomez, Daniel; Alvarez-Ruiz, Emilio; Barroso, Vanessa; Blanco, Delia; Crespo, Benigno; Escribano, Jaime; Gonzalez, Ruben; Lozano, Sonia; Huss, Sophie; Santos-Villarejo, Angel; Martin-Plaza, Jose Julio; Mendoza, Alfonso; Rebollo-Lopez, Maria Jose; Remuinan-Blanco, Modesto; Lavandera, Jose Luis; Perez-Herran, Esther; Gamo-Benito, Francisco Javier; Garcia-Bustos, Jose Francisco; Barros, David; Castro, Julia P.; Cammack, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With the aim of fuelling open-source, translational, early-stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible.  A set of 177 potent non-cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compds. toward a chem. genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead-generation activities.  Two addnl. drug-discovery-relevant datasets are included: (a) a drug-like property anal. reflecting the latest lead-like guidelines and (b) an early lead-generation package of the most promising hits within the clusters identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJ2sVPWfPALVg90H21EOLACvtfcHk0lh3gohlJ8rFNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D&md5=32c975dbe183849358c701ca697681d3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200428%26sid%3Dliteratum%253Aachs%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DAlvarez-Gomez%26aufirst%3DD.%26aulast%3DAlvarez-Ruiz%26aufirst%3DE.%26aulast%3DBarroso%26aufirst%3DV.%26aulast%3DBlanco%26aufirst%3DD.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DEscribano%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DR.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DMart%25C3%25ADn-Plaza%26aufirst%3DJ.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%26aulast%3DRemui%25C3%25B1an-Blanco%26aufirst%3DM.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DP%25C3%25A9rez-Herran%26aufirst%3DE.%26aulast%3DGamo-Benito%26aufirst%3DF.%2BJ.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DJ.%2BP.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DFueling%2520Open-Source%2520Drug%2520Discovery%253A%2520177%2520Small-Molecule%2520Leads%2520against%2520Tuberculosis%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D313%26epage%3D321%26doi%3D10.1002%2Fcmdc.201200428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, C.</span></span> <span> </span><span class="NLM_article-title">Development of a High-Throughput Electrophysiological Assay for the Human Ether-à-Go-Go Related Potassium Channel HERG</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2012.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1016%2Fj.vascn.2012.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=23103595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Kls73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=33-44&author=D.+J.+Gillieauthor=S.+J.+Novickauthor=B.+T.+Donovanauthor=L.+A.+Payneauthor=C.+Townsend&title=Development+of+a+High-Throughput+Electrophysiological+Assay+for+the+Human+Ether-%C3%A0-Go-Go+Related+Potassium+Channel+HERG&doi=10.1016%2Fj.vascn.2012.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high-throughput electrophysiological assay for the human ether-a-go-go related potassium channel hERG</span></div><div class="casAuthors">Gillie, Daniel J.; Novick, Steven J.; Donovan, Brian T.; Payne, Lisa A.; Townsend, Claire</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-44</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Drug-induced prolongation of the QT interval via block of the hERG potassium channel is a major cause of attrition in drug development.  The advent of automated electrophysiol. systems has enabled the detection of hERG block earlier in drug discovery.  In this study, we have evaluated the suitability of a second generation automated patch clamp instrument, the IonWorks Barracuda, for the characterization of hERG biophysics and pharmacol.All expts. were conducted with cells stably expressing hERG.  Recordings were made in perforated patch mode either on a conventional patch clamp setup or on the IonWorks Barracuda.  On the latter, all recordings were population recordings in 384-well patch plates.HERG channels activated with a V1/2 = - 3.2 ± 1.6 mV (n = 178) on the IonWorks Barracuda vs. - 11.2 ± 6.1 mV (n = 9) by manual patch clamp.  On the IonWorks Barracuda, seal resistances and currents were stable (< 30% change) with up to six cumulative drug addns. and 1-min incubations per addn.  Over 27 expts., an av. of 338 concn.-response curves were obtained per expt. (96% of the 352 test wells on each plate).  HERG pharmacol. was examd. with a set of 353 compds. that included well-characterized hERG blockers.  Astemizole, terfenadine and quinidine inhibited hERG currents with IC50 values of 159 nM, 224 nM and 2 μM, resp. (n = 51, 10 and 18).  This set of compds. was also tested on the PatchXpress automated electrophysiol. system.  We detd. through statistical methods that the two automated systems provided equiv. results.Evaluating drug effects on hERG channels is best performed by electrophysiol. methods.  HERG activation and pharmacol. on the IonWorks Barracuda automated electrophysiol. platform were in good agreement with published electrophysiol. results.  Therefore, the IonWorks Barracuda provides an efficient way to study hERG biophysics and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbgRW5sTJiDLVg90H21EOLACvtfcHk0lhJLL0eSRtCeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Kls73J&md5=1a94eeb8d044313b1f7b08c41a61cd4a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2012.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2012.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DGillie%26aufirst%3DD.%2BJ.%26aulast%3DNovick%26aufirst%3DS.%2BJ.%26aulast%3DDonovan%26aufirst%3DB.%2BT.%26aulast%3DPayne%26aufirst%3DL.%2BA.%26aulast%3DTownsend%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520a%2520High-Throughput%2520Electrophysiological%2520Assay%2520for%2520the%2520Human%2520Ether-%25C3%25A0-Go-Go%2520Related%2520Potassium%2520Channel%2520HERG%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2013%26volume%3D67%26spage%3D33%26epage%3D44%26doi%3D10.1016%2Fj.vascn.2012.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remuiñán, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullás, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemparte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Hoyos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esquivias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Muro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraile-Gabaldón, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spivey, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loman, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantinidou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minick, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo-López, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span> <span> </span><span class="NLM_article-title">Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium Tuberculosis Targeting MmpL3</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e60933</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0060933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1371%2Fjournal.pone.0060933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=23613759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFartro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=M.+J.+Remui%C3%B1%C3%A1nauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=J.+Rull%C3%A1sauthor=C.+Alemparteauthor=M.+Mart%C3%ADnez-Hoyosauthor=D.+J.+Dowauthor=J.+Afariauthor=N.+Mehtaauthor=J.+Esquiviasauthor=E.+Jim%C3%A9nezauthor=F.+Ortega-Muroauthor=M.+T.+Fraile-Gabald%C3%B3nauthor=V.+L.+Spiveyauthor=N.+J.+Lomanauthor=M.+J.+Pallenauthor=C.+Constantinidouauthor=D.+J.+Minickauthor=M.+Cachoauthor=M.+J.+Rebollo-L%C3%B3pezauthor=C.+Gonz%C3%A1lezauthor=V.+Sousaauthor=I.+Angulo-Barturenauthor=A.+Mendoza-Losanaauthor=D.+Barrosauthor=G.+S.+Besraauthor=L.+Ballellauthor=N.+Cammack&title=Tetrahydropyrazolo%5B1%2C5-a%5DPyrimidine-3-Carboxamide+and+N-Benzyl-6%E2%80%B2%2C7%E2%80%B2-Dihydrospiro%5BPiperidine-4%2C4%E2%80%B2-Thieno%5B3%2C2-c%5DPyran%5D+Analogues+with+Bactericidal+Efficacy+against+Mycobacterium+Tuberculosis+Targeting+MmpL3&doi=10.1371%2Fjournal.pone.0060933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3</span></div><div class="casAuthors">Remuinan, Modesto J.; Perez-Herran, Esther; Rullas, Joaquin; Alemparte, Carlos; Martinez-Hoyos, Maria; Dow, David J.; Afari, Johnson; Mehta, Nalini; Esquivias, Jorge; Jimenez, Elena; Ortega-Muro, Fatima; Fraile-Gabaldon, Maria Teresa; Spivey, Vickey L.; Loman, Nicholas J.; Pallen, Mark J.; Constantinidou, Chrystala; Minick, Douglas J.; Cacho, Monica; Rebollo-Lopez, Maria Jose; Gonzalez, Carolina; Sousa, Veronica; Angulo-Barturen, Inigo; Mendoza-Losana, Alfonso; Barros, David; Besra, Gurdyal S.; Ballell, Lluis; Cammack, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e60933</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB).  Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB.  As part of the authors' efforts towards the discovery of new anti-tubercular leads, a no. of potent tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (THPP) and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] (Spiro) analogs were recently identified against Mycobacterium tuberculosis and Mycobacterium bovis BCG through a high-throughput whole-cell screening campaign.  Herein, the authors describe the attractive in vitro and in vivo anti-tubercular profiles of both lead series.  The generation of M. tuberculosis spontaneous mutants and subsequent whole genome sequencing of several resistant mutants identified single mutations in the essential mmpL3 gene.  This genetic phenotype was further confirmed by a chem. phenotype, whereby M. bovis BCG treated with both the THPP and Spiro series resulted in the accumulation of trehalose monomycolate.  In vivo efficacy evaluation of two optimized THPP and Spiro leads showed how the compds. were able to reduce >2 logs bacterial cfu counts in the lungs of infected mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCGBbs5TLQArVg90H21EOLACvtfcHk0lhJLL0eSRtCeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFartro%253D&md5=22123e5b0f762bcd2467bae122c372ca</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0060933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0060933%26sid%3Dliteratum%253Aachs%26aulast%3DRemui%25C3%25B1%25C3%25A1n%26aufirst%3DM.%2BJ.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DRull%25C3%25A1s%26aufirst%3DJ.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DMart%25C3%25ADnez-Hoyos%26aufirst%3DM.%26aulast%3DDow%26aufirst%3DD.%2BJ.%26aulast%3DAfari%26aufirst%3DJ.%26aulast%3DMehta%26aufirst%3DN.%26aulast%3DEsquivias%26aufirst%3DJ.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DE.%26aulast%3DOrtega-Muro%26aufirst%3DF.%26aulast%3DFraile-Gabald%25C3%25B3n%26aufirst%3DM.%2BT.%26aulast%3DSpivey%26aufirst%3DV.%2BL.%26aulast%3DLoman%26aufirst%3DN.%2BJ.%26aulast%3DPallen%26aufirst%3DM.%2BJ.%26aulast%3DConstantinidou%26aufirst%3DC.%26aulast%3DMinick%26aufirst%3DD.%2BJ.%26aulast%3DCacho%26aufirst%3DM.%26aulast%3DRebollo-L%25C3%25B3pez%26aufirst%3DM.%2BJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DC.%26aulast%3DSousa%26aufirst%3DV.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DTetrahydropyrazolo%255B1%252C5-a%255DPyrimidine-3-Carboxamide%2520and%2520N-Benzyl-6%25E2%2580%25B2%252C7%25E2%2580%25B2-Dihydrospiro%255BPiperidine-4%252C4%25E2%2580%25B2-Thieno%255B3%252C2-c%255DPyran%255D%2520Analogues%2520with%2520Bactericidal%2520Efficacy%2520against%2520Mycobacterium%2520Tuberculosis%2520Targeting%2520MmpL3%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0060933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Pengxu Wang, Sarah M. Batt, Bin Wang, Lei Fu, Rongfei Qin, Yu Lu, Gang Li, Gurdyal S. Besra, <span class="NLM_string-name hlFld-ContribAuthor">Haihong Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 6241-6261. <a href="https://doi.org/10.1021/acs.jmedchem.1c00263" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00263%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BThiophene-arylamide%252BDerivatives%252Bas%252BDprE1%252BInhibitors%252Bwith%252BPotent%252BAntimycobacterial%252BActivities%26aulast%3DWang%26aufirst%3DPengxu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D10022021%26date%3D14042021%26volume%3D64%26issue%3D9%26spage%3D6241%26epage%3D6261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mahendra Awale, Jérôme Hert, Laura Guasch, Sereina Riniker, <span class="NLM_string-name hlFld-ContribAuthor">Christian Kramer</span>. </span><span class="cited-content_cbyCitation_article-title">The Playbooks of Medicinal Chemistry Design Moves. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (2)
                                     , 729-742. <a href="https://doi.org/10.1021/acs.jcim.0c01143" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DThe%252BPlaybooks%252Bof%252BMedicinal%252BChemistry%252BDesign%252BMoves%26aulast%3DAwale%26aufirst%3DMahendra%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D01102020%26date%3D01022021%26volume%3D61%26issue%3D2%26spage%3D729%26epage%3D742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected reported DprE1 inhibitors.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><sup>a</sup>AZ DprE1 inhibitor benchmark, compound <b>9</b> in ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Most potent representatives (<b>1–4</b>) published previously by our team.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The previous findings indicate that both the hydantoin core and the acetyl linker are crucial for the potency of the series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Approach toward Analogues with a Modified <i>Para</i>-Substitution Pattern on Ring A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, EtOH-H<sub>2</sub>O, microwave irradiation 70 °C or heating 55 °C, 7–17 h; (b) K<sub>2</sub>CO<sub>3</sub>, DMF or acetone, rt, 24–48 h.</p><p class="last">*The main isolated reaction product was the hydantoin sodium salt <b>8a</b> used for the alkylation.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Approach toward Analogues <b>16–18</b> with a Modified <i>Para</i>-Substitution Pattern on Ring A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>4</sub>OH, 90 °C, overnight; (b) K<sub>2</sub>CO<sub>3</sub>, DMF or acetone, rt, 24 h; (c) LiOH, THF, H<sub>2</sub>O, rt, 1 h; (d) NaN<sub>3</sub>, ZnCl<sub>2</sub>, <i>n</i>-PrOH, 95 °C, 24 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Approach to Analogues with N-Linked Sulfonamide Substituents on Ring A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) [PdCl(allyl)]<sub>2,</sub> t-BuXPhos, K<sub>2</sub>CO<sub>3</sub>, 2-MeTHF, 80 °C, 2 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Approach to Analogues with S-Linked Sulfonamide Substituents on Ring A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) amine·HCl, Et<sub>3</sub>N, or amine with no base, DCM, rt, 1 h; (b) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, EtOH-H<sub>2</sub>O, 70 °C (MW or heating), 7–17 h; (c) K<sub>2</sub>CO<sub>3</sub>, acetone, rt, 24–48 h.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Scheme of the Synthesis of Analogues with Variable Substitution on Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone or DMF, rt, 24–48 h.</p><p class="last">*Compound <b>50</b> was formed by hydrolysis of <b>49</b> in LiOH solution.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Approach to Analogues with Saturated or Heterocycle Moieties Replacing Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone or DMF, rt, 24–48 h.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/medium/jm0c00107_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antitubercular efficacy in an acute infection murine model of tuberculosis. Each point represents data from an individual mouse that received each product administered in a once a day schedule (qd). Treatment was administered for 4 days as detailed in the figure. *<i>p</i> < 0.05. ANOVA analysis with Dunnett’s post test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00107/20200520/images/large/jm0c00107_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00107&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i119">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Global tuberculosis report 2019</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2019</span>. Licence: CC BY-NC-SA 3.0
IGO. (accessed Nov 22, 2019)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=World+Health+Organization&title=Global+tuberculosis+report+2019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DGlobal%2520tuberculosis%2520report%25202019%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Joanis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarelli, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dianiskova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordulakova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrethsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenkrands, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosset, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones Kill Mycobacterium Tuberculosis by Blocking Arabinan Synthesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">801</span>, <span class="refDoi"> DOI: 10.1126/science.1171583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1126%2Fscience.1171583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=19299584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=801&author=V.+Makarovauthor=G.+Maninaauthor=K.+Mikusovaauthor=U.+Mollmannauthor=O.+Ryabovaauthor=B.+Saint-Joanisauthor=N.+Dharauthor=M.+R.+Pascaauthor=S.+Buroniauthor=A.+P.+Lucarelliauthor=A.+Milanoauthor=E.+De+Rossiauthor=M.+Belanovaauthor=A.+Bobovskaauthor=P.+Dianiskovaauthor=J.+Kordulakovaauthor=C.+Salaauthor=E.+Fullamauthor=P.+Schneiderauthor=J.+D.+McKinneyauthor=P.+Brodinauthor=T.+Christopheauthor=S.+Waddellauthor=P.+Butcherauthor=J.+Albrethsenauthor=I.+Rosenkrandsauthor=R.+Broschauthor=V.+Nandiauthor=S.+Bharathauthor=S.+Gaonkarauthor=R.+K.+Shandilauthor=V.+Balasubramanianauthor=T.+Balganeshauthor=S.+Tyagiauthor=J.+Grossetauthor=G.+Riccardiauthor=S.+T.+Cole&title=Benzothiazinones+Kill+Mycobacterium+Tuberculosis+by+Blocking+Arabinan+Synthesis&doi=10.1126%2Fscience.1171583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis</span></div><div class="casAuthors">Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5928</span>),
    <span class="NLM_cas:pages">801-804</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">New drugs are required to counter the tuberculosis (TB) pandemic.  Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB.  Using genetics and biochem., we identified the enzyme decaprenylphosphoryl-β-D-ribose 2'-epimerase as a major BTZ target.  Inhibition of this enzymic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death.  The most advanced compd., BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZiVvk0T_DOrVg90H21EOLACvtfcHk0li7CkIocer58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D&md5=1d80f14ba88460ef5c8ea31793dbb592</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1171583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1171583%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DManina%26aufirst%3DG.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DMollmann%26aufirst%3DU.%26aulast%3DRyabova%26aufirst%3DO.%26aulast%3DSaint-Joanis%26aufirst%3DB.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DLucarelli%26aufirst%3DA.%2BP.%26aulast%3DMilano%26aufirst%3DA.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DBelanova%26aufirst%3DM.%26aulast%3DBobovska%26aufirst%3DA.%26aulast%3DDianiskova%26aufirst%3DP.%26aulast%3DKordulakova%26aufirst%3DJ.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DFullam%26aufirst%3DE.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DWaddell%26aufirst%3DS.%26aulast%3DButcher%26aufirst%3DP.%26aulast%3DAlbrethsen%26aufirst%3DJ.%26aulast%3DRosenkrands%26aufirst%3DI.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DNandi%26aufirst%3DV.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DGaonkar%26aufirst%3DS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBalganesh%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DS.%26aulast%3DGrosset%26aufirst%3DJ.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DBenzothiazinones%2520Kill%2520Mycobacterium%2520Tuberculosis%2520by%2520Blocking%2520Arabinan%2520Synthesis%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D801%26doi%3D10.1126%2Fscience.1171583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brecik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centárová, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszár, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovská, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilacsková, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokošová, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svetlíková, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korduláková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikušová, K.</span></span> <span> </span><span class="NLM_article-title">DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1631</span>– <span class="NLM_lpage">1636</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1631-1636&author=M.+Brecikauthor=I.+Cent%C3%A1rov%C3%A1author=R.+Mukherjeeauthor=G.+S.+Kollyauthor=S.+Husz%C3%A1rauthor=A.+Bobovsk%C3%A1author=E.+Kilacskov%C3%A1author=V.+Moko%C5%A1ov%C3%A1author=Z.+Svetl%C3%ADkov%C3%A1author=M.+%C5%A0arkanauthor=J.+Neresauthor=J.+Kordul%C3%A1kov%C3%A1author=S.+T.+Coleauthor=K.+Miku%C5%A1ov%C3%A1&title=DprE1+Is+a+Vulnerable+Tuberculosis+Drug+Target+Due+to+Its+Cell+Wall+Localization&doi=10.1021%2Facschembio.5b00237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization</span></div><div class="casAuthors">Brecik, Miroslav; Centarova, Ivana; Mukherjee, Raju; Kolly, Gaelle S.; Huszar, Stanislav; Bobovska, Adela; Kilacskova, Emoke; Mokosova, Veronika; Svetlikova, Zuzana; Sarkan, Michal; Neres, Joao; Kordulakova, Jana; Cole, Stewart T.; Mikusova, Katarina</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1631-1636</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The flavo-enzyme DprE1 catalyzes a key epimerization step in the decaprenyl-phosphoryl D-arabinose (DPA) pathway, which is essential for mycobacterial cell wall biogenesis and targeted by several new tuberculosis drug candidates.  Here, using differential radiolabeling with DPA precursors and high-resoln. fluorescence microscopy, we disclose the unexpected extracytoplasmic localization of DprE1 and periplasmic synthesis of DPA.  Collectively, this explains the vulnerability of DprE1 and the remarkable potency of the best inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2tTdrWjQmBrVg90H21EOLACvtfcHk0ljrMSmk-wl55Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWns70%253D&md5=bc1317378445d84300aca1615ef8d058</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00237%26sid%3Dliteratum%253Aachs%26aulast%3DBrecik%26aufirst%3DM.%26aulast%3DCent%25C3%25A1rov%25C3%25A1%26aufirst%3DI.%26aulast%3DMukherjee%26aufirst%3DR.%26aulast%3DKolly%26aufirst%3DG.%2BS.%26aulast%3DHusz%25C3%25A1r%26aufirst%3DS.%26aulast%3DBobovsk%25C3%25A1%26aufirst%3DA.%26aulast%3DKilacskov%25C3%25A1%26aufirst%3DE.%26aulast%3DMoko%25C5%25A1ov%25C3%25A1%26aufirst%3DV.%26aulast%3DSvetl%25C3%25ADkov%25C3%25A1%26aufirst%3DZ.%26aulast%3D%25C5%25A0arkan%26aufirst%3DM.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DKordul%25C3%25A1kov%25C3%25A1%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DMiku%25C5%25A1ov%25C3%25A1%26aufirst%3DK.%26atitle%3DDprE1%2520Is%2520a%2520Vulnerable%2520Tuberculosis%2520Drug%2520Target%2520Due%2520to%2520Its%2520Cell%2520Wall%2520Localization%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1631%26epage%3D1636%26doi%3D10.1021%2Facschembio.5b00237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Škovierová, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovská, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nenci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikušová, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-Ribofuranose 2′-Oxidase DprE1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">912</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1021/ja211042r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja211042r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1CrsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=912-915&author=C.+Trefzerauthor=H.+%C5%A0kovierov%C3%A1author=S.+Buroniauthor=A.+Bobovsk%C3%A1author=S.+Nenciauthor=E.+Molteniauthor=F.+Pojerauthor=M.+R.+Pascaauthor=V.+Makarovauthor=S.+T.+Coleauthor=G.+Riccardiauthor=K.+Miku%C5%A1ov%C3%A1author=K.+Johnsson&title=Benzothiazinones+Are+Suicide+Inhibitors+of+Mycobacterial+Decaprenylphosphoryl-%CE%B2-d-Ribofuranose+2%E2%80%B2-Oxidase+DprE1&doi=10.1021%2Fja211042r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-D-ribofuranose 2'-Oxidase DprE1</span></div><div class="casAuthors">Trefzer, Claudia; Skovierova, Henrieta; Buroni, Silvia; Bobovska, Adela; Nenci, Simone; Molteni, Elisabetta; Pojer, Florence; Pasca, Maria R.; Makarov, Vadim; Cole, Stewart T.; Riccardi, Giovanna; Mikusova, Katarina; Johnsson, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">912-915</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzothiazinones (BTZs) are antituberculosis drug candidates with nanomolar bactericidal activity against tubercle bacilli.  Here we demonstrate that BTZs are suicide substrates of the FAD-dependent decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1, an enzyme involved in cell-wall biogenesis.  BTZs are reduced by DprE1 to an electrophile, which then reacts in a near-quant. manner with an active-site cysteine of DprE1, thus providing a rationale for the extraordinary potency of BTZs.  Mutant DprE1 enzymes from BTZ-resistant strains reduce BTZs to inert metabolites while avoiding covalent inactivation.  Our results explain the basis for drug sensitivity and resistance to an exceptionally potent class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9GAW2MIogOrVg90H21EOLACvtfcHk0li9oO5sbljsNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1CrsLrJ&md5=c2f3753e2bbdba3c06e274acf550baed</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fja211042r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja211042r%26sid%3Dliteratum%253Aachs%26aulast%3DTrefzer%26aufirst%3DC.%26aulast%3D%25C5%25A0kovierov%25C3%25A1%26aufirst%3DH.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DBobovsk%25C3%25A1%26aufirst%3DA.%26aulast%3DNenci%26aufirst%3DS.%26aulast%3DMolteni%26aufirst%3DE.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DMiku%25C5%25A1ov%25C3%25A1%26aufirst%3DK.%26aulast%3DJohnsson%26aufirst%3DK.%26atitle%3DBenzothiazinones%2520Are%2520Suicide%2520Inhibitors%2520of%2520Mycobacterial%2520Decaprenylphosphoryl-%25CE%25B2-d-Ribofuranose%25202%25E2%2580%25B2-Oxidase%2520DprE1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D912%26epage%3D915%26doi%3D10.1021%2Fja211042r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabeen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhowruth, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggeling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alderwick, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fütterer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Inhibition of Mycobacterium Tuberculosis DprE1 by Benzothiazinone Inhibitors</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">11354</span>– <span class="NLM_lpage">11359</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205735109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1073%2Fpnas.1205735109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=22733761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ahtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=11354-11359&author=S.+M.+Battauthor=T.+Jabeenauthor=V.+Bhowruthauthor=L.+Quillauthor=P.+A.+Lundauthor=L.+Eggelingauthor=L.+J.+Alderwickauthor=K.+F%C3%BCttererauthor=G.+S.+Besra&title=Structural+Basis+of+Inhibition+of+Mycobacterium+Tuberculosis+DprE1+by+Benzothiazinone+Inhibitors&doi=10.1073%2Fpnas.1205735109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors</span></div><div class="casAuthors">Batt, Sarah M.; Jabeen, Talat; Bhowruth, Veemal; Quill, Lee; Lund, Peter A.; Eggeling, Lothar; Alderwick, Luke J.; Futterer, Klaus; Besra, Gurdyal S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11354-11359, S11354/1-S11354/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Resistance against currently used antitubercular therapeutics increasingly undermines efforts to contain the worldwide tuberculosis (TB) epidemic.  Recently, benzothiazinone (BTZ) inhibitors have shown nanomolar potency against both drug-susceptible and multidrug-resistant strains of the tubercle bacillus.  However, their proposed mode of action is lacking structural evidence.  The authors report here the crystal structure of the BTZ target, FAD-contg. oxidoreductase Mycobacterium tuberculosis DprE1, which is essential for viability.  Different crystal forms of ligand-free DprEl reveal considerable levels of structural flexibility of two surface loops that seem to govern accessibility of the active site.  Structures of complexes with the BTZ-derived nitroso deriv. CT325 reveal the mode of inhibitor binding, which includes a covalent link to conserved Cys387, and reveal a trifluoromethyl group as a second key determinant of interaction with the enzyme.  The authors found that a noncovalent complex was formed between DprE1 and CT319, which is structurally identical to CT325 except for an inert nitro group replacing the reactive nitroso group.  This demonstrates that binding of BTZ-class inhibitors to DprE1 is not strictly dependent on formation of the covalent link to Cys387.  On the basis of the structural and activity data, the authors propose that the complex of DrpE1 bound to CT325 is a representative of the BTZ-target complex.  These results mark a significant step forward in the characterization of a key TB drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6SdfDjSFjobVg90H21EOLACvtfcHk0li9oO5sbljsNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ahtLrF&md5=a0aca9361eb3a84ad27a6d6cb58f9b7c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205735109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205735109%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DJabeen%26aufirst%3DT.%26aulast%3DBhowruth%26aufirst%3DV.%26aulast%3DQuill%26aufirst%3DL.%26aulast%3DLund%26aufirst%3DP.%2BA.%26aulast%3DEggeling%26aufirst%3DL.%26aulast%3DAlderwick%26aufirst%3DL.%2BJ.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26atitle%3DStructural%2520Basis%2520of%2520Inhibition%2520of%2520Mycobacterium%2520Tuberculosis%2520DprE1%2520by%2520Benzothiazinone%2520Inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D2012%26volume%3D109%26spage%3D11354%26epage%3D11359%26doi%3D10.1073%2Fpnas.1205735109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krchňák, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colon-Martinez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3549</span>, <span class="refDoi"> DOI: 10.1021/ja311058q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja311058q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=3539-3549&author=R.+Tiwariauthor=G.+C.+Moraskiauthor=V.+Krch%C5%88%C3%A1kauthor=P.+A.+Millerauthor=M.+Colon-Martinezauthor=E.+Herreroauthor=A.+G.+Oliverauthor=M.+J.+Miller&title=Thiolates+Chemically+Induce+Redox+Activation+of+BTZ043+and+Related+Potent+Nitroaromatic+Anti-Tuberculosis+Agents&doi=10.1021%2Fja311058q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span></div><div class="casAuthors">Tiwari, Rohit; Moraski, Garrett C.; Krchnak, Viktor; Miller, Patricia A.; Colon-Martinez, Mariangelli; Herrero, Eliza; Oliver, Allen G.; Miller, Marvin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3539-3549</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of multidrug resistant (MDR) and extensively drug resistant (XDR) forms of tuberculosis (TB) has stimulated research efforts globally to expand the new drug pipeline.  Nitroarom. compds., including 1,3-benzothiazin-4-ones (BTZs) and related agents, are a promising new class for the treatment of TB.  Research has shown that the nitroso intermediates of BTZs that are generated in vivo cause suicide inhibition of decaprenylphosphoryl-β-d-ribose 2' oxidase (DprE1), which is responsible for cell wall arabinogalactan biosynthesis.  We have designed and synthesized novel anti-TB agents inspired from BTZs and other nitroarom. compds.  Computational studies indicated that the unsubstituted arom. carbons of BTZ043 and related nitroarom. compds. are the most electron-deficient and might be prone to nucleophilic attack.  Our chem. studies on BTZ043 and the addnl. nitroarom. compds. synthesized by us and others confirmed the postulated reactivity.  The results indicate that nucleophiles such as thiolates, cyanide, and hydride induce nonenzymic redn. of the nitro groups present in these compds. to the corresponding nitroso intermediates by addn. at the unsubstituted electron-deficient arom. carbon present in these compds.  Furthermore, we demonstrate here that these compds. are good candidates for the classical von Richter reaction.  These chem. studies offer an alternate hypothesis for the mechanism of action of nitroarom. anti-TB agents, in that the cysteine thiol(ate) or a hydride source at the active site of DprE1 may trigger the redn. of the nitro groups in a manner similar to the von Richter reaction to the nitroso intermediates, to initiate the inhibition of DprE1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEXS_ZRRGRArVg90H21EOLACvtfcHk0lhl0sxwAcpjjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D&md5=e3671cfef9ef47c15087e8299d9db64e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja311058q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja311058q%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DKrch%25C5%2588%25C3%25A1k%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DColon-Martinez%26aufirst%3DM.%26aulast%3DHerrero%26aufirst%3DE.%26aulast%3DOliver%26aufirst%3DA.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DThiolates%2520Chemically%2520Induce%2520Redox%2520Activation%2520of%2520BTZ043%2520and%2520Related%2520Potent%2520Nitroaromatic%2520Anti-Tuberculosis%2520Agents%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D3539%26epage%3D3549%26doi%3D10.1021%2Fja311058q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boy-Röttger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degiacomi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarelli, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascal, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindal, C.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium Tuberculosis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">150ra121</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3004395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1126%2Fscitranslmed.3004395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=22956199" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=150ra121&author=J.+Neresauthor=F.+Pojerauthor=E.+Molteniauthor=L.+R.+Chiarelliauthor=N.+Dharauthor=S.+Boy-R%C3%B6ttgerauthor=S.+Buroniauthor=E.+Fullamauthor=G.+Degiacomiauthor=A.+P.+Lucarelliauthor=R.+J.+Readauthor=G.+Zanoniauthor=D.+E.+Edmondsonauthor=E.+De+Rossiauthor=M.+R.+Pascalauthor=J.+D.+McKinneyauthor=P.+J.+Dysonauthor=G.+Riccardiauthor=A.+Matteviauthor=S.+T.+Coleauthor=C.+Bindal&title=Structural+Basis+for+Benzothiazinone-Mediated+Killing+of+Mycobacterium+Tuberculosis&doi=10.1126%2Fscitranslmed.3004395"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004395%26sid%3Dliteratum%253Aachs%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DMolteni%26aufirst%3DE.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DBoy-R%25C3%25B6ttger%26aufirst%3DS.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DFullam%26aufirst%3DE.%26aulast%3DDegiacomi%26aufirst%3DG.%26aulast%3DLucarelli%26aufirst%3DA.%2BP.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DZanoni%26aufirst%3DG.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DPascal%26aufirst%3DM.%2BR.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBindal%26aufirst%3DC.%26atitle%3DStructural%2520Basis%2520for%2520Benzothiazinone-Mediated%2520Killing%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D150ra121%26doi%3D10.1126%2Fscitranslmed.3004395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fütterer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">Identification of a Small Molecule with Activity against Drug-Resistant and Persistent Tuberculosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E2510</span>– <span class="NLM_lpage">E2517</span>, <span class="refDoi"> DOI: 10.1073/pnas.1309171110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1073%2Fpnas.1309171110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=23776209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2510-E2517&author=F.+Wangauthor=D.+Sambandanauthor=R.+Halderauthor=J.+Wangauthor=S.+M.+Battauthor=B.+Weinrickauthor=I.+Ahmadauthor=P.+Yangauthor=Y.+Zhangauthor=J.+Kimauthor=M.+Hassaniauthor=S.+Huszarauthor=C.+Trefzerauthor=Z.+Maauthor=T.+Kanekoauthor=K.+E.+Mdluliauthor=S.+Franzblauauthor=A.+K.+Chatterjeeauthor=K.+Johnssonauthor=K.+Johnsonauthor=K.+Mikusovaauthor=G.+S.+Besraauthor=K.+F%C3%BCttererauthor=S.+H.+Robbinsauthor=S.+W.+Barnesauthor=J.+R.+Walkerauthor=W.+R.+Jacobsauthor=P.+G.+Schultz&title=Identification+of+a+Small+Molecule+with+Activity+against+Drug-Resistant+and+Persistent+Tuberculosis&doi=10.1073%2Fpnas.1309171110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a small molecule with activity against drug-resistant and persistent tuberculosis</span></div><div class="casAuthors">Wang, Feng; Sambandan, Dhinakaran; Halder, Rajkumar; Wang, Jianing; Batt, Sarah M.; Weinrick, Brian; Ahmad, Insha; Yang, Pengyu; Zhang, Yong; Kim, John; Hassani, Morad; Huszar, Stanislav; Trefzer, Claudia; Ma, Zhenkun; Kaneko, Takushi; Mdluli, Khisi E.; Franzblau, Scott; Chatterjee, Arnab K.; Johnsson, Kai; Mikusova, Katarina; Besra, Gurdyal S.; Fuetterer, Klaus; Robbins, Scott H.; Barnes, S. Whitney; Walker, John R.; Jacobs, William R., Jr.; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">E2510-E2517,SE2510/1-SE2510/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A cell-based phenotypic screen for inhibitors of biofilm formation in mycobacteria identified the small mol. TCA1, which has bactericidal activity against both drug-susceptible and -resistant Mycobacterium tuberculosis (Mtb) and sterilizes Mtb in vitro combined with rifampicin or isoniazid.  In addn., TCA1 has bactericidal activity against nonreplicating Mtb in vitro and is efficacious in acute and chronic Mtb infection mouse models both alone and combined with rifampicin or isoniazid.  Transcriptional anal. revealed that TCA1 down-regulates genes known to be involved in Mtb persistence.  Genetic and affinity-based methods identified decaprenyl-phosphoryl-β-D-ribofuranose oxidoreductase DprE1 and MoeW, enzymes involved in cell wall and molybdenum cofactor biosynthesis, resp., as targets responsible for the activity of TCA1.  These in vitro and in vivo results indicate that this compd. functions by a unique mechanism and suggest that TCA1 may lead to the development of a class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokxlddd-EfbbVg90H21EOLACvtfcHk0ligx0niUnPePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLnL&md5=caf496e25608bb98e61ab97bd603f2ab</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1309171110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1309171110%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DSambandan%26aufirst%3DD.%26aulast%3DHalder%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DWeinrick%26aufirst%3DB.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DS.%26aulast%3DTrefzer%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMdluli%26aufirst%3DK.%2BE.%26aulast%3DFranzblau%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DJohnsson%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DRobbins%26aufirst%3DS.%2BH.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DIdentification%2520of%2520a%2520Small%2520Molecule%2520with%2520Activity%2520against%2520Drug-Resistant%2520and%2520Persistent%2520Tuberculosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2510%26epage%3DE2517%26doi%3D10.1073%2Fpnas.1309171110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhart, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnappinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manikkam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gac, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murgolo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutphin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Via, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  III</span></span> <span> </span><span class="NLM_article-title">Discovery and Structure–Activity-Relationship Study of <i>N</i> -Alkyl-5-Hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β- d -Ribose 2′-Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9952</span>– <span class="NLM_lpage">9965</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2rsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9952-9965&author=S.+Ohauthor=Y.+Parkauthor=C.+A.+Engelhartauthor=J.+B.+Wallachauthor=D.+Schnappingerauthor=K.+Aroraauthor=M.+Manikkamauthor=B.+Gacauthor=H.+Wangauthor=N.+Murgoloauthor=D.+B.+Olsenauthor=M.+Goodwinauthor=M.+Sutphinauthor=D.+M.+Weinerauthor=L.+E.+Viaauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barry&title=Discovery+and+Structure%E2%80%93Activity-Relationship+Study+of+N+-Alkyl-5-Hydroxypyrimidinone+Carboxamides+as+Novel+Antitubercular+Agents+Targeting+Decaprenylphosphoryl-%CE%B2-+d+-Ribose+2%E2%80%B2-Oxidase&doi=10.1021%2Facs.jmedchem.8b00883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-D-ribose 2'-Oxidase</span></div><div class="casAuthors">Oh, Sangmi; Park, Yumi; Engelhart, Curtis A.; Wallach, Joshua B.; Schnappinger, Dirk; Arora, Kriti; Manikkam, Michelle; Gac, Brian; Wang, Hongwu; Murgolo, Nicholas; Olsen, David B.; Goodwin, Michael; Sutphin, Michelle; Weiner, Danielle M.; Via, Laura E.; Boshoff, Helena I. M.; Barry, Clifton E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9952-9965</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Magnesium plays an important role in infection with Mycobacterium tuberculosis (Mtb) as a signal of the extracellular environment, as a cofactor for many enzymes, and as a structural element in important macromols.  Raltegravir, an antiretroviral drug that inhibits HIV-1 integrase is known to derive its potency from selective sequestration of active-site magnesium ions in addn. to binding to a hydrophobic pocket.  In order to det. if essential Mtb-related phosphoryl transfers could be disrupted in a similar manner, a directed screen of known mols. with integrase inhibitor-like pharmacophores (N-alkyl-5-hydroxypyrimidinone carboxamides) was performed.  Initial hits afforded compds. with low-micromolar potency against Mtb, acceptable cytotoxicity and PK characteristics, and robust SAR.  Elucidation of the target of these compds. revealed that they lacked magnesium dependence and instead disappointingly inhibited a known promiscuous target in Mtb, decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1, Rv3790).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOxHRHtAf2rbVg90H21EOLACvtfcHk0ligx0niUnPePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2rsrfP&md5=5c8f50d73f857fcde7277ca80109fee9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00883%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DEngelhart%26aufirst%3DC.%2BA.%26aulast%3DWallach%26aufirst%3DJ.%2BB.%26aulast%3DSchnappinger%26aufirst%3DD.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DManikkam%26aufirst%3DM.%26aulast%3DGac%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMurgolo%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DGoodwin%26aufirst%3DM.%26aulast%3DSutphin%26aufirst%3DM.%26aulast%3DWeiner%26aufirst%3DD.%2BM.%26aulast%3DVia%26aufirst%3DL.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DDiscovery%2520and%2520Structure%25E2%2580%2593Activity-Relationship%2520Study%2520of%2520N%2520-Alkyl-5-Hydroxypyrimidinone%2520Carboxamides%2520as%2520Novel%2520Antitubercular%2520Agents%2520Targeting%2520Decaprenylphosphoryl-%25CE%25B2-%2520d%2520-Ribose%25202%25E2%2580%25B2-Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9952%26epage%3D9965%26doi%3D10.1021%2Facs.jmedchem.8b00883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium Tuberculosis and Are Efficacious in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9701</span>– <span class="NLM_lpage">9708</span>, <span class="refDoi"> DOI: 10.1021/jm401382v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401382v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9701-9708&author=P.+S.+Shirudeauthor=R.+Shandilauthor=C.+Sadlerauthor=M.+Naikauthor=V.+Hosagraharaauthor=S.+Hameedauthor=V.+Shindeauthor=C.+Bathulaauthor=V.+Humnabadkarauthor=N.+Kumarauthor=J.+Reddyauthor=V.+Pandugaauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=H.+Gardnerauthor=P.+Madhavapeddiauthor=V.+Ramachandranauthor=P.+Kaurauthor=A.+Narayanauthor=S.+Gupthaauthor=D.+Awasthyauthor=C.+Narayanauthor=J.+Mahadevaswamyauthor=K.+Vishwasauthor=V.+Ahujaauthor=A.+Srivastavaauthor=K.+Prabhakarauthor=S.+Bharathauthor=R.+Kaleauthor=M.+Ramaiahauthor=N.+R.+Choudhuryauthor=V.+K.+Sambandamurthyauthor=S.+Solapureauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Azaindoles%3A+Noncovalent+DprE1+Inhibitors+from+Scaffold+Morphing+Efforts%2C+Kill+Mycobacterium+Tuberculosis+and+Are+Efficacious+in+Vivo&doi=10.1021%2Fjm401382v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha; Sadler, Claire; Naik, Maruti; Hosagrahara, Vinayak; Hameed, Shahul; Shinde, Vikas; Bathula, Chandramohan; Humnabadkar, Vaishali; Kumar, Naveen; Reddy, Jitendar; Panduga, Vijender; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Whiteaker, James; McLaughlin, Robert E.; Gardner, Humphrey; Madhavapeddi, Prashanti; Ramachandran, Vasanthi; Kaur, Parvinder; Narayan, Ashwini; Guptha, Supreeth; Awasthy, Disha; Narayan, Chandan; Mahadevaswamy, Jyothi; Vishwas, K. G.; Ahuja, Vijaykamal; Srivastava, Abhishek; Prabhakar, K. R.; Bharath, Sowmya; Kale, Ramesh; Ramaiah, Manjunatha; Choudhury, Nilanjana Roy; Sambandamurthy, Vasan K.; Solapure, Suresh; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models.  The series emerged from scaffold morphing efforts and was demonstrated to noncovalently inhibit decaprenylphosphoryl-β-d-ribose2'-epimerase (DprE1).  With "drug-like" properties and no expectation of pre-existing resistance in the clinic, this chem. class has the potential to be developed as a therapy for drug-sensitive and drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskQvJK4M2yrVg90H21EOLACvtfcHk0liqeoq_msGf8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM&md5=eba42d1952b164f66fd0ca620aaa4f19</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm401382v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401382v%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DHameed%26aufirst%3DS.%26aulast%3DShinde%26aufirst%3DV.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVishwas%26aufirst%3DK.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DR.%26aulast%3DRamaiah%26aufirst%3DM.%26aulast%3DChoudhury%26aufirst%3DN.%2BR.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DAzaindoles%253A%2520Noncovalent%2520DprE1%2520Inhibitors%2520from%2520Scaffold%2520Morphing%2520Efforts%252C%2520Kill%2520Mycobacterium%2520Tuberculosis%2520and%2520Are%2520Efficacious%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9701%26epage%3D9708%26doi%3D10.1021%2Fjm401382v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanduri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5728</span>– <span class="NLM_lpage">5737</span>, <span class="refDoi"> DOI: 10.1021/jm500571f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500571f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5728-5737&author=P.+S.+Shirudeauthor=R.+K.+Shandilauthor=M.+R.+Manjunathaauthor=C.+Sadlerauthor=M.+Pandaauthor=V.+Pandugaauthor=J.+Reddyauthor=R.+Saralayaauthor=R.+Nanduriauthor=A.+Ambadyauthor=S.+Ravishankarauthor=V.+K.+Sambandamurthyauthor=V.+Humnabadkarauthor=L.+K.+Jenaauthor=R.+S.+Sureshauthor=A.+Srivastavaauthor=K.+R.+Prabhakarauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=S.+Sharmaauthor=C.+B.+Cooperauthor=K.+Mdluliauthor=S.+Butlerauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Lead+Optimization+of+1%2C4-Azaindoles+as+Antimycobacterial+Agents&doi=10.1021%2Fjm500571f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha K.; Manjunatha, M. R.; Sadler, Claire; Panda, Manoranjan; Panduga, Vijender; Reddy, Jitendar; Saralaya, Ramanatha; Nanduri, Robert; Ambady, Anisha; Ravishankar, Sudha; Sambandamurthy, Vasan K.; Humnabadkar, Vaishali; Jena, Lalit K.; Suresh, Rudrapatna S.; Srivastava, Abhishek; Prabhakar, K. R.; Whiteaker, James; McLaughlin, Robert E.; Sharma, Sreevalli; Cooper, Christopher B.; Mdluli, Khisi; Butler, Scott; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5728-5737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a previous report, we described the discovery of 1,4-azaindoles, a chem. series with excellent in vitro and in vivo antimycobacterial potency through noncovalent inhibition of decaprenylphosphoryl-β-D-ribose-2'-epimerase (DprE1).  Nevertheless, high mouse metabolic turnover and phosphodiesterase 6 (PDE6) off-target activity limited its advancement.  Herein, we report lead optimization of this series, culminating in potent, metabolically stable compds. that have a robust pharmacokinetic profile without any PDE6 liability.  Furthermore, we demonstrate efficacy for 1,4-azaindoles in a rat chronic TB infection model.  We believe that compds. from the 1,4-azaindole series are suitable for in vivo combination and safety studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKixMAsGzDqrVg90H21EOLACvtfcHk0liqeoq_msGf8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhsbY%253D&md5=058a48536ddeb1046e04a29ba68a3a17</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm500571f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500571f%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DNanduri%26aufirst%3DR.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DJena%26aufirst%3DL.%2BK.%26aulast%3DSuresh%26aufirst%3DR.%2BS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DMdluli%26aufirst%3DK.%26aulast%3DButler%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DLead%2520Optimization%2520of%25201%252C4-Azaindoles%2520as%2520Antimycobacterial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5728%26epage%3D5737%26doi%3D10.1021%2Fjm500571f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tantry, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjrekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koushik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanbhag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jatheendranath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorino-Gelo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinesh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghorpade, S. R.</span></span> <span> </span><span class="NLM_article-title">4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5419</span>– <span class="NLM_lpage">5434</span>, <span class="refDoi"> DOI: 10.1021/jm5005978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5005978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5419-5434&author=M.+Naikauthor=V.+Humnabadkarauthor=S.+J.+Tantryauthor=M.+Pandaauthor=A.+Narayanauthor=S.+Gupthaauthor=V.+Pandugaauthor=P.+Manjrekarauthor=L.+K.+Jenaauthor=K.+Koushikauthor=G.+Shanbhagauthor=S.+Jatheendranathauthor=M.+R.+Manjunathaauthor=G.+Goraiauthor=C.+Bathulaauthor=S.+Rudrapatnaauthor=V.+Acharauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Mahadevaswamyauthor=P.+Kaurauthor=V.+K.+Sambandamurthyauthor=D.+Awasthyauthor=C.+Narayanauthor=S.+Ravishankarauthor=P.+Madhavapeddiauthor=J.+Reddyauthor=K.+Prabhakarauthor=R.+Saralayaauthor=M.+Chatterjiauthor=J.+Whiteakerauthor=B.+McLaughlinauthor=L.+R.+Chiarelliauthor=G.+Riccardiauthor=M.+R.+Pascaauthor=C.+Bindaauthor=J.+Neresauthor=N.+Dharauthor=F.+Signorino-Geloauthor=J.+D.+McKinneyauthor=V.+Ramachandranauthor=R.+Shandilauthor=R.+Tommasiauthor=P.+S.+Iyerauthor=S.+Narayananauthor=V.+Hosagraharaauthor=S.+Kavanaghauthor=N.+Dineshauthor=S.+R.+Ghorpade&title=4-Aminoquinolone+Piperidine+Amides%3A+Noncovalent+Inhibitors+of+DprE1+with+Long+Residence+Time+and+Potent+Antimycobacterial+Activity&doi=10.1021%2Fjm5005978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity</span></div><div class="casAuthors">Naik, Maruti; Humnabadkar, Vaishali; Tantry, Subramanyam J.; Panda, Manoranjan; Narayan, Ashwini; Guptha, Supreeth; Panduga, Vijender; Manjrekar, Praveena; Jena, Lalit kumar; Koushik, Krishna; Shanbhag, Gajanan; Jatheendranath, Sandesh; Manjunatha, M. R.; Gorai, Gopinath; Bathula, Chandramohan; Rudrapatna, Suresh; Achar, Vijayashree; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Mahadevaswamy, Jyothi; Kaur, Parvinder; Sambandamurthy, Vasan K.; Awasthy, Disha; Narayan, Chandan; Ravishankar, Sudha; Madhavapeddi, Prashanti; Reddy, Jitendar; Prabhakar, K. R.; Saralaya, Ramanatha; Chatterji, Monalisa; Whiteaker, James; McLaughlin, Bob; Chiarelli, Laurent R.; Riccardi, Giovanna; Pasca, Maria Rosalia; Binda, Claudia; Neres, Joao; Dhar, Neeraj; Signorino-Gelo, Francois; McKinney, John D.; Ramachandran, Vasanthi; Shandil, Radha; Tommasi, Ruben; Iyer, Pravin S.; Narayanan, Shridhar; Hosagrahara, Vinayak; Kavanagh, Stefan; Dinesh, Neela; Ghorpade, Sandeep R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5419-5434</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Aminoquinolone piperidine amides (AQs) were identified as a novel scaffold starting from a whole cell screen, with potent cidality on Mycobacterium tuberculosis (Mtb).  Evaluation of the min. inhibitory concns., followed by whole genome sequencing of mutants raised against AQs, identified decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1) as the primary target responsible for the antitubercular activity.  Mass spectrometry and enzyme kinetic studies indicated that AQs are noncovalent, reversible inhibitors of DprE1 with slow on rates and long residence times of ∼100 min on the enzyme.  In general, AQs have excellent leadlike properties and good in vitro secondary pharmacol. profile.  Although the scaffold started off as a single active compd. with moderate potency from the whole cell screen, structure-activity relationship optimization of the scaffold led to compds. with potent DprE1 inhibition (IC50 < 10 nM) along with potent cellular activity (MIC = 60 nM) against Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo427Eycvs4I7Vg90H21EOLACvtfcHk0lizVoYoc_a60Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wqt7g%253D&md5=05e9a7f75679397a124088023762fe20</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm5005978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5005978%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DTantry%26aufirst%3DS.%2BJ.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DManjrekar%26aufirst%3DP.%26aulast%3DJena%26aufirst%3DL.%2BK.%26aulast%3DKoushik%26aufirst%3DK.%26aulast%3DShanbhag%26aufirst%3DG.%26aulast%3DJatheendranath%26aufirst%3DS.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DGorai%26aufirst%3DG.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DRudrapatna%26aufirst%3DS.%26aulast%3DAchar%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPrabhakar%26aufirst%3DK.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DChatterji%26aufirst%3DM.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DB.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DSignorino-Gelo%26aufirst%3DF.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DKavanagh%26aufirst%3DS.%26aulast%3DDinesh%26aufirst%3DN.%26aulast%3DGhorpade%26aufirst%3DS.%2BR.%26atitle%3D4-Aminoquinolone%2520Piperidine%2520Amides%253A%2520Noncovalent%2520Inhibitors%2520of%2520DprE1%2520with%2520Long%2520Residence%2520Time%2520and%2520Potent%2520Antimycobacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5419%26epage%3D5434%26doi%3D10.1021%2Fjm5005978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagalapur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raichurkar, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4761</span>– <span class="NLM_lpage">4771</span>, <span class="refDoi"> DOI: 10.1021/jm5002937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5002937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4761-4771&author=M.+Pandaauthor=S.+Ramachandranauthor=V.+Ramachandranauthor=P.+S.+Shirudeauthor=V.+Humnabadkarauthor=K.+Nagalapurauthor=S.+Sharmaauthor=P.+Kaurauthor=S.+Gupthaauthor=A.+Narayanauthor=J.+Mahadevaswamyauthor=A.+Ambadyauthor=N.+Hegdeauthor=S.+S.+Rudrapatnaauthor=V.+P.+Hosagraharaauthor=V.+K.+Sambandamurthyauthor=A.+Raichurkar&title=Discovery+of+Pyrazolopyridones+as+a+Novel+Class+of+Noncovalent+DprE1+Inhibitor+with+Potent+Anti-Mycobacterial+Activity&doi=10.1021%2Fjm5002937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity</span></div><div class="casAuthors">Panda, Manoranjan; Ramachandran, Sreekanth; Ramachandran, Vasanthi; Shirude, Pravin S.; Humnabadkar, Vaishali; Nagalapur, Kavitha; Sharma, Sreevalli; Kaur, Parvinder; Guptha, Supreeth; Narayan, Ashwini; Mahadevaswamy, Jyothi; Ambady, Anisha; Hegde, Naina; Rudrapatna, Suresh S.; Hosagrahara, Vinayak P.; Sambandamurthy, Vasan K.; Raichurkar, Anandkumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4761-4771</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel pyrazolopyridone class of inhibitors was identified from whole cell screening against Mycobacterium tuberculosis (Mtb).  The series exhibits excellent bactericidality in vitro, resulting in a 4 log redn. in colony forming units following compd. exposure.  The significant modulation of min. inhibitory concn. (MIC) against a Mtb strain overexpressing the Rv3790 gene suggested the target of pyrazolopyridones to be decaprenylphosphoryl-β-D-ribose-2'-epimerase (DprE1).  Genetic mapping of resistance mutation coupled with potent enzyme inhibition activity confirmed the mol. target.  Detailed biochem. characterization revealed the series to be a noncovalent inhibitor of DprE1.  Docking studies at the active site suggest that the series can be further diversified to improve the physicochem. properties without compromising the antimycobacterial activity.  The pyrazolopyridone class of inhibitors offers an attractive non-nitro lead series targeting the essential and vulnerable DprE1 enzyme for the discovery of novel antimycobacterial agents to treat both drug susceptible and drug resistant strains of Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdYV8Pi2ynA7Vg90H21EOLACvtfcHk0lizVoYoc_a60Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShtrw%253D&md5=dd3c1daf880d2f50d3187a0f9d1ab363</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm5002937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5002937%26sid%3Dliteratum%253Aachs%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DNagalapur%26aufirst%3DK.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DRudrapatna%26aufirst%3DS.%2BS.%26aulast%3DHosagrahara%26aufirst%3DV.%2BP.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DRaichurkar%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Pyrazolopyridones%2520as%2520a%2520Novel%2520Class%2520of%2520Noncovalent%2520DprE1%2520Inhibitor%2520with%2520Potent%2520Anti-Mycobacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4761%26epage%3D4771%26doi%3D10.1021%2Fjm5002937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadupudi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorme, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jesus
Lopes Ribeiro, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">2-Carboxyquinoxalines Kill <i>Mycobacterium Tuberculosis</i> through Noncovalent Inhibition of DprE1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1021/cb5007163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5007163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyqt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=705-714&author=J.+Neresauthor=R.+C.+Hartkoornauthor=L.+R.+Chiarelliauthor=R.+Gadupudiauthor=M.+R.+Pascaauthor=G.+Moriauthor=A.+Venturelliauthor=S.+Savinaauthor=V.+Makarovauthor=G.+S.+Kollyauthor=E.+Molteniauthor=C.+Bindaauthor=N.+Dharauthor=S.+Ferrariauthor=P.+Brodinauthor=V.+Delormeauthor=V.+Landryauthor=A.+L.+de+Jesus%0ALopes+Ribeiroauthor=D.+Farinaauthor=P.+Saxenaauthor=F.+Pojerauthor=A.+Cartaauthor=R.+Lucianiauthor=A.+Portaauthor=G.+Zanoniauthor=E.+De+Rossiauthor=M.+P.+Costiauthor=G.+Riccardiauthor=S.+T.+Cole&title=2-Carboxyquinoxalines+Kill+Mycobacterium+Tuberculosis+through+Noncovalent+Inhibition+of+DprE1&doi=10.1021%2Fcb5007163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1</span></div><div class="casAuthors">Neres, Joao; Hartkoorn, Ruben C.; Chiarelli, Laurent R.; Gadupudi, Ramakrishna; Pasca, Maria Rosalia; Mori, Giorgia; Venturelli, Alberto; Savina, Svetlana; Makarov, Vadim; Kolly, Gaelle S.; Molteni, Elisabetta; Binda, Claudia; Dhar, Neeraj; Ferrari, Stefania; Brodin, Priscille; Delorme, Vincent; Landry, Valerie; de Jesus Lopes Ribeiro, Ana Luisa; Farina, Davide; Saxena, Puneet; Pojer, Florence; Carta, Antonio; Luciani, Rosaria; Porta, Alessio; Zanoni, Giuseppe; De Rossi, Edda; Costi, Maria Paola; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">705-714</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phenotypic screening of a quinoxaline library against replicating Mycobacterium tuberculosis led to the identification of lead compd. Ty38c (3-((4-methoxybenzyl)amino)-6-(trifluoromethyl)quinoxaline-2-carboxylic acid).  With an MIC99 and MBC of 3.1 μM, Ty38c is bactericidal and active against intracellular bacteria.  To investigate its mechanism of action, we isolated mutants resistant to Ty38c and sequenced their genomes.  Mutations were found in rv3405c, coding for the transcriptional repressor of the divergently expressed rv3406 gene.  Biochem. studies clearly showed that Rv3406 decarboxylates Ty38c into its inactive keto metabolite.  The actual target was then identified by isolating Ty38c-resistant mutants of an M. tuberculosis strain lacking rv3406.  Here, mutations were found in dprE1, encoding the decaprenylphosphoryl-D-ribose oxidase DprE1, essential for biogenesis of the mycobacterial cell wall.  Genetics, biochem. validation, and X-ray crystallog. revealed Ty38c to be a noncovalent, noncompetitive DprE1 inhibitor.  Structure-activity relationship studies generated a family of DprE1 inhibitors with a range of IC50's and bactericidal activity.  Co-crystal structures of DprE1 in complex with eight different quinoxaline analogs provided a high-resoln. interaction map of the active site of this extremely vulnerable target in M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUParezeusZ7Vg90H21EOLACvtfcHk0ljzKpnlenJjzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyqt7rL&md5=83e64a019613003778c80079e4f8b978</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fcb5007163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5007163%26sid%3Dliteratum%253Aachs%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DGadupudi%26aufirst%3DR.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DMori%26aufirst%3DG.%26aulast%3DVenturelli%26aufirst%3DA.%26aulast%3DSavina%26aufirst%3DS.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DKolly%26aufirst%3DG.%2BS.%26aulast%3DMolteni%26aufirst%3DE.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DDelorme%26aufirst%3DV.%26aulast%3DLandry%26aufirst%3DV.%26aulast%3Dde%2BJesus%2BLopes%2BRibeiro%26aufirst%3DA.%2BL.%26aulast%3DFarina%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DP.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DCarta%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DPorta%26aufirst%3DA.%26aulast%3DZanoni%26aufirst%3DG.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3D2-Carboxyquinoxalines%2520Kill%2520Mycobacterium%2520Tuberculosis%2520through%2520Noncovalent%2520Inhibition%2520of%2520DprE1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D705%26epage%3D714%26doi%3D10.1021%2Fcb5007163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullick, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagalapur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbulakshmi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellows, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachaspati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarkar, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandodkar, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of Benzothiazoles as Antimycobacterial Agents: Synthesis, Structure–Activity Relationships and Binding Studies with Mycobacterium Tuberculosis Decaprenylphosphoryl-β-d-Ribose 2′-Oxidase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7694</span>– <span class="NLM_lpage">7710</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1016%2Fj.bmc.2015.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=26643218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7694-7710&author=S.+Landgeauthor=A.+B.+Mullickauthor=K.+Nagalapurauthor=J.+Neresauthor=V.+Subbulakshmiauthor=K.+Muruganauthor=A.+Ghoshauthor=C.+Sadlerauthor=M.+D.+Fellowsauthor=V.+Humnabadkarauthor=J.+Mahadevaswamyauthor=P.+Vachaspatiauthor=S.+Sharmaauthor=P.+Kaurauthor=M.+Mallyaauthor=S.+Rudrapatnaauthor=D.+Awasthyauthor=V.+K.+Sambandamurthyauthor=F.+Pojerauthor=S.+T.+Coleauthor=T.+S.+Balganeshauthor=B.+G.+Ugarkarauthor=V.+Balasubramanianauthor=B.+S.+Bandodkarauthor=M.+Pandaauthor=V.+Ramachandran&title=Discovery+of+Benzothiazoles+as+Antimycobacterial+Agents%3A+Synthesis%2C+Structure%E2%80%93Activity+Relationships+and+Binding+Studies+with+Mycobacterium+Tuberculosis+Decaprenylphosphoryl-%CE%B2-d-Ribose+2%E2%80%B2-Oxidase&doi=10.1016%2Fj.bmc.2015.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase</span></div><div class="casAuthors">Landge, Sudhir; Mullick, Amrita B.; Nagalapur, Kavitha; Neres, Joao; Subbulakshmi, Venkita; Murugan, Kannan; Ghosh, Anirban; Sadler, Claire; Fellows, Mick D.; Humnabadkar, Vaishali; Mahadevaswamy, Jyothi; Vachaspati, Prakash; Sharma, Sreevalli; Kaur, Parvinder; Mallya, Meenakshi; Rudrapatna, Suresh; Awasthy, Disha; Sambandamurthy, Vasan K.; Pojer, Florence; Cole, Stewart T.; Balganesh, Tanjore S.; Ugarkar, Bheemarao G.; Balasubramanian, V.; Bandodkar, Balachandra S.; Panda, Manoranjan; Ramachandran, Vasanthi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7694-7710</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the discovery of benzothiazoles, a novel anti-mycobacterial series, identified from a whole cell based screening campaign.  Benzothiazoles exert their bactericidal activity against Mycobacterium tuberculosis (Mtb) through potent inhibition of decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1), the key enzyme involved in arabinogalactan synthesis.  Specific target linkage and mode of binding were established using co-crystn. and protein mass spectrometry studies.  Most importantly, the current study provides insights on the utilization of systematic medicinal chem. approaches to mitigate safety liabilities while improving potency during progression from an initial genotoxic hit, the benzothiazole N-oxides (BTOs) to the lead-like AMES neg., crowded benzothiazoles (cBTs).  These findings offer opportunities for development of safe clin. candidates against tuberculosis.  The design strategy adopted could find potential application in discovery of safe drugs in other therapy areas too.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS7rEts75x7bVg90H21EOLACvtfcHk0lj7oVQmscnhWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3E&md5=cea6212afa6aee18530c45717f98b5c6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DLandge%26aufirst%3DS.%26aulast%3DMullick%26aufirst%3DA.%2BB.%26aulast%3DNagalapur%26aufirst%3DK.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DSubbulakshmi%26aufirst%3DV.%26aulast%3DMurugan%26aufirst%3DK.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DFellows%26aufirst%3DM.%2BD.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVachaspati%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DMallya%26aufirst%3DM.%26aulast%3DRudrapatna%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBalganesh%26aufirst%3DT.%2BS.%26aulast%3DUgarkar%26aufirst%3DB.%2BG.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBandodkar%26aufirst%3DB.%2BS.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520Benzothiazoles%2520as%2520Antimycobacterial%2520Agents%253A%2520Synthesis%252C%2520Structure%25E2%2580%2593Activity%2520Relationships%2520and%2520Binding%2520Studies%2520with%2520Mycobacterium%2520Tuberculosis%2520Decaprenylphosphoryl-%25CE%25B2-d-Ribose%25202%25E2%2580%25B2-Oxidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7694%26epage%3D7710%26doi%3D10.1016%2Fj.bmc.2015.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chikhale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menghani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansode, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhargavi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karodia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajasekharan, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paradkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khedekar, P.</span></span> <span> </span><span class="NLM_article-title">Development of Selective DprE1 Inhibitors: Design, Synthesis, Crystal Structure and Antitubercular Activity of Benzothiazolylpyrimidine-5-Carboxamides</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1016%2Fj.ejmech.2015.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=25874329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtF2qsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=30-46&author=R.+Chikhaleauthor=S.+Menghaniauthor=R.+Babuauthor=R.+Bansodeauthor=G.+Bhargaviauthor=N.+Karodiaauthor=M.+V.+Rajasekharanauthor=A.+Paradkarauthor=P.+Khedekar&title=Development+of+Selective+DprE1+Inhibitors%3A+Design%2C+Synthesis%2C+Crystal+Structure+and+Antitubercular+Activity+of+Benzothiazolylpyrimidine-5-Carboxamides&doi=10.1016%2Fj.ejmech.2015.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides</span></div><div class="casAuthors">Chikhale, Rupesh; Menghani, Sunil; Babu, Ramavath; Bansode, Ratnadeep; Bhargavi, G.; Karodia, Nazira; Rajasekharan, M. V.; Paradkar, Anant; Khedekar, Pramod</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-46</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Decaprenylphosphoryl-b-D-ribose 20-epimerase (DprE1) is a potential drug target for development of antitubercular agents.  Structure based drug discovery approach yielded twenty novel derivs. of benzothiazolylpyrimidine-5-carboxamides which were synthesized by three component one pot reaction involving benzothiazolyl oxobutanamide, thiourea and substituted arom. benzaldehydes.  These derivs. were evaluated for antitubercular activity to det. MIC.  Log P of these compds. is 2.0-3.0 making them suitable for oral dosing.  DprE1 selectivity and pharmacokinetic studies were carried out for these compds. of which N-(benzo[d]thiazol-2-yl)-1,2,3,4-tetrahydro-6-methyl-4-phenyl-2-thioxopyrimidine-5-carboxamide and N-(benzo[d]thiazol-2-yl)-4-(4-(dimethylamino)phenyl)1,2,3,4-tetrahydro-6-methyl-2-thioxopyrimidine-5-carboxamide are highly selective and bioavailability is >52% by oral dose.  Crystal structure of N-(benzo[d]thiazol-2-yl)-1,2,3,4-tetrahydro-6-methyl-4-phenyl-2-thioxopyrimidine-5-carboxamide was studied and mol. packing was detd., it exhibited a triclinic crystal lattice arrangement having hydrogen bonded dimeric arrangement.  Drug receptor interactions were studied which exhibited docking in the active site of receptor with hydrogen bonding, hydrophobic interactions, vdW interactions with amino acid residues such as Cys387, Asn385, Lys418, Tyr314, Gln334 and Lys367 resp. 3D QSAR anal. was carried out by kNN-MFA method to det. and develop theor. model, best suitable model is based on Simulated Annealing k-Neariest Neighbor Mol. Field Anal. (SA kNN-MFA).  The model provided with hydrophobic descriptors in pos. side indicating the need of bulky groups, steric and electroneg. descriptors in neg. coordinates hints with contribution by the electroneg. substitutions as favorable and desirable moieties for enhancing the activity.  The q2, q2_se and Pred_r2se are 0.5000, 0.6404 and 1.0094, resp.  A pharmacophore model was generated which suggested for necessity of arom., aliph. carbon center and hydrogen bond donor for development of newer DprE1 selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1VETL6MDO3LVg90H21EOLACvtfcHk0lj7oVQmscnhWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtF2qsL8%253D&md5=984772d5ddc286a1bc818635c91211a3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DChikhale%26aufirst%3DR.%26aulast%3DMenghani%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DR.%26aulast%3DBansode%26aufirst%3DR.%26aulast%3DBhargavi%26aufirst%3DG.%26aulast%3DKarodia%26aufirst%3DN.%26aulast%3DRajasekharan%26aufirst%3DM.%2BV.%26aulast%3DParadkar%26aufirst%3DA.%26aulast%3DKhedekar%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520Selective%2520DprE1%2520Inhibitors%253A%2520Design%252C%2520Synthesis%252C%2520Crystal%2520Structure%2520and%2520Antitubercular%2520Activity%2520of%2520Benzothiazolylpyrimidine-5-Carboxamides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D96%26spage%3D30%26epage%3D46%26doi%3D10.1016%2Fj.ejmech.2015.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbut, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilchèze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajayi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrassi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fütterer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span> <span> </span><span class="NLM_article-title">Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">13011</span>– <span class="NLM_lpage">13015</span>, <span class="refDoi"> DOI: 10.1002/anie.201707324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1002%2Fanie.201707324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeqs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=13011-13015&author=R.+Liuauthor=X.+Lyuauthor=S.+M.+Battauthor=M.-H.+Hsuauthor=M.+B.+Harbutauthor=C.+Vilch%C3%A8zeauthor=B.+Chengauthor=K.+Ajayiauthor=B.+Yangauthor=Y.+Yangauthor=H.+Guoauthor=C.+Linauthor=F.+Ganauthor=C.+Wangauthor=S.+G.+Franzblauauthor=W.+R.+Jacobsauthor=G.+S.+Besraauthor=E.+F.+Johnsonauthor=M.+Petrassiauthor=A.+K.+Chatterjeeauthor=K.+F%C3%BCttererauthor=F.+Wang&title=Determinants+of+the+Inhibition+of+DprE1+and+CYP2C9+by+Antitubercular+Thiophenes&doi=10.1002%2Fanie.201707324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes</span></div><div class="casAuthors">Liu, Renhe; Lyu, Xiaoxuan; Batt, Sarah M.; Hsu, Mei-Hui; Harbut, Michael B.; Vilcheze, Catherine; Cheng, Bo; Ajayi, Kehinde; Yang, Baiyuan; Yang, Yun; Guo, Hui; Lin, Changyou; Gan, Fei; Wang, Chen; Franzblau, Scott G.; Jacobs, William R., Jr.; Besra, Gurdyal S.; Johnson, Eric F.; Petrassi, Mike; Chatterjee, Arnab K.; Fuetterer, Klaus; Wang, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">13011-13015</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis (Mtb) DprE1, an essential isomerase for the biosynthesis of the mycobacterial cell wall, is a validated target for tuberculosis (TB) drug development.  Here we report the X-ray crystal structures of DprE1 and the DprE1 resistant mutant (Y314C) in complexes with TCA1 derivs. to elucidate the mol. basis of their inhibitory activities and an unconventional resistance mechanism, which enabled us to optimize the potency of the analogs.  The selected lead compd. showed excellent in vitro and in vivo activities, and low risk of toxicity profile except for the inhibition of CYP2C9.  A crystal structure of CYP2C9 in complex with a TCA1 analog revealed the similar interaction patterns to the DprE1-TCA1 complex.  Guided by the structures, an optimized mol. was generated with differential inhibitory activities against DprE1 and CYP2C9, which provides insights for development of a clin. candidate to treat TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZuWj2STE_rVg90H21EOLACvtfcHk0lj7oVQmscnhWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeqs73P&md5=ddbe9365e539f1935eeea02f1a697be3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.201707324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201707324%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLyu%26aufirst%3DX.%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DHsu%26aufirst%3DM.-H.%26aulast%3DHarbut%26aufirst%3DM.%2BB.%26aulast%3DVilch%25C3%25A8ze%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DB.%26aulast%3DAjayi%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DGan%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DPetrassi%26aufirst%3DM.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DDeterminants%2520of%2520the%2520Inhibition%2520of%2520DprE1%2520and%2520CYP2C9%2520by%2520Antitubercular%2520Thiophenes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D13011%26epage%3D13015%26doi%3D10.1002%2Fanie.201707324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chikhale, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barmade, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murumkar, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. R.</span></span> <span> </span><span class="NLM_article-title">Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8563</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00281</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00281" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVGjsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8563-8593&author=R.+V.+Chikhaleauthor=M.+A.+Barmadeauthor=P.+R.+Murumkarauthor=M.+R.+Yadav&title=Overview+of+the+Development+of+DprE1+Inhibitors+for+Combating+the+Menace+of+Tuberculosis&doi=10.1021%2Facs.jmedchem.8b00281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis</span></div><div class="casAuthors">Chikhale, Rupesh V.; Barmade, Mahesh A.; Murumkar, Prashant R.; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8563-8593</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1), a vital enzyme for cell wall synthesis, plays a crucial role in the formation of lipoarabinomannan and arabinogalactan.  It was first reported as a druggable target on the basis of inhibitors discovered in high throughput screening of a drug library.  Since then, inhibitors with different types of chem. scaffolds have been reported for their activity against this enzyme.  Formation of a covalent or noncovalent bond by the interacting ligand with the enzyme causes loss of its catalytic activity which ultimately leads to the death of the mycobacterium.  This Perspective describes various DprE1 inhibitors as anti-TB agents reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3s3ks2Vmg7Vg90H21EOLACvtfcHk0libeRim_HKnZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVGjsrzO&md5=b057993247c1c6c208907c474191c1d0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00281%26sid%3Dliteratum%253Aachs%26aulast%3DChikhale%26aufirst%3DR.%2BV.%26aulast%3DBarmade%26aufirst%3DM.%2BA.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DOverview%2520of%2520the%2520Development%2520of%2520DprE1%2520Inhibitors%2520for%2520Combating%2520the%2520Menace%2520of%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8563%26epage%3D8593%26doi%3D10.1021%2Facs.jmedchem.8b00281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lupien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foo, C. S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blattes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillon, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>, <span class="NLM_elocation-id">e00840</span> <span class="refDoi"> DOI: 10.1128/AAC.00840-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1128%2FAAC.00840-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=30126954" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&author=A.+Lupienauthor=A.+Vocatauthor=C.+S.-Y.+Fooauthor=E.+Blattesauthor=J.-Y.+Gillonauthor=V.+Makarovauthor=S.+T.+Cole&title=Optimized+Background+Regimen+for+Treatment+of+Active+Tuberculosis+with+the+Next-Generation+Benzothiazinone+Macozinone+%28PBTZ169%29&doi=10.1128%2FAAC.00840-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.00840-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00840-18%26sid%3Dliteratum%253Aachs%26aulast%3DLupien%26aufirst%3DA.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DFoo%26aufirst%3DC.%2BS.-Y.%26aulast%3DBlattes%26aufirst%3DE.%26aulast%3DGillon%26aufirst%3DJ.-Y.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DOptimized%2520Background%2520Regimen%2520for%2520Treatment%2520of%2520Active%2520Tuberculosis%2520with%2520the%2520Next-Generation%2520Benzothiazinone%2520Macozinone%2520%2528PBTZ169%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26doi%3D10.1128%2FAAC.00840-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vjecha, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiberi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span> <span> </span><span class="NLM_article-title">Accelerating the Development of Therapeutic Strategies for Drug-Resistant Tuberculosis</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1038%2Fnrd.2018.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=29567994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlWgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=607-608&author=M.+J.+Vjechaauthor=S.+Tiberiauthor=A.+Zumla&title=Accelerating+the+Development+of+Therapeutic+Strategies+for+Drug-Resistant+Tuberculosis&doi=10.1038%2Fnrd.2018.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerating the development of therapeutic strategies for drug-resistant tuberculosis</span></div><div class="casAuthors">Vjecha, Michael J.; Tiberi, Simon; Zumla, Alimuddin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">607-608</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Recent progress in the discovery, development and evaluation of new drugs and combination regimens for drug-resistant tuberculosis through greater collaboration between industry, donors and academia provides renewed hope for overcoming the challenges in tuberculosis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriQpkkVoCzWLVg90H21EOLACvtfcHk0libeRim_HKnZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlWgt74%253D&md5=2132b33f71055e8fc076a1d1ae03d383</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.28%26sid%3Dliteratum%253Aachs%26aulast%3DVjecha%26aufirst%3DM.%2BJ.%26aulast%3DTiberi%26aufirst%3DS.%26aulast%3DZumla%26aufirst%3DA.%26atitle%3DAccelerating%2520the%2520Development%2520of%2520Therapeutic%2520Strategies%2520for%2520Drug-Resistant%2520Tuberculosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D607%26epage%3D608%26doi%3D10.1038%2Fnrd.2018.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogacki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Ruano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vande Velde, C. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span> <span> </span><span class="NLM_article-title">Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11221</span>– <span class="NLM_lpage">11249</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11221-11249&author=M.+K.+Rogackiauthor=E.+Pittaauthor=O.+Balabonauthor=S.+Hussauthor=E.+M.+Lopez-Romanauthor=A.+Argyrouauthor=D.+Blanco-Ruanoauthor=M.+Cachoauthor=C.+M.+L.+Vande+Veldeauthor=K.+Augustynsauthor=L.+Ballellauthor=D.+Barrosauthor=R.+H.+Batesauthor=F.+Cunninghamauthor=P.+Van+der+Veken&title=Identification+and+Profiling+of+Hydantoins%E2%80%94A+Novel+Class+of+Potent+Antimycobacterial+DprE1+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors</span></div><div class="casAuthors">Rogacki, Maciej K.; Pitta, Eleni; Balabon, Olga; Huss, Sophie; Lopez-Roman, Eva Maria; Argyrou, Argyrides; Blanco-Ruano, Delia; Cacho, Monica; Vande Velde, Christophe M. L.; Augustyns, Koen; Ballell, Lluis; Barros, David; Bates, Robert H.; Cunningham, Fraser; Van der Veken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11221-11249</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis is the leading cause of death worldwide from infectious diseases.  With the development of drug-resistant strains of Mycobacterium tuberculosis, there is an acute need for new medicines with novel modes of action.  Herein, we report the discovery and profiling of a novel hydantoin-based family of antimycobacterial inhibitors of the decaprenylphospho-β-D-ribofuranose 2-oxidase (DprE1).  In this study, we have prepd. a library of more than a 100 compds. and evaluated them for their biol. and physicochem. properties.  The series is characterized by high enzymic and whole-cell activity, low cytotoxicity, and a good overall physicochem. profile.  In addn., we show that the series acts via reversible inhibition of the DprE1 enzyme.  Overall, the novel compd. family forms an attractive base for progression to further stages of optimization and may provide a promising drug candidate in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMw2Vn8XKan7Vg90H21EOLACvtfcHk0ljVs_GLWeSwzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzE&md5=647fdfe146a1802016d7e38a8543e522</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01356%26sid%3Dliteratum%253Aachs%26aulast%3DRogacki%26aufirst%3DM.%2BK.%26aulast%3DPitta%26aufirst%3DE.%26aulast%3DBalabon%26aufirst%3DO.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DArgyrou%26aufirst%3DA.%26aulast%3DBlanco-Ruano%26aufirst%3DD.%26aulast%3DCacho%26aufirst%3DM.%26aulast%3DVande%2BVelde%26aufirst%3DC.%2BM.%2BL.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DCunningham%26aufirst%3DF.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DIdentification%2520and%2520Profiling%2520of%2520Hydantoins%25E2%2580%2594A%2520Novel%2520Class%2520of%2520Potent%2520Antimycobacterial%2520DprE1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11221%26epage%3D11249%26doi%3D10.1021%2Facs.jmedchem.8b01356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bucherer, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieb, V. A.</span></span> <span> </span><span class="NLM_article-title">Über Die Bildung Substituierter Hydantoine Aus Aldehyden Und Ketonen. Synthese von Hydantoinen</span>. <i>J. Prakt. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1934</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1002/prac.19341410102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1002%2Fprac.19341410102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADyaA2MXhtVOk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=1934&pages=5-43&author=H.+T.+Buchererauthor=V.+A.+Lieb&title=%C3%9Cber+Die+Bildung+Substituierter+Hydantoine+Aus+Aldehyden+Und+Ketonen.+Synthese+von+Hydantoinen&doi=10.1002%2Fprac.19341410102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of hydantoins. II. Formation of substituted hydantoins from aldehydes and ketones</span></div><div class="casAuthors">Bucherer, Hans Th.; Libe, Viktor A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal fuer Praktische Chemie (Leipzig)</span>
        (<span class="NLM_cas:date">1934</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-43</span>CODEN:
                <span class="NLM_cas:coden">JPCEAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-8383</span>.
    </div><div class="casAbstract">The following methods were used for the synthesis of hydantoins: 1 mol. ketone or aldehyde, 3 mols. (NH4)2CO3 and 4 parts by wt. of ligroin, treated with 1.5-2 mols. HCN and allowed to stand 3-4 days at room temp. (I); the same but in 50% EtOH, 4-5 hrs. at 50° and 1 hr. at 70-80° (II); the same as I but with 1-1.5 mols. KCN 4-10 days at room temp. (III); the same as III but with 50% EtOH (IV); 1 mol. NaHSO3 compd., 2 mols. KCN and 4 mols. (NH4)2CO3 in 50% EtOH 4-5 hrs. at 50-5° (V).  The following yields are reported: Dimethylhydantoin from Me2CO, I 30-40%, II 40%, III 30%, IV 80%, V 90%; pentamethylenehydantoin (VI) from cyclohexanone, I 50-60%, II 90%, III small, IV 95%, V 95%; methylethylhydantoin from MeEtCO, I 50%, IV 90%; phenylmethylhydantoin from PhAc, I 40-50%, II 90%, IV 90%; phenylethylhydantoin from PhCOEt, II 80-5%, IV 80-5%; benzylmethylhydantoin, m. 225°, from PhCH2Ac, II 70%, IV 80%, V 80-5%; it does not yield an ω-Br deriv. (PhCH2)2CO, with IV, gives a poor yield of dibenzylhydantoin(?).  Ac2, with II, gives 10% of the hypothetical dimethylbishydantoin (VII), decompg. 265-70°; the cyanohydrin with (NH4)2CO3 gives about 20% of the same compd.; hydrolysis gives a compd., C6H12O4N2, m. 280° (decompn.); MeC(NOH)Ac gives 20% of VII.  Phenylhydantoin (VIII) from BzH, I 10%, II 25-30%, IV 20%, V 85%; BZ2 gives 20% and BzAc 45% VIII.  Benzylhydantoin from PhCH2CHO, I 10-12%, II 20-5%, IV 15%, V 80%; carbethoxydimethylhydantoin from AcCH2CO2Et, II 60%, V 80%.  1,3-Diketones (Ac2CH2) and hydroxy ketones (benzoin) did not react.  Hydrolysis of the hydantoins with 60% H2SO4 yields NH2 acids.  The acid from VI and BzCl give the N-Bz deriv. of hexahydroanilinecarboxylic acid, m. 190°.  Tyrosine (IX) was prepd. by the following steps: benzylhydantoin yields 95% of a mixt. of o-, m. 213-15°, and p-NO2 derivs., m. 240-5°; through the NH2 and diazo compds. there was prepd. the p-HO deriv., m. 260-2°; hydrolysis with H2SO4 gives IX.  Me2C(OH)CN (X) or cyclohexanone cyanohydrin (XI) do not react with MeNH2.HCl and Na2CO3 in EtOH.  XI, CS2 and 25% NH4OH in EtOH give a compd., m. 225° (see part I), and a compd. C13H21NS2, golden yellow with violet reflex, m. 195°; without EtOH there results a compd. m. 261-5°.  XI, CS2 and gaseous NH3 give compds. m. 223°, 195° and 72-5° (see part I).  X, CS2 and NH4OH give the compd. C7H14N2S, m. 154-5°; gaseous NH3 gives this compd. and one, m. 297°.  Me2C(NH2)CN gives the same compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFUmP0PMcp_bVg90H21EOLACvtfcHk0ljVs_GLWeSwzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA2MXhtVOk&md5=34b29a54e7ba20796e5fe8b8c14e60e2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fprac.19341410102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprac.19341410102%26sid%3Dliteratum%253Aachs%26aulast%3DBucherer%26aufirst%3DH.%2BT.%26aulast%3DLieb%26aufirst%3DV.%2BA.%26atitle%3D%25C3%259Cber%2520Die%2520Bildung%2520Substituierter%2520Hydantoine%2520Aus%2520Aldehyden%2520Und%2520Ketonen.%2520Synthese%2520von%2520Hydantoinen%26jtitle%3DJ.%2520Prakt.%2520Chem.%26date%3D1934%26volume%3D141%26spage%3D5%26epage%3D43%26doi%3D10.1002%2Fprac.19341410102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruble, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, A.</span></span> <span> </span><span class="NLM_article-title">Mild Pd-Catalyzed N -Arylation of Methanesulfonamide and Related Nucleophiles: Avoiding Potentially Genotoxic Reagents and Byproducts</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2564</span>– <span class="NLM_lpage">2567</span>, <span class="refDoi"> DOI: 10.1021/ol200660s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol200660s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVGgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=2564-2567&author=B.+R.+Rosenauthor=J.+C.+Rubleauthor=T.+J.+Beauchampauthor=A.+Navarro&title=Mild+Pd-Catalyzed+N+-Arylation+of+Methanesulfonamide+and+Related+Nucleophiles%3A+Avoiding+Potentially+Genotoxic+Reagents+and+Byproducts&doi=10.1021%2Fol200660s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mild Pd-catalyzed N-arylation of methanesulfonamide and related nucleophiles: avoiding potentially genotoxic reagents and byproducts</span></div><div class="casAuthors">Rosen, Brandon R.; Ruble, J. Craig; Beauchamp, Thomas J.; Navarro, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2564-2567</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A convenient, general, and high yielding Pd-catalyzed cross-coupling of methanesulfonamide with aryl bromides and chlorides is reported.  The use of this method eliminates concern over genotoxic impurities that can arise when an aniline is reacted with methanesulfonyl chloride.  The application of this method to the synthesis of dofetilide (I) is also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4xC6C7zikuLVg90H21EOLACvtfcHk0ljVs_GLWeSwzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVGgsbs%253D&md5=4bb02fa40337c4a0e858893f712f2e03</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fol200660s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol200660s%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DB.%2BR.%26aulast%3DRuble%26aufirst%3DJ.%2BC.%26aulast%3DBeauchamp%26aufirst%3DT.%2BJ.%26aulast%3DNavarro%26aufirst%3DA.%26atitle%3DMild%2520Pd-Catalyzed%2520N%2520-Arylation%2520of%2520Methanesulfonamide%2520and%2520Related%2520Nucleophiles%253A%2520Avoiding%2520Potentially%2520Genotoxic%2520Reagents%2520and%2520Byproducts%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D2564%26epage%3D2567%26doi%3D10.1021%2Fol200660s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho Izquierdo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro Pichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela-Glez
Del Peral, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouzon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros Aguirre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span> <span> </span><span class="NLM_article-title">Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium Tuberculosis Decaprenylphosphoryl-β- d -Ribose Oxidase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00065</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2016&pages=615-626&author=S.+M.+Battauthor=M.+Cacho+Izquierdoauthor=J.+Castro+Pichelauthor=C.+J.+Stubbsauthor=L.+Vela-Glez%0ADel+Peralauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=N.+Dharauthor=B.+Mouzonauthor=M.+Reesauthor=J.+P.+Hutchinsonauthor=R.+J.+Youngauthor=J.+D.+McKinneyauthor=D.+Barros+Aguirreauthor=L.+Ballellauthor=G.+S.+Besraauthor=A.+Argyrou&title=Whole+Cell+Target+Engagement+Identifies+Novel+Inhibitors+of+Mycobacterium+Tuberculosis+Decaprenylphosphoryl-%CE%B2-+d+-Ribose+Oxidase&doi=10.1021%2Facsinfecdis.5b00065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00065%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DCacho%2BIzquierdo%26aufirst%3DM.%26aulast%3DCastro%2BPichel%26aufirst%3DJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DVela-Glez%2BDel%2BPeral%26aufirst%3DL.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DMouzon%26aufirst%3DB.%26aulast%3DRees%26aufirst%3DM.%26aulast%3DHutchinson%26aufirst%3DJ.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBarros%2BAguirre%26aufirst%3DD.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DArgyrou%26aufirst%3DA.%26atitle%3DWhole%2520Cell%2520Target%2520Engagement%2520Identifies%2520Novel%2520Inhibitors%2520of%2520Mycobacterium%2520Tuberculosis%2520Decaprenylphosphoryl-%25CE%25B2-%2520d%2520-Ribose%2520Oxidase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D1%26spage%3D615%26epage%3D626%26doi%3D10.1021%2Facsinfecdis.5b00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warrier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapilashrami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandakumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somersan-Karakaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porras-De Francisco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Hoyos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Huang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span> <span> </span><span class="NLM_article-title">N-Methylation of a Bactericidal Compound as a Resistance Mechanism in Mycobacterium Tuberculosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E4523</span>– <span class="NLM_lpage">E4530</span>, <span class="refDoi"> DOI: 10.1073/pnas.1606590113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1073%2Fpnas.1606590113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=27432954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOrsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E4523-E4530&author=T.+Warrierauthor=K.+Kapilashramiauthor=A.+Argyrouauthor=T.+R.+Ioergerauthor=D.+Littleauthor=K.+C.+Murphyauthor=M.+Nandakumarauthor=S.+Parkauthor=B.+Goldauthor=J.+Miauthor=T.+Zhangauthor=E.+Meilerauthor=M.+Reesauthor=S.+Somersan-Karakayaauthor=E.+Porras-De+Franciscoauthor=M.+Martinez-Hoyosauthor=K.+Burns-Huangauthor=J.+Robertsauthor=Y.+Lingauthor=K.+Y.+Rheeauthor=A.+Mendoza-Losanaauthor=M.+Luoauthor=C.+F.+Nathan&title=N-Methylation+of+a+Bactericidal+Compound+as+a+Resistance+Mechanism+in+Mycobacterium+Tuberculosis&doi=10.1073%2Fpnas.1606590113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis</span></div><div class="casAuthors">Warrier, Thulasi; Kapilashrami, Kanishk; Argyrou, Argyrides; Ioerger, Thomas R.; Little, David; Murphy, Kenan C.; Nandakumar, Madhumitha; Park, Suna; Gold, Ben; Mi, Jianjie; Zhang, Tuo; Meiler, Eugenia; Rees, Mike; Somersan-Karakaya, Selin; Porras-De Francisco, Esther; Martinez-Hoyos, Maria; Burns-Huang, Kristin; Roberts, Julia; Ling, Yan; Rhee, Kyu Y.; Mendoza-Losana, Alfonso; Luo, Minkui; Nathan, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">E4523-E4530</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The rising incidence of antimicrobial resistance (AMR) makes it imperative to understand the underlying mechanisms.  Mycobacterium tuberculosis (Mtb) is the single leading cause of death from a bacterial pathogen and estd. to be the leading cause of death from AMR.  A pyrido-benzimidazole, 14, was reported to have potent bactericidal activity against Mtb.  Here, we isolated multiple Mtb clones resistant to 14.  Each had mutations in the putative DNA-binding and dimerization domains of rv2887, a gene encoding a transcriptional repressor of the MarR family.  The mutations in Rv2887 led to markedly increased expression of rv0560c.  We characterized Rv0560c as an S-adenosyl-L-methionine-dependent methyltransferase that N-methylates 14, abolishing its mycobactericidal activity.  An Mtb strain lacking rv0560c became resistant to 14 by mutating decaprenylphosphoryl-β-d-ribose 2-oxidase (DprE1), an essential enzyme in arabinogalactan synthesis; 14 proved to be a nanomolar inhibitor of DprE1, and methylation of 14 by Rv0560c abrogated this activity.  Thus, 14 joins a growing list of DprE1 inhibitors that are potently mycobactericidal.  Bacterial methylation of an antibacterial agent, 14, catalyzed by Rv0560c of Mtb, is a previously unreported mechanism of AMR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW6Cwmyogp3bVg90H21EOLACvtfcHk0liR81lVOy73mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOrsr7I&md5=9042ee902a0bf5ad1710f0dc2a0d0ffd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1606590113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1606590113%26sid%3Dliteratum%253Aachs%26aulast%3DWarrier%26aufirst%3DT.%26aulast%3DKapilashrami%26aufirst%3DK.%26aulast%3DArgyrou%26aufirst%3DA.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DLittle%26aufirst%3DD.%26aulast%3DMurphy%26aufirst%3DK.%2BC.%26aulast%3DNandakumar%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DGold%26aufirst%3DB.%26aulast%3DMi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DMeiler%26aufirst%3DE.%26aulast%3DRees%26aufirst%3DM.%26aulast%3DSomersan-Karakaya%26aufirst%3DS.%26aulast%3DPorras-De%2BFrancisco%26aufirst%3DE.%26aulast%3DMartinez-Hoyos%26aufirst%3DM.%26aulast%3DBurns-Huang%26aufirst%3DK.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DRhee%26aufirst%3DK.%2BY.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26atitle%3DN-Methylation%2520of%2520a%2520Bactericidal%2520Compound%2520as%2520a%2520Resistance%2520Mechanism%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE4523%26epage%3DE4530%26doi%3D10.1073%2Fpnas.1606590113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Pérez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelievre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diacon, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugonnet, J.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros-Aguirre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span> <span> </span><span class="NLM_article-title">Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4997</span>– <span class="NLM_lpage">4999</span>, <span class="refDoi"> DOI: 10.1128/AAC.01063-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1128%2FAAC.01063-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=25987618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KntL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=4997-4999&author=J.+Rullasauthor=N.+Dharauthor=J.+D.+McKinneyauthor=A.+Garc%C3%ADa-P%C3%A9rezauthor=J.+Lelievreauthor=A.+H.+Diaconauthor=J.-E.+Hugonnetauthor=M.+Arthurauthor=I.+Angulo-Barturenauthor=D.+Barros-Aguirreauthor=L.+Ballell&title=Combinations+of+%CE%B2-Lactam+Antibiotics+Currently+in+Clinical+Trials+Are+Efficacious+in+a+DHP-I-Deficient+Mouse+Model+of+Tuberculosis+Infection&doi=10.1128%2FAAC.01063-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Combinations of β-lactam antibiotics currently in clinical trials are efficacious in a DHP-I-deficient mouse model of tuberculosis infection</span></div><div class="casAuthors">Rullas, Joaquin; Dhar, Neeraj; McKinney, John D.; Garcia-Perez, Adolfo; Lelievre, Joel; Diacon, Andreas H.; Hugonnet, Jean-Emmanuel; Arthur, Michel; Angulo-Barturen, Inigo; Barros-Aguirre, David; Ballell, Lluis</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4997-4999</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report here a dehydropeptidase-deficient murine model of tuberculosis (TB) infection that is able to partially uncover the efficacy of marketed broad-spectrum β-lactam antibiotics alone and in combination.  Redns. of up to 2 log CFU in the lungs of TB-infected mice after 8 days of treatment compared to untreated controls were obtained at blood drug concns. and time above the MIC (T>MIC) below clin. achievable levels in humans.  These findings provide evidence supporting the potential of β-lactams as safe and mycobactericidal components of new combination regimens against TB with or without resistance to currently used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVH9ILBVaFDrVg90H21EOLACvtfcHk0ljSl8oLJHnqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KntL7J&md5=6f58fae04c45bbd01c4202899856236f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.01063-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01063-15%26sid%3Dliteratum%253Aachs%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DGarc%25C3%25ADa-P%25C3%25A9rez%26aufirst%3DA.%26aulast%3DLelievre%26aufirst%3DJ.%26aulast%3DDiacon%26aufirst%3DA.%2BH.%26aulast%3DHugonnet%26aufirst%3DJ.-E.%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DBarros-Aguirre%26aufirst%3DD.%26aulast%3DBallell%26aufirst%3DL.%26atitle%3DCombinations%2520of%2520%25CE%25B2-Lactam%2520Antibiotics%2520Currently%2520in%2520Clinical%2520Trials%2520Are%2520Efficacious%2520in%2520a%2520DHP-I-Deficient%2520Mouse%2520Model%2520of%2520Tuberculosis%2520Infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D4997%26epage%3D4999%26doi%3D10.1128%2FAAC.01063-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogacki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span> <span> </span><span class="NLM_article-title">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-Yloxyacetamides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6709</span>– <span class="NLM_lpage">6728</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6709-6728&author=E.+Pittaauthor=M.+K.+Rogackiauthor=O.+Balabonauthor=S.+Hussauthor=F.+Cunninghamauthor=E.+M.+Lopez-Romanauthor=J.+Joossensauthor=K.+Augustynsauthor=L.+Ballellauthor=R.+H.+Batesauthor=P.+Van+der+Veken&title=Searching+for+New+Leads+for+Tuberculosis%3A+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+2-Quinolin-4-Yloxyacetamides&doi=10.1021%2Facs.jmedchem.6b00245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides</span></div><div class="casAuthors">Pitta, Eleni; Rogacki, Maciej K.; Balabon, Olga; Huss, Sophie; Cunningham, Fraser; Lopez-Roman, Eva Maria; Joossens, Jurgen; Augustyns, Koen; Ballell, Lluis; Bates, Robert H.; Van derVeken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6709-6728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, a new series of more than 60 quinoline derivs. has been synthesized and evaluated against Mycobacterium tuberculosis (H37Rv).  Apart from the SAR exploration around the initial hits, the optimization process focused on the improvement of the physicochem. properties, cytotoxicity, and metabolic stability of the series.  The best compds. obtained exhibited MIC values in the low micromolar range, excellent intracellular antimycobacterial activity, and an improved physicochem. profile without cytotoxic effects.  Further investigation revealed that the amide bond was the source for the poor blood stability obsd., while some of the compds. exhibited hERG affinity.  Compd. I, which contains a benzoxazole ring instead of the amide group, was found to be a good alternative, with good blood stability and no hERG affinity, providing new opportunities for the series.  Overall, the obtained results suggest that further optimization of soly. and microsomal stability of the series could provide a strong lead for a new anti-TB drug development program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrjBguBpaWgbVg90H21EOLACvtfcHk0ljSl8oLJHnqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7%252FE&md5=8b4cc0d1c032dde93c91811cdbba557b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00245%26sid%3Dliteratum%253Aachs%26aulast%3DPitta%26aufirst%3DE.%26aulast%3DRogacki%26aufirst%3DM.%2BK.%26aulast%3DBalabon%26aufirst%3DO.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DF.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DSearching%2520for%2520New%2520Leads%2520for%2520Tuberculosis%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25202-Quinolin-4-Yloxyacetamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6709%26epage%3D6728%26doi%3D10.1021%2Facs.jmedchem.6b00245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Gomez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Ruiz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escribano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Villarejo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Plaza, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo-Lopez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuiñan-Blanco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavandera, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo-Benito, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span> <span> </span><span class="NLM_article-title">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1002%2Fcmdc.201200428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=23307663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=313-321&author=L.+Ballellauthor=R.+H.+Batesauthor=R.+J.+Youngauthor=D.+Alvarez-Gomezauthor=E.+Alvarez-Ruizauthor=V.+Barrosoauthor=D.+Blancoauthor=B.+Crespoauthor=J.+Escribanoauthor=R.+Gonz%C3%A1lezauthor=S.+Lozanoauthor=S.+Hussauthor=A.+Santos-Villarejoauthor=J.+J.+Mart%C3%ADn-Plazaauthor=A.+Mendozaauthor=M.+J.+Rebollo-Lopezauthor=M.+Remui%C3%B1an-Blancoauthor=J.+L.+Lavanderaauthor=E.+P%C3%A9rez-Herranauthor=F.+J.+Gamo-Benitoauthor=J.+F.+Garc%C3%ADa-Bustosauthor=D.+Barrosauthor=J.+P.+Castroauthor=N.+Cammack&title=Fueling+Open-Source+Drug+Discovery%3A+177+Small-Molecule+Leads+against+Tuberculosis&doi=10.1002%2Fcmdc.201200428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span></div><div class="casAuthors">Ballell, Lluis; Bates, Robert H.; Young, Rob J.; Alvarez-Gomez, Daniel; Alvarez-Ruiz, Emilio; Barroso, Vanessa; Blanco, Delia; Crespo, Benigno; Escribano, Jaime; Gonzalez, Ruben; Lozano, Sonia; Huss, Sophie; Santos-Villarejo, Angel; Martin-Plaza, Jose Julio; Mendoza, Alfonso; Rebollo-Lopez, Maria Jose; Remuinan-Blanco, Modesto; Lavandera, Jose Luis; Perez-Herran, Esther; Gamo-Benito, Francisco Javier; Garcia-Bustos, Jose Francisco; Barros, David; Castro, Julia P.; Cammack, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With the aim of fuelling open-source, translational, early-stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible.  A set of 177 potent non-cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compds. toward a chem. genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead-generation activities.  Two addnl. drug-discovery-relevant datasets are included: (a) a drug-like property anal. reflecting the latest lead-like guidelines and (b) an early lead-generation package of the most promising hits within the clusters identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJ2sVPWfPALVg90H21EOLACvtfcHk0ljSl8oLJHnqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D&md5=32c975dbe183849358c701ca697681d3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200428%26sid%3Dliteratum%253Aachs%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DAlvarez-Gomez%26aufirst%3DD.%26aulast%3DAlvarez-Ruiz%26aufirst%3DE.%26aulast%3DBarroso%26aufirst%3DV.%26aulast%3DBlanco%26aufirst%3DD.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DEscribano%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DR.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DMart%25C3%25ADn-Plaza%26aufirst%3DJ.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%26aulast%3DRemui%25C3%25B1an-Blanco%26aufirst%3DM.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DP%25C3%25A9rez-Herran%26aufirst%3DE.%26aulast%3DGamo-Benito%26aufirst%3DF.%2BJ.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DJ.%2BP.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DFueling%2520Open-Source%2520Drug%2520Discovery%253A%2520177%2520Small-Molecule%2520Leads%2520against%2520Tuberculosis%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D313%26epage%3D321%26doi%3D10.1002%2Fcmdc.201200428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, C.</span></span> <span> </span><span class="NLM_article-title">Development of a High-Throughput Electrophysiological Assay for the Human Ether-à-Go-Go Related Potassium Channel HERG</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2012.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1016%2Fj.vascn.2012.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=23103595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Kls73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=33-44&author=D.+J.+Gillieauthor=S.+J.+Novickauthor=B.+T.+Donovanauthor=L.+A.+Payneauthor=C.+Townsend&title=Development+of+a+High-Throughput+Electrophysiological+Assay+for+the+Human+Ether-%C3%A0-Go-Go+Related+Potassium+Channel+HERG&doi=10.1016%2Fj.vascn.2012.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high-throughput electrophysiological assay for the human ether-a-go-go related potassium channel hERG</span></div><div class="casAuthors">Gillie, Daniel J.; Novick, Steven J.; Donovan, Brian T.; Payne, Lisa A.; Townsend, Claire</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-44</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Drug-induced prolongation of the QT interval via block of the hERG potassium channel is a major cause of attrition in drug development.  The advent of automated electrophysiol. systems has enabled the detection of hERG block earlier in drug discovery.  In this study, we have evaluated the suitability of a second generation automated patch clamp instrument, the IonWorks Barracuda, for the characterization of hERG biophysics and pharmacol.All expts. were conducted with cells stably expressing hERG.  Recordings were made in perforated patch mode either on a conventional patch clamp setup or on the IonWorks Barracuda.  On the latter, all recordings were population recordings in 384-well patch plates.HERG channels activated with a V1/2 = - 3.2 ± 1.6 mV (n = 178) on the IonWorks Barracuda vs. - 11.2 ± 6.1 mV (n = 9) by manual patch clamp.  On the IonWorks Barracuda, seal resistances and currents were stable (< 30% change) with up to six cumulative drug addns. and 1-min incubations per addn.  Over 27 expts., an av. of 338 concn.-response curves were obtained per expt. (96% of the 352 test wells on each plate).  HERG pharmacol. was examd. with a set of 353 compds. that included well-characterized hERG blockers.  Astemizole, terfenadine and quinidine inhibited hERG currents with IC50 values of 159 nM, 224 nM and 2 μM, resp. (n = 51, 10 and 18).  This set of compds. was also tested on the PatchXpress automated electrophysiol. system.  We detd. through statistical methods that the two automated systems provided equiv. results.Evaluating drug effects on hERG channels is best performed by electrophysiol. methods.  HERG activation and pharmacol. on the IonWorks Barracuda automated electrophysiol. platform were in good agreement with published electrophysiol. results.  Therefore, the IonWorks Barracuda provides an efficient way to study hERG biophysics and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbgRW5sTJiDLVg90H21EOLACvtfcHk0lgqP-LPPIRjWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Kls73J&md5=1a94eeb8d044313b1f7b08c41a61cd4a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2012.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2012.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DGillie%26aufirst%3DD.%2BJ.%26aulast%3DNovick%26aufirst%3DS.%2BJ.%26aulast%3DDonovan%26aufirst%3DB.%2BT.%26aulast%3DPayne%26aufirst%3DL.%2BA.%26aulast%3DTownsend%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520a%2520High-Throughput%2520Electrophysiological%2520Assay%2520for%2520the%2520Human%2520Ether-%25C3%25A0-Go-Go%2520Related%2520Potassium%2520Channel%2520HERG%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2013%26volume%3D67%26spage%3D33%26epage%3D44%26doi%3D10.1016%2Fj.vascn.2012.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remuiñán, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullás, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemparte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Hoyos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esquivias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Muro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraile-Gabaldón, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spivey, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loman, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantinidou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minick, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo-López, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span> <span> </span><span class="NLM_article-title">Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium Tuberculosis Targeting MmpL3</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e60933</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0060933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=10.1371%2Fjournal.pone.0060933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=23613759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFartro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=M.+J.+Remui%C3%B1%C3%A1nauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=J.+Rull%C3%A1sauthor=C.+Alemparteauthor=M.+Mart%C3%ADnez-Hoyosauthor=D.+J.+Dowauthor=J.+Afariauthor=N.+Mehtaauthor=J.+Esquiviasauthor=E.+Jim%C3%A9nezauthor=F.+Ortega-Muroauthor=M.+T.+Fraile-Gabald%C3%B3nauthor=V.+L.+Spiveyauthor=N.+J.+Lomanauthor=M.+J.+Pallenauthor=C.+Constantinidouauthor=D.+J.+Minickauthor=M.+Cachoauthor=M.+J.+Rebollo-L%C3%B3pezauthor=C.+Gonz%C3%A1lezauthor=V.+Sousaauthor=I.+Angulo-Barturenauthor=A.+Mendoza-Losanaauthor=D.+Barrosauthor=G.+S.+Besraauthor=L.+Ballellauthor=N.+Cammack&title=Tetrahydropyrazolo%5B1%2C5-a%5DPyrimidine-3-Carboxamide+and+N-Benzyl-6%E2%80%B2%2C7%E2%80%B2-Dihydrospiro%5BPiperidine-4%2C4%E2%80%B2-Thieno%5B3%2C2-c%5DPyran%5D+Analogues+with+Bactericidal+Efficacy+against+Mycobacterium+Tuberculosis+Targeting+MmpL3&doi=10.1371%2Fjournal.pone.0060933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3</span></div><div class="casAuthors">Remuinan, Modesto J.; Perez-Herran, Esther; Rullas, Joaquin; Alemparte, Carlos; Martinez-Hoyos, Maria; Dow, David J.; Afari, Johnson; Mehta, Nalini; Esquivias, Jorge; Jimenez, Elena; Ortega-Muro, Fatima; Fraile-Gabaldon, Maria Teresa; Spivey, Vickey L.; Loman, Nicholas J.; Pallen, Mark J.; Constantinidou, Chrystala; Minick, Douglas J.; Cacho, Monica; Rebollo-Lopez, Maria Jose; Gonzalez, Carolina; Sousa, Veronica; Angulo-Barturen, Inigo; Mendoza-Losana, Alfonso; Barros, David; Besra, Gurdyal S.; Ballell, Lluis; Cammack, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e60933</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB).  Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB.  As part of the authors' efforts towards the discovery of new anti-tubercular leads, a no. of potent tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (THPP) and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] (Spiro) analogs were recently identified against Mycobacterium tuberculosis and Mycobacterium bovis BCG through a high-throughput whole-cell screening campaign.  Herein, the authors describe the attractive in vitro and in vivo anti-tubercular profiles of both lead series.  The generation of M. tuberculosis spontaneous mutants and subsequent whole genome sequencing of several resistant mutants identified single mutations in the essential mmpL3 gene.  This genetic phenotype was further confirmed by a chem. phenotype, whereby M. bovis BCG treated with both the THPP and Spiro series resulted in the accumulation of trehalose monomycolate.  In vivo efficacy evaluation of two optimized THPP and Spiro leads showed how the compds. were able to reduce >2 logs bacterial cfu counts in the lungs of infected mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCGBbs5TLQArVg90H21EOLACvtfcHk0lircmjS59zEuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFartro%253D&md5=22123e5b0f762bcd2467bae122c372ca</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0060933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0060933%26sid%3Dliteratum%253Aachs%26aulast%3DRemui%25C3%25B1%25C3%25A1n%26aufirst%3DM.%2BJ.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DRull%25C3%25A1s%26aufirst%3DJ.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DMart%25C3%25ADnez-Hoyos%26aufirst%3DM.%26aulast%3DDow%26aufirst%3DD.%2BJ.%26aulast%3DAfari%26aufirst%3DJ.%26aulast%3DMehta%26aufirst%3DN.%26aulast%3DEsquivias%26aufirst%3DJ.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DE.%26aulast%3DOrtega-Muro%26aufirst%3DF.%26aulast%3DFraile-Gabald%25C3%25B3n%26aufirst%3DM.%2BT.%26aulast%3DSpivey%26aufirst%3DV.%2BL.%26aulast%3DLoman%26aufirst%3DN.%2BJ.%26aulast%3DPallen%26aufirst%3DM.%2BJ.%26aulast%3DConstantinidou%26aufirst%3DC.%26aulast%3DMinick%26aufirst%3DD.%2BJ.%26aulast%3DCacho%26aufirst%3DM.%26aulast%3DRebollo-L%25C3%25B3pez%26aufirst%3DM.%2BJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DC.%26aulast%3DSousa%26aufirst%3DV.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DTetrahydropyrazolo%255B1%252C5-a%255DPyrimidine-3-Carboxamide%2520and%2520N-Benzyl-6%25E2%2580%25B2%252C7%25E2%2580%25B2-Dihydrospiro%255BPiperidine-4%252C4%25E2%2580%25B2-Thieno%255B3%252C2-c%255DPyran%255D%2520Analogues%2520with%2520Bactericidal%2520Efficacy%2520against%2520Mycobacterium%2520Tuberculosis%2520Targeting%2520MmpL3%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0060933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i114"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00107">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_05704"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00107?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00107</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional experimental information for intermediate compounds (synthetic protocols and analytical details); references for synthetic procedures; LC-MS chromatograms for key compounds <b>30</b> (racemic mixture), <b>30R</b> (<i>R</i>-enantiomer), <b>30S</b> (<i>S</i>-enantiomer), <b>31</b>, <b>45</b>, <b>46</b>, <b>47</b>, <b>48</b>, <b>51</b>, <b>52</b>, <b>55</b>, <b>61</b>, <b>65</b>, <b>67</b>, <b>68</b>, <b>69</b>, and <b>82</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all reported final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_001.pdf">jm0c00107_si_001.pdf (1.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00107/suppl_file/jm0c00107_si_002.csv">jm0c00107_si_002.csv (9.4 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00107&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00107%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00107" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679954a5eae63c28","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
